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Abstract 
This thesis consists of three relative independent projects all of which 
concentrate on the syntheses of biologically active natural products. 
In the first project, a convenient route for synthesis of [8- 3H]-berberine sulfate 
has been established and two routes for preparation of 14C labelled 
berberine are explored. A series of compounds containing a 
methylenedioxyphenyl functionality have been synthesised for using as 
antigens in immunogical studies. 
The second project concerns development of chemistry directed towards the 
stereocontrolled synthesis of Baogongteng A, a novel 2,6-disubstituted 
tropane alkaloid which is a powerful M-cholinergic agonist used in the 
treatment of glaucoma. By exploiting 4-hydroxy-L-proline as the chiral 
synthon, useful methods such as preparation of 2-formyl 4-hydroxy-L-proline 
derivatives, and the stereoselective bromination of the C-3 of 4-hydroxy-L-
proline derivatives, have been established. About forty new organic 
compounds have been synthesied and identified. 
The final project concerns exploration of new routes for the syntheses of 
biotin biosynthetic precursors and their fluorined analogues which are types 
of compounds potentially valuable in agricultural chemistry. This work has 
led to the development of methods of wide application, such as the 
preparation of highly purified N-Boc-L-alaninal, which should prove to be of 
use in future studies in this and related fields. 
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Chapter 1. Introduction and Scope 
The synthesis of natural products has been a major part of organic chemistry 
since its inception with synthesis of urea in 1828. In combination with other 
fields, such as biology, medicine and agriculture, the synthesis of natural 
products has proven to be a powerful scientific tool which promotes greatly 
the developments of other research areas. The accumulation of knowledge 
and technique on synthetic designs, organic reactions, structural-mechanistic 
theories, selective reagents and spectral methodology has greatly stimulated 
the development of this field and synthetic studies on natural products 
remains a dynamic area --- Many new principles, strategies and methods are 
still waiting to be discovered. The synthesis of complex natural products with 
interesting structures or bioactivities therefore poses a continuing challenge 
for chemists. 
The synthesis of radiolabelled natural products is an important aspect in the 
natural products synthesis area. By exploiting radiolabelled and stable 
isotope enriched materials as probes, sensitive, general, and powerful 
methodologies can be established, which have led to materials used in 
various fields such as biosynthetic and metabolic studies of natural products 
in plants, animals and human beings. Probes of this nature are of particular 
importance in pharmacology and toxicology. It is noteworthy that synthesis of 
labelled compounds demands specialist techniques and frequently the 
development of new routes for the generation of natural product types. 
Chapter one in this thesis focuses on the synthesis of radiolabelled 
berberine, a natural toxicant alkaloid presented in many plants, and of other 
compounds containing a methylenedioxybenzyl group to provide useful 
probes and antigens to establish radioimmunological assays for the 
investigation of plant product metabolism in mammals. 
A lot of natural products have been shown to be powerful drugs for treatment 
of diseases, but the difficulties of obtaining these materials from natural 
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sources can be complicated by either their presence in minute amounts or 
the difficulties involved in their purification which restrict further studies and 
application of these compounds. Thus the synthesis of rare, physiologically 
active, materials is another important aspect in synthetic studies on natural 
products. An additional value of synthetic work in this area is that during the 
synthetic work, intermediates and analogues can be generated and both 
can be potentially useful in the improvement of our knowledge of the 
structure-activity relationship of the drugs. 
Chapter three in this thesis describes approaches to the synthesis of 
baogongteng A, a tropane alkaloid with powerful M-cholinergic agonist 
activity which is used to treat glaucoma. Although the target product was not 
synthesised in the study, the strategies explored and the intermediates 
synthesised in this project are potentially useful for future work in this area. 
The synthesis of the biosynthetic precursors and analogues of important 
bioactive substances such as vitamins, coenzymes and pheromones, to 
provide inhibitors of possible use in agriculture and other fields, is also an 
important aspect of natural product synthesis. In this area, as in medicinal 
chemistry, the synthesis of fluorinated analogues is of especial importance 
as fluorine-containing analogues have frequently proven to be valuable 
inhibitors of enzyme action. 
The final project in this thesis describes developments of a biogenetic route 
to precursors of biotin.biosynthesis, and fluorinated analogues which may be 
potentially useful as biocides in agrochemical applications. 
2 
Chapter 2. The Synthesis of Labelled Berberine 
and of Methylenedioxyphenyl Antigens for 
Immunological Studies of Plant Natural Product 
Metabolism 
2.1. Introduction 
The human diet consists of a large variety of materials from many different 
natural sources. Apart from the carbohydrates, proteins and lipids and 
vitamins and the other micronutrients necessary to support life most human 
diets also contain a wide range of non-essential compounds foreign to 
mammalian metabolism. For example most plants produce secondary 
metabolites such as alkaloids and terpenes which have no function in 
animals. Some of these compounds can be regarded as normal dietary 
constituents which enhance food acceptability --- such as flavouring 
materials and plant colourants, while others have no useful role. Although it 
is generally accepted that small quantities of such compounds in a normal 
diet have no detrimental effect, more and more evidence has shown that 
some of these compounds in fact are harmful to human health. The 
harmfulness of these materials for human health will depend in part on the 
amounts consumed in the diet. Some substances may be relatively weak 
toxins, but if present in staple foods the potential poisoning to people is high. 
One classical example is solanidine (2-1 in Fig.2-1) in potatoes, it may 
induce serious poisoning if relative large amounts are ingested from unripe 
'green potatoes'. Other types of secondary metabolite which are potentially 
harmful are those present in foods or ' foodlike' plants that form a minor part 
of the diet. Some of these substances are acutely as well as chronically toxic 
and potentially very harmful to human health. One example is the alkaloid 
berberine (2-2 in Fig. 2-1), a constituent of numerous plants of some which 
are ingested as herbal remedies. This alkaloid is particularly toxic having an 
LD50 in mice of 24.3 mg/kg. Indeed herbal extracts which contain berberine 
are rated by the Ministry of Agriculture, Fisheries and Food (MAFF) as the 
second highest natural toxicant risk in the UK. Another example is safrole (2- 
3 
3 in Fig. 2-1), a constituent of many essential oils, which is a cancer suspect 
agent although its LD50 is 1950 mg/kg in rats when administered orally. 
Safrole lies in 4th place on the MAFF list of toxic compounds in the UK diet. 
There is increasing concern that ingestion of large amounts of 'health foods' 
containing these types of compound may lead to serious side effects, 
therefore obtaining information on the accumulation and/or excretion of 
potential toxins and whether these are metabolised to other harmful 
compounds will be very important to the etiology of human disease and may 














2-3 	 2-4 
Fig. 2-1 
As the first step in investigating this problem, berberine and safrole were 
chosen as subjects of a trial by the U.K. Ministry of Agriculture Food and 
Fisheries in 1992. A key part of this study was to investigate the fate of 
berberine administered in diet with respect to its accumulation in various 
organs and its conversion to other products both by whole organisms and by 
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model systems such as liver microsomes. One feature of these two 
molecules is the presence of the methylenedioxy bridge functionality which is 
common to many plant alkaloids but is not found in normal mammalian 
metabolites (2-4 in Fig. 2-1). Antibodies to this epitope would be useful in 
quantifying the amounts of alkaloids (such as berberine or its degradation 
products) accumulated in organs or body fluids. 
The aims of the first, chemical part, of this study were to prepare radioactive 
berberine for metabolism studies and to construct suitable antigenic 
molecules for linkage to proteins so that antibodies specific for these types of 
molecules could be raised for immunological assays. 
2.1.1. Synthesis of Radiolabelled Berberine 
Since a major aim in the overall study was to examine the products formed 
from berberine in mammalian liver, there was therefore a need to develop a 
synthesis of radiolabelled berberine which could be used for biological 
studies. Although many routes have been developed for the synthesis of 
berberine alkaloids 1 , only a few routes could be considered in this work due 
to the limitation of having to prepare a radiolabelled product. 
A). Total synthesis: 
This is a reliable method and a possible approach is outlined in Scheme 2-1. 
However, development of a total synthesis route was considered to be too 

















B). Substitution of one of the methyl groups or of the carbon of the 
methylenedioxy bridge: 
This method is conceptually very simple but it was necessary to devise 
selective reactions for removal and replacement of the different 
functionalities. Two different approaches are shown in Scheme 2-2. Both of 
these methods were evaluated in the work described in this thesis. 
Q. Tritium labelling of the aromatic rings: 
Although this approach is experimentally straightforward it was discounted 
on the basis of the difficulties involved in evaluating the degree of tritiation at 
each position in the labelled alkaloid. Furthermore the exchange of tritium at 
aryl positions is reversible and it could be envisaged that exchange during 
6 
metabolic studies might result in misleading results. So this approach could 
not be usefully employed in this case. 
3 4 	5 	
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= 12c or 14C 
Scheme 2-2 
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D). Introduction of tritium at C-8 by reduction and oxidation: 
This is a simple, direct and economical strategy from which specifically 
tritium labelled berberine derivative could be obtained. The preparation of [8-


































X = H, 2H or 3H 
Scheme 2-3 
2.1.2. Synthesis of 1-substituted derivatives of 6.7-methylenedioxy-1 .2.3.4- 
tetrahyd roisoguinoline and 2-(3.4-methylened ioxy phenyl)ethyl mercaptan 
The second component in this investigation was to develop a general radio 
immunoassay method for compounds possessing an aryl methylenedioxy 
8 
functionality 2-4. The rationale behind this was that since the methylenedioxy 
group is foreign to mammalian metabolism, these would be valuable tools in 
evaluating the accumulation of plant products such as berberine and safrole 
in mammalian tissue. This would enable development of a general assay of 
metabolites of berberine and safrole (and other plant compounds). To do this 
we required to synthesise two different types of compounds both of which 
contained the methylenedioxyphenyl functionality. The first of these was 
based on the A, B ring structure of berberine --- but had to have a suitable 
functionality to enable it to be covalently bonded to a carrier protein. Our 
original plan for the 7,8-methylenedioxytetrahyd roisoq uinoline derivatives 
was to synthesise the thiol 2-16 which would allow the immunologists to 
effect preparation of a bovine serum albumin (BSA) conjugate by disulfide 
bonding. However we wished to retain the flexibility of other methods of 
protein-antigen complex formation either through the carboxylic acid 2-14 or 
a linker extended amine such as 2-17. This strategy is shown on the Scheme 
2-4. For compounds related to the 3,4-methylenedioxy phenyl nucleus of 
safrole the approach is conceptionally much easier. Here we decided to 
prepare the compound 2-19. Although many routes may be available for 
synthesis of these compounds 2 , only two direct strategies shown in Scheme 
2-4 and Scheme 2-5 were developed in this work. The construction and 
characterisation of these products is outlined in the following section. 
O 
2-14: R = COOH; 2-15: R = CH 20H 
	
2-19 
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2-26: R=Me 	2R  
2-27: R = -C6H4Me 
$ 
< 	 We 
IIDY_ 
2-16 
Reagents: a. LiAIH4/AICI3IEt2O; b. CICOCOOEtIPy/CHCI3; c. POCI3/P205/CeIite/CH3CN; 
d. CH3I/CH3COCH3; e. LiAIH4JEt2O; HCl/MeOH; f. TsCl/Py or MsCl/Py; 
g. NaBH4/MeOH; h. HCl/H20; i. (CH2NH2)2/DCC or (CH2NH2)2/EEDQ; 
j. (CH2NH2)2M; k. (CH2NH2)2/AI(CH3)3/CH2Cl2. 


















Reagents: a. LIAIH4/Et20; b. TsC1/Py; c. KSAC/CH3COCH3; d. KOH/MeOH; e. HCl/H20. 
Scheme 2-5: Route to 2-(3,4-methylenedioxyphenyl)-1-thioethane 2-19 
2.2. Results and discussion 
2.2.1. Radiolabelled berberine 
2.2.1.1. Approaches to the synthesis of 14C labelled berberine 
Strategy 1. Labelling of the methylenedioxy bridge carbon 
The first target we considered was making 
14  C labelled berbenne labelled at 
the C-2 (methylenedioxy bridge) position (Scheme 2-2). The key step in this 
route was selectively removing the methylene group. Although the chemical 
characteristics of the methylenedioxy fuctionality and methoxy groups in the 
berberine molecule are almost the same, it is possible to remove one 
selectively. Several methods have previously been used to selectively cleave 
methylenedioxy groups in similar compounds 3; BBr3 and BCI3 have 
11 
previously been found to have some selectivity for cleaving methylenedioxy 
groups in compounds which also contain methoxy groups 4. However when 
berberine chloride 2-5 was reacted with BBr3, both the methienedioxy and 
methyl groups were cleaved. Conversely when 2-5 was reacted with BCI3 at 
room temperature, the expected demethylene product 2-6 was formed in a 
73.7% yield. The NMR spectrum of 2-6 showed that the -OCH20- was lost 
but that the two OCH3 groups were retained in the product (8 4.24, 3H, 5; 
4.30, 3H, s). Satisfactory elemental analysis and MS data were obtained. 
When 2-6 was acetylated with Ac20 in pyridine the diacetate 2-7 was 
obtained in 75% yield. The IH-NMR of 2-7 showed two 3H singlets at ö 2.30 
and 2.40 confirming the structure of the product. 
The second step was to put the methylene group back. Several methods 
have been developed by other workers to methylenylate vicinal 
dihydroxybenzene derivatives 5. However, the target product was not 
obtained by using literature methods such as CH2Br2/NaOH/Adogen-464 6 
and CH2Cl2/DMF/KF7 perhaps due to problems associated with the 
quaternary nitrogen of demethylene berberine. However, the expected 
product 2-5 was finally synthesised in a 40.4% yield by reaction of 2-6 and 
CH2Br2/NaH/DMF. The NMR of this compound showed it contained a - 
OCH20- (8 6.08 2H, s), and two OCH3 groups (ö 3.94 3H, s and 3.98 3H, s). 
The MS showed the expected molecular ion at m/z 336. The identity of the 
synthesised berberine chloride was further confirmed by comparing it (mixed 
m.p., tIc.) with an authentic sample of berberine chloride. Although this route 
could be further developed by refining the conditions to obtain a higher yield, 
it had to be abandoned because during the course of the work, the 14CH 2 Br2 
reagent which we required for the synthesis became no longer commercially 
available. 
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Strategy 2. Labelling of the methoxy groups 
Another route for synthesis of 14C  labelled berberine was to introduce a 
methyl group using 14C  methylation reagents (Scheme 2-2). To explore this 
route, 2-5 was reduced by NaBH4 to give a 89% yield of tetra hyd roberbe ri ne 
(2-11, Scheme 2-3). However when 2-11 was reacted with (CH3)3Sil to 
remove the methyl group 8 , no demethylation was achieved. A monodemethyl 
compound could however be obtained in 32% yield by reaction of 2-11 and 
[(C6H5CH2Se)2/NaBH4] 9 . 
Table 2-1: 13C  NMR data of tetrahydroberberine 2-11 and nandinine 2-8 
* 
Carbon Tetrahydroberberine 
This work 	Ref.' ° 
Nandinine 
This work 	Ref.' ° 
2 100.6 100.3 100.6 100.8 
3a 146.0 145.7 146.0 146.2 
4 108.2 107.5 108.3 108.5 
4a 127.6 127.3 127.7 128.0 
5 29.4 29.3 29.4 29.7 
6 51.2 .51.1 51.2 51.4 
8 53.8 53.8 53.3 53.5 
8a 127.5 127.3 121.1 121.4 
9 150.1 149.8 141.4 141.7 
10 144.8 144.7 143.9 144.2 
11 110.8 110.7 108.8 109.1 
12 123.7 123.4 119.1 119.4 
12a 128.5 128.2 127.8 128.1 
13 36.3 36.1 36.3 36.5 
13a 59.2 59.3 59.4 59.7 
13b 130.7 130.4 130.8 131.1 
14 105.4 105.1 105.4 105.7 
14a 145.6 145.4 145.7 146.1 
9-OCH3 60.0 59.8  
10-OCH3 55.7 55.5 56.0 56.2 
* Shifts are in ppm relative to TMS 
By comparing the 
13 
 C NMR data of the product 2-11 and literature values
10 
13 
(Table 2-1), the product was identified as nandinine 2-8, i.e. the methyl group 
removed during above reaction was that at C-9 rather than C-10. Since 
nandinine 2-8 should be easily converted back to tetra hyd robe rberi ne (and 
hence berberine by the route shown in Scheme 2-2), this route to [9-methy4 
14C] berberine can be considered valid. However a route to tritiated berberine 
(discussed below) had been devised in the meantime and as a result no 
further work on the 14C labelling route was carried out. 
2.2.1.2. Synthesis of 3H labelled berberine 
An alternative approach to radiolabelled berberine is to tritiate the C ring at 
position 8 (Scheme 2-3) and preliminary experiments had shown that it was 
possible to reduce berberine chloride 2-5 to tetra hyd robe rberi ne 2-11 with 
NaBH4. Additionally we were able to show that 2-I1 could be reoxidised with 
12/KOAc to give berberine iodide 2-12 in 75% yield. The iodide was 
converted to berberine sulfate 2-13 in 88% yield by treatment with A92SO4. 
Since the C-3H bond is significantly stronger than the C- 1 H bond, 
dehydrogenation of [8,13a- 3H21-2-11 should afford a berberine salt 
significantly enriched with 3H at position 8. Trial reactions with NaB 2H4 
afforded [8,13a-2H21-2-11 (2-11d), MS of which showed a (M + 1) ion at m/z 
342 (cf 340 for unlabelled material). Oxidation and anion exchange gave 
monodeuterated berberine sulfate 2-13d in 75.4% yield overall. 1 H NMR of 
compound 2-13d shown ca 80% monodeuteration at C-8. When the reaction 
sequence was carried out with NaB 3 H4 [0.925 GBq, 18.5 GBq/mmol] 
radiolabelled berberine, crystallised as its sulfate 2-131t, was obtained. The 
specific activity of the radiolabelled berberine sulfate was determined by 
recrystallisation to constant activity (20.5% radiochemical yield, 1.72 
GBq/mmol). 
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2.2.2. Synthesis of compounds containing methylenedioxy antigen moieties 
2.2.2.1. 7.8-Methylenedioxytetrahydroisoquinolifle derivatives 
To prepare compound of this type (shown in Fig. 2-2), 3,4-methylenedioxy 
phenylacetonitrile 2-20 was used as starting material via a modification of 
literature route 11 shown in Scheme 2-5. Thus 2-20 was reduced with 
LiAIH4/AICI3 to give 2-21, which was then acylated with CICOCOEt to afford 
2-22 in 77.4% overall yield. Several methods such • as PCI5/CHCI3 12 , 
PPC/C6H613 , POCI3/C6H6 14 and POCI3/CH3CN 15 were tried in an attempt to 
cyclise 2-22 to 2-23, but poor yields were obtained in all cases. Cyclisation to 
2-23 was achieved finally in 61% yield by treatment of 2-22 with a 
heterogeneous POCI3/P205/Celite system in CH3CN. The product formed 
from 2-23 by reduction with NaBH4 or NaH3BCN 16 was quite unstable, so 2-
23 was first methylated with Mel to give the N-methylated quaternary salt 2-
24. This was then reduced with LiAIH4 to afford 2-15 in 65.6% overall yield 
from 2-23. Attempts to tosylate or mesylate the primary alcohol 2-15 with 
toluene sulfonyl chloride and methyl sulfonyl chloride failed however, a result 
similar to that obtained by other investigators 17 . It is difficult to explain the 
unreactiveness of the primary alcohol in this tetrahydroisoquinoline system. 
However compound 2-24 could be converted to 2-25 in 92% yield by 
borohydride reduction and 2-25 was easily hydrolysed with aqueous HCI to 
the acid 2-14 in 90% yield. While it had been originally thought that coupling 
of the acid 2-14 to a linker diamine could be easily accomplished , attempts 
to synthesise compound 2-17 from 2-14 using typical amide formation 
methods such as DCC/(CH2NH2)2 18 and EEDQ/(CH2NH2)2 19 were 
unsuccessful. Synthesis of compound 2-17 was finally achieved in 48.5% 
yield by aminolysis of the ester 2-25 with Al(CH3)3/(CH2NH2)2/CH2Cl2. 
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Aminolysis of 2-25 with (CH2NH2)2/A in the absence of Al(CH3)3 also gave 
compound 2-17, but the yield was very much lower under these conditions. 
All of the compounds described above gave satisfactory data which are 
summarised in Table 2-2. 
Table 2-2: Experimental data for 7,8-methylenedioxy tetrahydroisoquinoline 
derivatives* 
compd. Vm m/z Microanalysis M.P. °C Yield 
No. cm  [b.p.°C] % 
2-21 3370, 166 (M + 1), 149 [102-4/0.2 86.5 
3286 (M - NH2), 136 mbar] 
(NH2) IN  +1)-CH2NH2f. 221.HC1a 
208-2 10  
2-22 3381 226(M-1),192 C, 58.77; H, 5.67; N, 5.13; 135-6.5 90 
(NH) (M - COOEt), 149 C 13H 15N05 req.: 
1705 (M-NHCOOEt) C, 58.86; H, 5.70; N, 5.28%. 
(C=O)  
2-23 1724 248(M+1),174 C, 63.35; H, 5.35; N, 5.56; 78.0-9 61 
(C=O) (M - COOEt) C 13H13N04 req.: 
1585 C, 63.15; H, 5.30; N, 5.66% 
(C=N)  
2-24 1742 262 (cation), 188 C, 43.38; H, 4.20; N, 3.56; 139.5-40.5 82 
(C=O) (M - COOEt) C 14H16N041 req.: 
1651 C, 43.21; H, 4.14; N, 3.60%. 
(C=N)  
2-25 1727 264.12358 [(M+1), oil 93.5 
(C=O) C 14H18N04 MH req: 1-25.HCI 
264.12357],234 (M 162-4 
- Et), 190(M- 
CO2Et).  
2-14 3408 234 (M -1), C, 52.96; H, 5.22; N, 4.92; 196-8 90 
(OH) 220 (M - CH3) C 12H 14NO4C1 req.: 
1738 C, 53.05; H, 5.19;N, 5.16%. 
(C=O)  
2-15 3225 222 (cation), 206 C, 54.80; H, 6.33; N, 5.21; 226-8 76 
(OH) (M - CH3), 190 (M C 12H 16NO3 Cl.1/2H2O req.: 
- CH2OH) C, 54.04; H, 6.42; N, 5.25%  
2-17 3453, 278.15047 [(M+1), 50.5-1.5 48.5 
3306 C 14H20N302 MH 
(NFl2) req.: 278.15046J, 
1663 234 [(M+1)-C 2H4 
(C=O) -NH2],190 (M - 
CONHC2H4NH2) 
a). lit. 142 , m.p. 210-211°C 
1 H NMR data are given in the experimental section. 
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The compounds 2-14 and 2-17 have been send to the MAFF laboratories at 
Norwich for coupling to BSA, but no immunochemical results are available at 
the time of writing. It should be noted that compounds 2-14, 2-15, 2-17 and 
2-25 are racemic. For the purposes of this project it was not necessary to 
separate the enantiomers since our collaborators wished to select antibodies 
to the disubstituted methylenedioxy moiety of these compounds and the 
chirality at C-i was immaterial. Nevertheless, the potential exists for 
development of stereoselective synthesis of 1-substituted methylenedioxy 
isoquinolines by this route since the quaternary imine 2-24 is easily reduced 
and it is reasonable that a chiral reducing agent could be used at this step. 
Compound 2-23 is potentially a versatile useful intermediate for preparation 
of 1-, 2- or 1,2-substituted and other tetrahydroisoquinoline derivatives 
because its imine functionality should react easily with many types of 
reagents. Some possible types of compounds which might be synthesised 
from 2-23 are shown in Scheme 2-7. 
2.2.2.2. 2-( 3. 4-Methylenedioxyphenyl )-1-thioethane 
This compound was synthesised via the route shown in Scheme 2-5. The 
acid 2-28 was reduced with LiAIH4 in Et20 to give a 95% yield of 2-29. 
Tosylation of 2-29 afforded only a 50% yield of 2-30, but the unreacted 2-29 
could be recovered from the reaction mixture which raises the effective yield 
to 82%. The tosylate 2-30 was converted to the corresponding thioacetate 2-
31 by treatment with KSAc and the thioester was hydrolysed by successive 
treatment with base (KOH/MeOH) and (aq. HCI) to afford the thiol 2-19 as an 
oil in an overall yield of 47.5% from 2-30. Spectroscopic data on these 
compounds is shown in Table 2-3. It is noteworthy that ca 6% of the disulfide 
2-32 was isolated from alkali hydrolysis of 2-31. Compound 2-32 is a 
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crystalline compound (m.p. 78 - 78.5°C) and as such might prove a better 
form of storing the thiol. 
Compound 2-19 should prove useful for disulfide linkage to proteins such as 
BSA or keyhole limpit haemogluttinin (KCH) for raising antibodies to the 
methylenedioxyphenyl group. Samples have been tested by our 
collaborators at MAFF, Norwich but no results are available at the time of 
writing. 
Table 2-3: Experimental data of 2-( 3,4-Methylenedioxyphenyl )-1- 
thioethane and its d erivatives* 
Compd Vma, cm' m/z 	[Microanalysis] m.p.[b.p.] °C Yield% 
2-29 3356 (OH) 166 (M), 149 (M - OH), oil 95 
135 (M - CH20H) 
2-30 320 (M), 165 (M - Ts), 149 55-55.5 50 
(M - TsO-), 135 (M - TsOCH2-) 
[C, 60.62; H, 4.98; C 16H 1605 S 
requires: C, 59.99; H, 5.03%]  
2-31 1689 (C=O) 224.05074 (M t , C 11 H12O3 S M [240/ 66.9 
requires: 224.05071), 181(M - Ac) 0.3 mbar] 
149 (M - AcS), 135(M-AcSCH 2) 
2-32 362 (M), 226 (M - C8H702), 78.0-78.5 - 
181, 149, 135; [C, 58.33; H, 4.89; 
C 18H1804S2 . 1/2H2O requires: 
C, 58.20; H, 5.16%]  
2-19  182.04014(M, C9H 1002S M oil 71 
requires: 182.04015), 181 (M - 1), 
149 (M_-_SH),135_(M_-CH2SH)t  
. For 1 H NMR data see the experimental section. 
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Chapter 3. Approaches to the Synthesis of 
Baogongteng A 
A 2,6-Disubstituted Tropane Alkaloid 
3.1 Introduction 
3.1.1 Baogongteng A (BGTA) 
Baogongteng A (BGTA, 3-1) is an unusual 2,6-disubstituted natural tropane 
alkaloid. It was isolated by Yao and Chen from Erycibe Obtusifolia in 197120 
and Lu and Wang subsequently isolated this compound from E. Elliptilimba 
and E. Hainannesis21 ' 22 BGTA is a powerful M-cholinergic agonist in both 
central and peripheral nervous systems 23 ' 24 and it has been used to replace 
pilocarpine, a typical myotic medicine in clinical practice, for treatment of 
glaucoma25 ' 26 . BGTA is recognized as a better ophthalmic medicine than 
pilocarpine because its myotic effect is ninety times greater 27 ' 28 . Another 
important use of BGTA is as a pharmacological reagent in the inducement of 
a pathological model of Parkinson's disease. 
BGTA was identified as 63-acetoxy-23-hydroxyl nortropane on the basis of 
chemical degradation and NMR decoupling studies 30 ' 31 and its absolute 
configuration was determined as (2S,6S)-6f-acetoxy-2f-hyd roxylnortropane 
(3-1, Fig. 3-1) using a combination of the exciton chirality method, Pr(dpm)3 
induced CD split Cotton effects and by the kinetic resolution approach 32 . The 
first synthetic work was done by Xiang and his co-workers who synthesised 
racemic BGTA using 63-acetoxytropanone (3-7) as the starting material 33 . 
This synthesis was, however, accomplished in a very low yield (Scheme 3-
1). Jung has also synthesised racemic BGTA using the 1,3-dipolar 
cycloaddition of acrylonitrile to N-benzyl-3-hydroxypyridinium bromide (3-8) 
as the key step (Scheme 3-2). A similar route has also been used by other 
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Fig. 3-1 
The further investigation of the biological effects of this compound and its 
application in medicine are seriously restricted by supply --- not only is its 
content in plants less than 10 ppm but it is also unstable 20 ' 27 . Even though 
BGTA has a tropane nucleus, it is a cholinergic agonist, and its biologically 
activity contrasts markedly with those of the major tropane alkaloids such as 
atropine (3-2), anisodamine (3-3 ), anisodine (3-4), scopolamine (3-5) and 
atropamine (3-6) (Fig. 3-1) which are cholinergic inhibitors. Racemic BGTA 
has a myotic activity of half that the natural product 38 . All of this evidence 
implies that the biologically activities of BGTA have a strict enantiomer 
dependence and that the relationship between the cholinergic receptor and 
2,6-disubstituted tropane is different from that of other tropane alkaloids. So, 
developing an efficient and versatile route for the synthesis of optically active 
BGTA and its analogues should be very valuable for exploring the structure-
activity relationship of the compound with its receptor and developing BGTA 
like compounds as useful ophthalmic agents. 
21 
MeN  M&J 	OH 	Md'.J 
AcO 	











reagents: a, Br2; b, A9CO3/H0; c, (CH2SH )2;  d, Ra-Ni/H2; 
e, Cr03; f, NaBH4; g, CICOOCH2CI3/Zn-AcOH 
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Scheme 3-2 
3.1.2. Using trans-4-hydroxy-L-proline as a chiral synthon 
Trans-4-hydroxy-L-proline (4HP, 3-9) is a nonessential amino acid and a 
main constituent of collagen, and can be obtained from gelatin 
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hydrolyzates39'40 . Since it contains two chiral carbons, 4HP has four 
stereoisomers4 ' (3-9 -- 3-12, Fig. 3-2), of which only 4HP itself (the 2S,4R 
form) is suitable for use as a synthetic starting material because of 
commercial constraints. However other isomers can in principle be obtained 
from the (2S, 4R) form by chemical conversion 39 , 42 . 
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Fig. 3-2 
The chemistry of 4HP has been reviewed and investigated by other 
workers39 ' 43 . Their work has shown that the 4-hydroxy group can be easily 
transformed into other functionalities; for example it can be oxidised to the 
corresponding ketone and substituted by R2N-, RS-, halogen, or 
organometallic reagents. Another position easily reacted is the 2-carboxy 
group; it can be converted to an alcohol, aldehyde or acid chloride, and then 
reacted with nucleophilic reagents to extend the C-2 side chain 45. Groups 
have also been introduced at the C-5 position by anodic oxidation 46, and at 
C-3 position by enamine alkylation 47 . 
(2S, 4R) 4HP has been used successfully as a starting material for the 
synthesis of biologically active compounds, natural products, optically active 
polymers and other interesting compounds. For example, N-protected 5-aza-
2-oxa-3-oxo-bicyclo-(2,2,1) heptanes (3-13) derived from 4HP have been 
used as conformationally rigid models 48 and optically active phosphino- 
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pyrrolidine-rhodium catalysts (3-14) have been used for asymmetric 
hydrogenation 49 . (-)-Detoxinine (3-15), a subunit amino acid of detoxin, a 
compound which has potent antagonistic activity to the cytotoxicity of 
blasticidins45b ,  has been synthesied from 4HP; as have 2,5-diazabicyclo-
(2,2,1)-heptanes (3-16, 3-17), which are precursors of the antibacterial 
quinolone carboxylic acids 50 and of kainoid analogues (3-18), which have a 
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Fig. 3-3 
It is well known that besides being the nucleus of pyrrolidine alkaloids 51 , the 
pyrrolidine ring is also an important constituent in the structures of many 
other natural products, such as pyrrolizidine alkaloids, indolizine alkaloids 
and tropane alkaloids. The fact that (2S,4R) 4HP has a pyrrolidine nucleus, 
two chiral carbons and three functional groups (1-amino, 2-carboxy and 4-
hydroxy), makes it a versatile starting material for the stereocontrolled 
synthesis of natural products. The fact that it has a 4-hydroxy chiral 
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functionality, makes 4HP potentially a more valuable starting material for 
chiral synthesis than proline --- provided efficient routes which can exploit the 










NX  COOR2 
Ri 
R 40  






















I ,2-cyclisation products 










N C(CH2)  ny 
Ri 	11 
)J 12) n 
Ri 	g 
2,3-cyclisation products 
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Besides those compounds mentioned above, some other possible types of 
products which could be derived from (2S,4R) 4HP are shown in Scheme 3-
3. Of course, other stereoisomers should be also available from the different 
isomers of 4HP. 
3.1.3. Synthesis of BGTA from (2S. 4R) 4HP 
Although various routes have been developed for synthesis of tropane 
alkaloids52 , most of them are not suitable for the synthesis of BGTA due to 
the 2,6-disubstituted structUre of the target compound. The 1,3-dipolar 
cycloadition of pyridinium betaines is a useful method for preparing 2,6-
disubstituted tropane derivatives 53 , but only the racemic product can be 
prepared by this route. We wished to develop a versatile chiral synthesis of 
BGTA which would enable us to vary the chirality of individual functions 
within the structure. For this reason we decided to explore the route shown in 
Scheme 3-4. 
Potentially this route has the following advantages: 
It uses cheap, commercially available (2S,4R) 4HP as the starting 
material; 
Diastereomers of BGTA as well as analogues besides BGTA itself could 
be prepared through this stereocontrolled route by varying the chemistry 
involved in the synthesis. These compounds should be interesting and 
valuable both for chemical studies of 2.6-disubstituted tropane compounds 
and for studies of the structure-activity relationship between BGTA and its 
receptor; 
4HP is a potentially useful chiral synthon, but compared with proline the 
research literature using 4HP as a starting material is quite sparse, perhaps 
due to the difficulties of working with this starting material. By exploring the 
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route described in Scheme 3-4, useful knowledge on using 4HP as a chiral 
synthon in asymmetric synthesis should be obtained and this knowledge 
should provide valuable insights for synthetic chemists who wish to use 4HP 
isomers as chiral synthons in the future. 
This chapter describes the synthetic approaches towards BGTA using the 
strategy outlined in Scheme 3-4, and the results obtained en route. 
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Scheme 3-4: Proposed synthesis of BGTA 
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3.2. Results and Discussion 
3.2.1 Epimerisation of (2S. 4R) 4-hydroxyproline to 
(2R. 4R) 4-hydroxyproline 
The first problem encountered in the development of this synthetic route was 
that the 2R isomers of 4HP; i.e. (2R, 4S) 4HP (3-12) or (2R, 4R) 4HP (3-10), 
are available commercially only at high cost. However conversion of the 
readily available (2S, 4R) form to the HCI salts of (2R, 4R) 4HP (3-21) and its 
ethyl ester (3-22) could be readily achieved by literature methods, and both 
salts were easily converted to their corresponding free bases 3-10 and 3-
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Scheme 3-5: Epimerisation of 4HP to ( 2R, 4R ) form 
Products 3-21 and 3-22 could be used in the next steps directly, so the first 
problem in this synthesis was resolved. 
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Table 3-1: Epimerisation products from (2S,4R) 4HP 
compd [aID 	(m.p.°C) yield lit. 	[a]D 	(m.p °C) 
3-21 19.3 (c, 2.01, H20) (158-9.5) 56.5 54a, 	not reported, (161-3) 
3-10 54.9 (c, 1.18, H20) (236-8.) 84.4 56, 	58.0 (c, 2, H20) (243) 
3-22 20.8 (c, 2.07, H20) (154-5.5) not reported, (155-6) 
3-23 43.9 (c, 2.0, H20) 	(oil) 81.0 28.5 (c, 2, H20) 
3.2.2. Protection and reaction of functional groups 
To develop the route shown in Scheme 3-4, the hydroxyl, amine, and 
carboxyl functional groups had to be efficiently protected. The most readily 
available (2S, 4R) 4HP isomer (3-9) was used to develop the conditions of 
the earlier steps in this synthesis. Two main strategies were used for 
functional group protection: one was protecting the amine first, and then the 
OH and carboxyl group; another was esterifying the carboxyl first, and then 
protecting the other groups. Different types of derivatives which could be 
exploited to explore various strategies for the next steps were obtained by 
these two routes. The network of conversions carried out are shown in 
Scheme 3-6 and the characteristics of these derivatives are described in 
Table 3-2. 
In the reactions outlined in Scheme 3-6, four reagents were used to protect 
the secondary amino group. The t-butyloxycarbonyl (Boc) group is a widely 
used protective group for amines due to its formation under mild conditions 
and its ease of removal57 . The derivatives made from N-Boc (2S,4R) 4HP 
such as 3-42, 3-43 are potentially useful for exploring activation of the C-5 
position via anodic oxidation 58 but in the route we envisaged (Scheme 3-4) 
the Boc group might be expected to react with other reagents such as 
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Scheme 3-6: protection and reaction of groups of (2S,4R) 4HP* 
. For the structures of these compounds please see Table 3-2. 
The benzyl (Bz) group is also a useful protecting group because it is stable 
to Grignard reagents and can be removed by catalytic hydrogenation 59 . 
However the N-Bz (2S, 4R) 4HP ethyl ester 3-37 could not be easily oxidised 
to the corresponding 4-oxo product; perhaps because of the interference of 
the basic tertiary amine itself. PhCOCI is a cheap reagent for derivatisation 
but benzoyl protection has seldom been used for amines since its removal is 
not so easy60 . In our experiments (see section 3.2.3) we found however that 
the PhCO group could be readily reduced to a Bz group which could be 
easily removed, so the derivatives of N-benzoyl (25,4R) 4HP did in fact 
prove valuable in subsequent work. 
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Table 3-2: Derivatives of (2S,4R) 4HP 
R4, 
C~~ COOR 2 


















3 -25 Boc H OH a. Boc20 
NaOH  
128.5-30 -68.4 99 
3-26 PhCO H OH PhCOCI 
K2CO3 (190.5 -93) (-125.2)  
77.8 62 
3-27 H.HBr Et OH  173-4.5 -23.4 75.7 - 





3-29 Boc Me OH  oil -77.4 88.7 





3-31 Boc H 0  161-2.5 -15.9 87.5 - 
3-32 PhCO H 0  oil  87.2 - 





3-34 Boc Me 0  oil -43.8 99 
3-35 Ts Et OH TsC1 
Na2CO3  
129-31 -54.2 71 - 
3-36 PhCO Et OH b. PhCOCI 
K2CO3  
93.5-4.5 -138.5 77.8 
3-37 Bz Et OH b. BzBr 
K2CO3  
oil -49.9 73.1 
3-38 PhCO Et 0  oil -71.6 94.4 
3-39 Ts Et 0  129-31 -54.2 81.7 - 
3-40 Ts H AcO  124.5-5.5 -90.3 78.7 - 
3-41 Boc H AcO  110-11 -47.3 71.7 
3-42 Bz Et AcO  oil -41.0 59 - 
3-43 Boc Me AcO  oil -56.5 95.8 - 
After comparing different methods of protection the tosyl (Ts) group 
appeared better than the others due to the following: Firstly the tosylamide 
was neutral and did not interfere within subsequent reactions using Grignard 
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reagents, and the operations and purification were much easier due to the 
fact that N-Ts (2S,4R) 4HP derivatives were crystalline; Secondly, the tosyl 
group is a stronger electron withdrawing group than the others considered 
and thus should be better able to stabilise a C-5 enolate (rather than a C-3 
enolate) of a 4-oxo derivative which was desired later in the reaction 
scheme. Of course, eventual removal of the tosyl group might not prove easy 
but it seemed reasonable to use this approach in the early steps of route 
development. 
3.2.3. Synthesis of N-tosyl-4-oxo-2-acryloylpyrrolidifle (3-19 in Scheme 3-4) 
In the route shown in Scheme 3-4, the compound 3-19 to be used for 
Michael addition is a key intermediate. To synthesis this target product, the 
.most important reaction was transformation of the C-2 carboxy group to an 
a,-unsaturated ketone. 
Strategy 1. Attempted Synthesis of the a13-unsaturated ketone (3-19) from 
4HP derived esters (Scheme 3-7) 
Esters can be reacted with organometallic reagents to produce 
ketones63 ,and when vinylmagnesium bromide (VMB) is used in this reaction, 
an a,13-unsaturated ketone is produced. Thus in our case, Grignard reaction 
of 3-35 and VMB gave a 83.8% yield of product 3-44 which contained a 
carbon carbon double bond (oH  6.4-4.8 3H, 1641 cm) a carbonyl group 
(1713 cm) and a hydroxy group (3518 cm 1 ). However, Jones oxidation of 
3-44 gave only a 38% yield of compound 3-45. 
From the spectra of 3-45, two carbonyl groups were evident (1762 and 1723 
cm 1 ), one isolated monosubstituted C=C (OH  6.3-4.9 3H, ABC, 1641 cm) 
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and four CH 2 groups of a total sixteen carbons (c  21.7, 38.0, 38.1 and 58.0). 
The MS also confirmed the structure of 3-45 [322 (M + l), 294 (M - 
CH=CH2), 265 (M - CH2CH2CH=CH2) and 238 (M - COCH2CH2CH=CH2)4]. 
The product 3-44 (and hence 3-45) clearly results from addition of a second 
equivalent of vinylmagnesium bromide to the desired product (3-46). 
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reagents: a. BrMgCHCHITHF; b. Cr03/1-12SO4/acetone; 
c. (CH20H)2fTsOH/C6H6; d. TsOH/acetone 
Scheme 3-7 
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It should be noted however that this reaction required use of an excess of 
the Grignard reagent --- since deprotonation of the 4-hydroxyl neutralised 
one equivalent. Envisaging that Michael addition to the a,1 -unsatuated 
ketone could be reduced if a 1:1 equivalence of ester and reagent were 
employed, the ketal 3-47 was prepared from the ketone 3-39 by treatment 
with (CH 20H)2/C6H6/TsOH in 94% yield. The ketal 3-47 was then reacted 
with a 1.35 fold excess of VMB affording 3-48 in 68% yield. The structure of 
3-48 was confirmed by hydrolysis using TsOH/acetone, which gave 3-45 in a 
31.7% yield (Scheme 3-7). Although different conditions were tried, such as 
lowering the quantity of VMB, using lower reaction temperatures, using the 
methyl esters 3-28 and 3-33 as reactants and using Cu1 2 as catalyst64 , the 
desired a,13-unsaturated ketone (3-19) could not be prepared. This is 
probably because the ester group reacts more slowly with VMB than the 
desired a,-unsaturated ketone produced during the reaction (Scheme 3-7). 
Strategy 2. Using an acid chloride as a starting material for synthesis of the 
a4-unsaturated ketone 3-19 
The results from the above experiments suggested that if this strategy were 
to be effective then the ester group had to be replaced by a more reactive 
functionality. Acid chlorides are in principle more active than the 
corresponding esters, and the reaction of an acid chloride with Grignard or 
other organometallic reagents is a useful method for making ketones65 . Thus 
the acid chloride 3-50 was prepared by reaction of 3-40 with SOCl 2/C6 H 6 in 
84.8% yield. The identity of the product was evident from the shift in the 2-H 
resonance from 8 4.6 to 4.72 in the product, and the structure was also 
confirmed by elemental analysis and spectral data [ir 1822 and 1741 cm 1 ; 
m/z 347/349 (ca 1:3), 283, 240 and 222]. However when 3-50 was reacted 
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with VMB, then treated by aq. NH 4CI only 3-51 was obtained in a 35% yield 
(Scheme 3-8). The spectra of 3-51 showed an amide group (3429, 3211 and 
1673 cm 1 ; 8 5.68 1H, brs and 8 6.77, IH, brs) and the structure of this amide 
was also confirmed by elemental analysis, 13C NMR and MS data. Several 
repeated experiments showed the same result indicating that the acid 
chloride is relatively unreactive towards the Grignard reagent. 
AcO, 	 AcO 	 AcO
Ile 
SOCl2/C6H6 	 1.BrMgCHCH2 
A 
0 	 C 2.NH4Cl/H207- 	 'CONH2 COOH 	 N 	COCI 
Ts 	 Is Is 
3-40 	 3-50 	 3-51 
Scheme 3-8 
Strategy 3. Synthesis of the a4-unsaturated ketone (3-19) using ethynyl 
metallic reagents 
In an attempt to avert further reaction of the product with the reagent, ethynyl 
metallic reagents were used for the synthesis the target compound. The 
expected ethynyl ketone intermediate should be less active than an a43-
unsaturated ketone to Michael addition since its conjugation would not be so 
efficient, but it could be reduced to an a,p-unsaturated ketone using catalytic 
hydrogenation or other reagents 66 . However, when the acid chloride 3-50 
was reacted with LiCCTMS, BrMgCCH and NaCCH respectively, complex 
mixtures were obtained from which the only characterisable product isolated 
was the acid 3-40. A complex mixture was also obtained when the ester 3-28 
was reacted with LiCCTMS. 
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From the reaction of 3-28 and NaCCH, two products were separated: one 
was TsOH, another seemed to be a pyrrole derivative the structure of which 
is uncertain (3-28-1, Scheme 3-9). The Grignard reaction of 3-28 and 
BrMgCCH gave a 36% yield of 3-52. Compound 3-52 contained two hydroxy 
and two ethynyl groups (ir 3407, 3265 and 2105 cm 1 ; 62.0 IH and 5.64 IH; 
exchanged by D 20; 8 2.70 2H, 2 X CCH). Its structure was confirmed by 
elemental analysis and MS data [mlz 320 (M + 1), 302 (M - OH) and 240 
(M - COH(CCH)21. These results clearly showed that the ethylyl ketone 3-53 
was too reactive towards the Grignard reagent to be prepared cleanly under 
these conditions. 
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Scheme 3-9 
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Strategy 4. Synthesis a4-unsaturated ketones from aldehyde derivatives of 
(2S.4R) 4-hydroxyproline 
The results from the above experiments strongly implied that an aldehyde 
was probably necessary if addition of only a single two-carbon unit was 
required. Of course, the expected reaction product of the aldehyde and VMB 
would be an alcohol which would have to be oxidised to give the desired cx,1 3-
unsaturated ketone (Scheme 3-10). 
R4,, 	 R4,, 	 R4,, 	 R4,, 
OH 
cCOOEtc 	 cHc 
OH 







Z N Z 
Is OH 
Scheme 3-10 
A). Preparation of protected aldehydes 
Many methods have been developed to prepare aldehyde from esters 67 , acyl 
halides68 , amides69 and alcohols70 in the literature. Although all these types 
of compounds (except the alcohols) were available from the work described 
above, an efficient route using mild conditions had to be developed because 
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the desired aldehyde would be expected to be unstable and the C-2 chiral 
centre could be expected to be vulnerable to epimerisation. 
The first reaction tried was reducing the acyl chloride 3-50 using 
LiAI[OC(CH 3)3]3H71 . However NMR analysis of the complex mixture of 
products formed showed that the desired aldehyde was only present in about 
30% yield (ö 9.58, 0.3 H). The yield could not be raised even though different 
conditions were attempted, and the separation and purification of the 
aldehyde was very difficult due to its instability. 
The second way to make the aldehyde was to oxidise the corresponding 
primary alcohol. The alcohol 3-54 was obtained in a 69.6% yield by reducing 
the ketal ester 3-47 with L1AIH 4 in THF. The compound 3-54 was also 
synthesised from 3-30 by making the ketal ester 3-55, which was then 
reduced with LiAIH 4 to give 3-54 in a 84.2% overall yield (Scheme 3-1 1). This 
route was shorter and the yield was higher and was used to prepare 3-54 in 
subsequent work. 
The first oxidation reagent which was used to oxidise 3-54 to the aldehyde 3-
56 was pyridinium chlorochromate (PCC) 72 . However, this reaction could not 
be driven to completion even though excess reagent was used and reaction 
continued for three days. 
However, the aldehyde 3-56 could besynthesised via the Swern oxidation73 
of 3-54 in 95% yield (Scheme 3-1 1). The specific rotation of 3-56 ([cx]D2° - 
39.50) suggested that the C-2 chiral centre was retained during the reaction. 
In the spectral data of 3-56 bands in the ir at 2830, 1728 cm 1 (C=O) and the 
presence of a ö 9.58 (11-1, d, J 3.3) resonance in the 1 H NMR spectrum 
clearly showed the presence of a CHO group. The 1 H NMR spectrum of 3-56 
was totally in accord with the desired structure: The protons of the C-5 
methylene were observed as an AB [8 3.09 (1H, J 10.3) and 8 3.42 (IH, J 
10.3)], the C-3 methylene and C-2 methine protons gave rise to a ABX 
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pattern [6 1.89 (1H, J 13.1 and 9.2), 6 2.07 (1H, J 13.1 and 5.7) and 6 3.85 
(IH, J 3.3, 9.2 and 5.7)] and the C-2 methine proton was also coupled to the 
CHO proton (J 3.3). The structure of the aldehyde was further confirmed by 
MS data [m/z 312 (M + 1), 282 (M - CHO) and 156 (M - Ts)]. 
























B). Synthesis of the (S)-N-tosyl-2-oxo-acryloylprrolidine 3-59 
The next step was Grignard reaction of aldehyde 3-56 with VMB to give a 
90% yield of alcohol 3-57. The products were expected to be a mixture of 
diastereolsomers due to the formation of a new chiral centre. However, the 
separation of these isomers was unnecessary because both of them would 
be oxidised to the same product in the next step. The spectra of 3-57 
showed a hydroxy group and a carbon carbon double bond clearly [3497 and 
1643 cm 1 ; 6 3.36 (IH, exchanged by D 20) and 6 5.83-5.11 (3H, m, ABC); 
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the protons on double bond formed a ABC system which was further coupled 
with 6-HI (Scheme 3-12). The structure of 3-57 was also confirmed by MS 
data [m/z 340 (M + 1), 322 (M - OH) and 282 (M - CHOHCH=CH 2)J. 
To make the expected a,-unsaturated ketone from 3-57, two ways were 
considered: one was hydrolysing the ketal group first, then oxidising the 6-
OH; another was oxidation first, then hydrolysis. The former way seemed 
better because the aj3-unsaturated ketone group which was desired in the 
final product could be sensitive to hydrolytic conditions. 
The hydrolysis of ketal 3-57 was unexpectedly difficult. Many methods such 
as acetone/TsOH/A74, acetone/T5OH/py/H20 75, aq. HCl/THF76 , 
AcOH(80%)/A 77 Resin (H+)IMeOHIE 78 and H2SO4/acetone/H 2079 were tried 
but either the yield was very low or the expected product was not formed. 
Finally, the ketone 3-58 (Scheme 3-12) was obtained in a 50.7% yield by 
hydrolysis of 3-57 with HCI04/THF at r.t. for three days. Its structure was 
confirmed by spectroscopic analysis (see Tables 3-3 and 3-4). 
We hoped that compound 3-58 could be oxidised using mild conditions. 
However different mild oxidation systems, such as Mn0 2/CH 2C1280, 
DDQ/Et20, DDQ/acetone, DDQIAcOHIEtOH 81 , DDQ1H 51061C6H682 and 
(COCI)2/DMSO/CH 2Cl2/-78°C73, either failed to afford the expected product 
or gave unsatisfactory yields. However, a high yield (93%) of the target 
product 3-59 (Scheme 3-12) was achieved simply by Jones oxidation. Using 
the same reagent the protected cx,13-unsaturated  ketone 3-60 (Scheme 3-12) 
could be prepared from 3-57 in 79% yield, but only a 53.7% yield of 3-60 was 
obtained using activated Mn0283. Both 3-60 and 3-59 gave satisfactory 
spectral data (see Tables 3-3 and 3-4). From the difficulty of oxidising these 
alcohols it seems reasonable to infer that the bulk of the tetra hyd ropyrrole 
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Now that a route for synthesis of the key intermediate 3-59 had been 
established the same strategy was used to obtain other N-protected (2S,4R) 
4HP derivatives with similar results. Thus, 3-61 was obtained from 3-32 in 
81.9% yield, and this was then reduced with LiBH 4 to give the alcohol 3-62 
which was oxidised via the Swern reaction affording 3-63. The two steps 
gave an overall 59.3% yield. When 3-61 was reduced with LiAIH 4 , 3-64 was 
obtained in a 80.1% yield and the benzoyl group was also reduced to a 
benzyl group at the same time. From 3-64, a 69% yield of aldehyde 3-65 was 
also achieved using the Swern reaction. Both 3-63 and 3-65 were converted 
to their corresponding propenylenols 3-66 and 3-67 by reacting with VMB. 
The yields were 47.97% and 50.45% respectively (Scheme 3-14). All the 
compounds above gave satisfied spectral data which are summarised in 
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To reduce the number steps in the above route, another strategy shown in 
Scheme 3-13 was attempted. From 3-24 a 42.3% yield of 3-68 was obtained 
by reducing with LiAIH4, but the expected dicarbonyl product could not 















Scheme -1 3 
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Table 3-3: experimental data of compounds described in section 3.2.3 
compd vm /cm' m/z 	 [requires] [aID2°  m.p. °C yield % 
3-54 3517 (OH) 314.10624 (M + 1), 3.67 oil 88.7 
C 14H20NO5S MH [314.106211 
282 (M - CH20H)  
3-55 3537(OH) 372.11174(M+1)-  -53.68 oil 95 
1746 (C=O) C 16H22N07S MH [372.11169] 
354 (M -OH), 328 
282 (M - COOCH2CH2OH)  
3-56 2830 312.09055 (M + -39.5 64.5- 95 
1728 (C=O) C 14H18N05S MH [312.090561 65.5 
282 (M - CHO)  
3-57 3497(OH) 340.12184(M+1),C 16H22N 113.0- 90 
1643 (C=O) 05 S MH [340.12186], 322 (M  114.0 
-OH), 282 (M - C 3H4OH)  
3-58 3493 (OH) 296.09604(M+1),C 14H 1 8N 154.5- 50.7 
1762 (C=O) 04 S MH [296.09566], 278 (M  156.0 
1594 (C=C) -OH),238 (M - C3H4OH)  
3-60 1697 (C=O) 338.10623 (M + 1) -23.97 76.0 - 79 
1612 (C=C) C 16H20NO5 S MI-I [338.10621] 78.0 53.7 
282 (M - COCH=CH2)  
3-59 1757 (C=O) 294.08000 (M + 1) -85.33 145.0 - 93 
1711 (C=O) C 14H 16NO4SMH[294.08001] 146.0 
1689 (C=C) 238 (M - COCH=CH2)+  
3-61 3403 (OH) 332(M+ 1)-,304(M-OH) -68.06 62.0- 81.9 
1745 (C=O) 232 (M - COOCH2CH2OH) 64.0 
1630 (C=O)  
3-62 3405 (OH) 264.12326(M+l)t,C14H18NO4 - 138.5- 75.84 
1612 (C=O) MH[264.12358],246(M- 111.5 140.0 
OH), 232 (M-CH20H) 9 
3-63 2832 262.10731(M+1) oil 78.16 
1730 (C=O) C 14H 16N04 MH [262.10793] 
1631 (C=O) 232 (M - CHO)  
3-64 3438 (OH) 250.14484(M+1),C14H20NO3 -87.39 63-65 80.11 
MH [250.14432], 232 (M - 
OH),2 18 (M - CH20H)  
3-65 2807 248 (M + 1), 218 (M -CHO) oil 69.07 
1727 (C=O) 128 (M - CHO - PhCH2) 
3-66 3365 (OH) 290.13985(M+1),C 16H20NO4 oil 47.97 
1680 (C=C) MH [290.13923], 272 (M - 
1612 (C=O) OH), 232 (M-C 3H4OH)  
3-67 3453 (OH) 276.15962(M+1',C 16H22NO3 80-82 50.45 
1633 (C=C) MU [276.15997],258 (M-  
OH), 218 (M - C3H4OH)  
3-68 3394 (OH) 272 (M + 1)*, 254 (M - OH) -51.6 134.5 - 42.3 
3295 (OH) 240 (M -CH20H)  136.5  
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Table 3-4: NMR data of compounds described in section 3.2.3 
compd 8H 	 [c] 
No 2 X 5-H 	2 X 3-H, 2-H 6-H 	2 X 8-H, 7-H 	others 
(AB) (ABX) (ABC)  
3-56 3.09 1.89 (1H, q, J 9.58 2.34 (3H,s, 
(1H, q, J 13.1,9.2,3-H), (IH, d, ArCH3), 3.78- 
10.3) 2.07(1H, q, J J 3.3) 3.67 (4H, m, 
- 3.42 13.1,5.7, 3-H) 0C2H40,A2B2), 
(1H, q, J 3.85 (1H, q-d, J 7.63-7.27 (4H, m, 
10.3) 9.2, 5.7, 3.3,2-H) Ar-H, A2B2) 
3-57 3.53 1.73 (IH, q, J 4.62 5.37-5.11 (2H, 2.38 (3H, s), 3.12 
(2H, s) 13.4,8.3, 3-H) (1H, m, 8-H) (1H, brs, OH), 
2.14 (1H, q, J brs) 5.83-5.56 3.82-3.37 (4H, m, 
13.4,7.9, 3-H) (IH, m, 7-H) 0C2H40, A2B2), 
- 3.6 (1H,m,2-H) 7.70-7.24 (4H, q, 
Ar-H) 
3-58 3.64 2.03 (1H, q, J 4.64 5.39-5.18 2.39 (3H, s, Ar- 
(1H, q, J 18.2,9.5, 3-H) (1H, (2H, m, 8-H) CH3), 2.82 (1H, 
18.0) 2.38 (1H, q, J brs) 5.83-5.67 (1H, brs, OH), 7.72- 
3.82 18.2,2.2, 3-H) [C-6 m, 7-H) 7.29 (4H, m, Ar- 
(IH, q, J 4.18 (1H, q, J 74.8] [C-7 135.8, C- I-I, A2B2). [21.4, 
18.0) 9.5,2.2,2-H) 8117.1] 126.9, 130.,134.4, 
[C-S 53.9] [C-3 36.4, C-4 144.2, 208.5] 
60.9]  
3-59 3.65 (1H, q, 2.32 (1H, q, J 5.98 (1H, q, J 2.43 (3H, s, Ar- 
J 18.0) 18.3,9.1, 3-H) 10.5,1.3,8-H) CH3), 7.71-7.31 
3.74 (1H, q, 2.56 (1H, q, J 6.50 (1H, q, J (4H, q, Ar-H, 
J 18.0) 18.3,3.7, 3-H) 17.5,1.3,8-H) A2B2) 	[21.5, 
[C-S 53.0] 4.93 (1H, q, J 6.78 (1H, q, 127.5, 130.1, 
9.1,3.7, 2-H) 17.5,10.5,7-H) 133,4, 144.8, 
[C-3 38.5, C-2 [C-7 131.7,C-8 195.0, 206.7] 
61.2]  131.8]  
3-62 3.41(1H, q, 1.97 (1H, q, J 3.96- 3.96-3.70 (4H, m, 
J 11.4)3.56 13.2,8.4, 3-H) 3.70 OC2H40), 4.50 
(ill, q, J 2.21 (1H, q, J (2H,m) (IH,brs, OH), 
11.4) 13.2,8.1, 3-H) [C-6 7.48-7.30 (5H, m, 
[C-S 57.3] 4.52 (1H, q, 8.4, 65.7] Ar-H) [64.4, 
8.1, 2-H) [C-3 64.9, 111.8 (C-4), 
36.7, C-2 59.5] 128.0,128.2,130.1 
135.8, 171.9] 
3-63 3.58 (1H, q, 2.18 (1H, q, J 9.62 4.01-3.77 (4H, m, 
J 11.1)3.64 13.2, 5.5, 3-H) (1H, d, OC2H40), 7.57 
(1H, q, J 2.32 (IH, q, J J 2.0) -7.36 (SH, m,Ar- 
11.1) 13.2, 9.4, 3-H) [C-6 H) 	[64.1, 64.9, 
[C-S 56.6] 4.68 (1H, q-d, J 199.6] 112.8 (C4), 127.2, 
9.4, 5.5, 2.0,2-H) 128.3, 130.6, 
[C-3 35.6, C-2  134.8, 170.2] 
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63.2]  
3-64 2.47 (1H, q, 2.13 (2H, d, J 3.44- 2.77 (1H, brs, 
J 10.3) 2.96 8.2, 3-H) 3.83 OH), 3.31 (1H, q, 
(1H,q,J --3.83 (2H, J 13.1, Ph- 
10.3) (1H, m, 2-H) m) CH,AB), 4.00 
[C-5 57.71 [C-3 38.0, C-2 [C-6 (1H, q, J 13.1, Ph- 
62.91 61.91 CH, AB), 3.95- 
3.70 (4H, m, 
0C2H40), 7.30- 
7.22 (5H, m, 
ArH); [60.2, 64.2, 
113.3,126.9,128.1 
128.4,13 8. 1] 
3-65 2.70 (1H, q, 2.25 (2H,m, 3-H) 9.65 3.82 (2H, brs, 
J 10.5) 3.36 (IH,m, 2-H) (1H, d, Ph-CH2), 3.96 
3.25 (1H, q, J 4.0) (4H,m, OC2H40), 
J 10.5)  7.84 (SH,s, Ar-H) 
3-66 3.44 (1H, q, 1.99 (IH,m, 3-H) 4.36 5.92-5.19 3.96-3.40 (4H, m, 
J 11.6)3.55 2.13 (1H,m,3-H) (1H,m) (3H,m) 0C2H40),4.91 
(1H, q, J 4.55 (1H,m, 2-H) [C-6 [C-8 117.6, (1H, brs,OH), 
11.6) [C-3 36.8, C-2 76.5] C-7 137.0] 7.48-7.36 (5H, m, 




3-67 2.55 (1H, q, 1.99 (IH,m, 3-H) 3.52 5.99-5.13 (3H, 3.37 (IH, brs, 
J 11.5) 2.23 (1H,m, 3-H) (1H,m) m) [C-8 115.5, OH),3.52 (IH, q, 
2.94 (1H, q, 3.04 (1H,m, 2-H) [C-6 C-7 139.0] J 13.0, Ph-CH, 
J 11.5) [C-3 38.2, 73.0] AB), 3.96-3.78 
[C-S 60.6] C-2 66.4] (4H, m,OC2H40), 
4.10 (1H, q, J 
13 .0,Ph-CH, 
AB),7.29 (5H, m, 
Ar-H); [60.7,64.2, 
114.4 (C4), 126.9, 
128.2, 128.4, 
138.8] 
3.2.4 Approaches to intramolecular cyclisation to make the tropane nucleus 
The next target was synthesis of a 2,6-dicarbonyl tropane (3-20) via an 
intramolecular cyclisation strategy. At this point in the synthesis two different 
options were considered feasible (Scheme 3-25). The first, and most direct, 
was closure of the ring using a Michael strategy by addition of a C-5 anion to 
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the aj-unsaturated ketone. However we were aware through model 
building studies that the rigidity of the enone system might make it difficult to 
achieved the conformation required for intramolecular attack. A second 
approach was to modify the enone introducing a good leaving group at the 
terminal position generating a more flexible side chain which could undergo 
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Scheme 3-25 
Strategy 1: Intramolecular Michael addition 
Michael addition, the addition of carbanions to Michael acceptors, is one of 
the most useful reactions for carbon-carbon bond formation in organic 
synthesis84 . In the structure of 3-59 the C-2 ctj3-unsaturated ketone was a 
typical Michael acceptor and C-5, the a-C of the ketone, should easily form a 
carbanion by removal of its acidic hydrogen with a base. So, the Michael 
addition of 3-59 should in principle give the expected cyclisation product. 
However when 3-59 was reacted with Cs2CO3/CH3CN at r.t. 85 , 3-69 was 
obtained in a 41.4% yield. The spectral data of 3-69 shown it contained two 
carbonyl groups (ir 1762 and 1720 cm-i), two Ts groups [6 2.42 (3H,$), 2.44 
(3H, s), 7.38 (4H, q, A 2 132) and 7.79-7.76 (4H, q, A2 132)] and a -CH 2CH2- unit 
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[6 3.58- 3.13 (4H, m, A2 132)]. The 1 H NMR showed that the AB system from 5-
H [6 3.64 (IH, J 10.1) and 3.71 (IH, J 10.1)] and the ABX system from 3-H 
and 2-H [6 2.30 (1H, J 10.4, 5.2), 2.62 (1H, J 10.4, 2.6) and 4.58 ( H, J 5.2, 
2.6)] were present indicating that the ring structure was intact. However from 
the lack of optical rotation of 3-69 it was evident that the chiral integrity of the 
C-2 position was destroyed. This structure was also confirmed by MS data 











































The above results revealed an imine intermediate was formed during the 
reaction and; from the racemisation it is clear that the C-2 rather than the C-5 
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anion is formed in this reaction. This could decompose by elimination of the 
Ts- group which can react with the starting material to give 3-69 (Scheme 3-
15). Comparing the chemical environments of 2-H and 5-H, the acidity of 2-H 
should be greater than that of 5-H because the negative charge of C-2 
carbanion can be efficiently shared by a longer conjugated system 86. Similar 
results were obtained with reaction of 3-59 with Lil/DME87 at r.t. which also 
gave 3-69 in a 48.7% yield (Scheme 3-15). 
When Michael additions of 3-59 catalysed by other bases such as LDA/THF/-
78°C, Cs2CO3/CH2Cl2/r.t., NaOH/MeOH/r.t., NaH/TH FI-78°C84 and Lithium 
prolinate/MeOH/r.t. 88  or acids including LDAJTMSCI-TiCl4ITi(OPr-
i)4/CH2C1289 , BF3.Et20/CH2Cl2 and AcOH/CH3CN/E 90 were carried out, the 
desired product was also not obtained. Most of these reactions gave 
complex mixtures, possibly due to the sensitivity of the cx,-unsaturated 
ketone to base. 
Strategy 2: Intramolecular cyclization --- using intermediates containing a 3 
substituted leaving groups 
To avoid the sensitivity of the a4-unsaturated ketone to base and inhibit the 
interference of anion formation at the C-2 position, the alternative strategy of 
introducing a leaving group at the C-8 position in the side chain was 
evaluated. 
Addition products with anti-Markovnikov orientation can be prepared from 
compounds containing substituted carbon-carbon double bonds by reaction 
with (BH 3)3/H20291 or HBr catalyzed by peroxides 92 . Acylation of 3-57 and 3-
58 gave the 6-hydroxy protected products 3-70 and 3-71 in 77.3% and 85% 
yields respectively (Scheme 3-16), but attempts to make the anti- 
48 
Markovnikov products failed although many conditions such as 
H Br(g)I(PhCO2 )21CCI41-78°C, H Br(g)/(PhCO2)21CCl4-CH2Cl2 , H Br(g)/(PhCO2)2 
ICH 2Cl2 , HBr(g)I(PhCO2)2ICCI4IA, HBr(g)/(PhCO 2)2/MeOH, HBr(g)I(PhCO2)21 
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Scheme 3-16 
When a,3-unsaturated ketones are reacted with nucleophilic reagents, two 
types of reactions, 1,2-addition and 1,4-addition, can happen, and the main 
product depends on the characteristics of the reactant as well as the reaction 
conditions93 . 
Thus 3-60 was reacted with EtSH/NaOMe at r.t. giving the expected 1,2- 
addition product 3-72 in a 66% yield. The rationale of this route involved 
making a -SRR' functionality as the leaving group used in cyclisation 
(Scheme 3-17), but this approach had to be given up because attempts to 
hydrolyse the ketal group of 3-72 failed. Compound 3-60 was also converted 
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to 3-73 in a 57.8% yield, but preparation of the diketone could not be 
achieved from 3-73 (Scheme 3-17). Both 3-72 and 3-73 gave satisfactory 
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Scheme 3-17 
The 13-bromosubstituted diketone 3-74 was finally prepared by reaction of 3- 
59 and HBr(g)/CH2Cl2-Et20 at 0 °C in a 94% yield (Scheme 3-17). But 
unfortunately, the expected cyclisation product was not obtained when 3-74 
was reacted with Cs2CO3/CH3CN. Under these conditions elimination of HBr 
to give 3-59 occurred. Attempts to protect the C-6 carbonyl by making a 
dithio ketal was also unsuccessful. The spectra data of 3-74 are summarised 
in Table 3-5. 
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Strategy 3. Approaches to activation of the C-5 position 
All of the above experiments showed that the C-5 position was quite difficult 
to react in this system. An alternative way was to introduce a functionality at 
the C-5 position to activate it, then the cyclization at C-5 should be easier 
than with an inactivated compound. 
A). Bromination 
If a Br group was introduced at the C-5 position, the intramolecular 
cyclisation should in principle be easier. The most suitable compound for this 
purpose was 3-58 because it contained only the C-4 carbonyl group. C-5 
should be easier to brominate than C-3 due to the stronger acidity of the 
former through the field effect94 of the N-I (Scheme 3-18). Other compounds 
such as 3-59 were not suitable because several positions in these 
compounds could be brominated during the reaction. 
The desired C-5 brominated product could not synthesised although several 
conditions such as CuBr2/CHCl3-EtOAch 95, Br2/Et20-CH2C12 96 were tried. 
When the NMR spectra of crude products from these experiments were 
examined it was clear that C-5 was not brominated because the 
characteristic resonance of 5-H was retained while disappearance of the 3-
H's signal implied that C-3 was brominated in the reactions.. To test this, 3-33 
was reacted with Br2/AcOH at r.t.. The spectral data of the product confirmed 
that only the 3-brominated product 3-75 was produced. In this product it was 
evident that the Br and C-2 functionality were trans to each other because 
the 1 H NMR showed a coupling constant between 3-H and 2-H close to zero, 
i.e. their dihedral angle was about 90 0 [8 4.31 (1 H, s, 3-H) and 4.70 (1 H, s, 2-
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Since the results of bromination indicated that the C-3 position appeared to 
be more reactive than C-5 towards reaction with an electrophilic species we 
decided to try to prepare the enolate ethers of the C-4 ketone to characterise 
the more stable enolate. However neither the methyl nor the trimethyl silyl 
ethers of 3-33 could be prepared under classic conditions using 
(CH30)2S02/MeOH97  and LDA/TMSCI98 . Evidence that the C-3 rather than 
the C-5 enolate was formed under the latter conditions was obtained by 
quenching the reaction with D 20 which resulted in deuteration at C-3 rather 
than C-5. Taken with the result of the bromination experiment this implies 
that hydrogen abstraction from C-3 is easier than from C-5 (Scheme 3-20). 
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Strategy 4. Introduction of a C3 group at C-5 of the tetra hyd ropyrrole nucleus 
It was now clear that ring closure by the routes envisaged in the original plan 
could not be achieved. An alternative approach was to introduce a 
CH2CH2CO2R group at the C-5 position and to effect cyclisation via a 
Dieckmann condensation 99 . The Stork enamine alkylation is a useful method 
for introducing an alkyl or an acyl group at the carbon a to a carbonyl 
functionality 100 . By using this method, the route shown in Scheme 3-21 
should be available if it were possible to form an enamine intermediate such 
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However when 3-33 was reacted with pyrrolidine/C 6H6/A, then heated with 
CH2=CHCN, only 3-78 and 3-79 were obtained in 28.2% and 24.2% yields 
respectively (Scheme 3-22). Similarly when 3-33 was heated with pyrrolidine 
in ether, 3-78 was the only detectable product. When 3-78 was reacted with 
Mel, only the N methylation product (3-80, 62% yield) was obtained (Scheme 
3-22). These compounds gave satisfactory spectral data which are 
summarised in Table 3-5. 
A possible alternative route might be using 3-58 as starting material. If the 
4,5 enamine (3-81) were formed, it might be possible to produce the 
cylisation product by a intramolecular nucleophilic addition of the enamine to 
the carbon-carbon double bond (Scheme 3-23). However the final product 
separated from this reaction was 3-82 (70.4% yield). The spectra data 
showed that 3-82 contained an amine [3272 cm-i, ö 10.1 (1H, brs)], a 
carbonyl group (ir 1625 cm-i) and an ethyl group [8 1.38 (3H, t, J 7), 2.96 
(2H, q, J 7)], its structure was further confirmed by MS [m/z 193 (M + i), 163 
(M - Et) and 135 (M - COEt)J. 
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Clearly the Ts group in this system is sufficiently electron withdrawing to 
labilise the 2-H under mildly basic conditions. To avoid this problem the route 
shown in Scheme 3-24 was explored. Thus 3-64 was reacted with 
methanolic HBr to give a 90% yield of 3-83, acylation of 3-83 gave 3-84 in a 
74.2% yield. However when either 3-83 or 3-84 was reacted with pyrrolidine 
in benzene, then treated by CH2=CHCN, only complex mixtures were 
obtained. The above results reinforced the earlier experiments in this study 
which demonstrated the lability of the hydrogen at the C-2 position in these 
molecules. 
Table 3-5: Experimental data of compounds described in section 3.2.4. 
compd Vmax 6H 	[öc] * mlz [requires] [a]D2° m.p.°C yield 
cm % 
3-69 1762 2.42 (314, s), 2.44 450 (M + 1), 294 0 135.5-  
(C0) (3Ff, s), 7.38-7.34, (M - Ts ), 265, 136.5 41.4 
1720 (4H, q), 7.79-7.76 238;  
(C=O) (4H, q)  48.7 
3-70 1744 2.0 (3H,s,COCH3 ) 382.13245 (M + 1) 113- 77.3 
(C=O) [C 18H24NO6SMH 114.5 
1643 382.13242], 337 [(M 
(C=C) - 1) - COCH3], 323 
[(M + 1) -OCOCH3] 
3-71 1771 2.08 ( 3H, s, COCH3) 338.10623 (M + 1) 126.5- 85 
(C=O) [C 16H20N05 SM11 127.5 
1738 338.10621], 278 (M - 
(C=O) OCOCH3), 238 (M - 
CHOAcCHCH2)  
3-72 1715 1.23 (3H, t, J 7.5), 400.12524 (M + 1) -52.6 61.5- 66 
(C0) 2.53 (2H, q, J 7.5) [C 18H26N05 S2 MH 62.5 
400.12523], 338 (M - 
SEt), 282 (M - 
COCH2CH2SEt)  
3-73 1716 3.9-3.6 (4H, m, 420.03046 (M + 1) -37.05 119- 57.8 
(C0) -CH2CH2-, A2132), [C 1 6H21 8 ' BrNO5 S 120.5 
4.96-3.92 (4H, m, MH 420.030451, 
-OCH2CH20-, A2B2) 418.03246 (M + 1) 
[C, 6H21 79BrNO5 S 
MH 418.03242], 338  
56 
(M - Br), 282 (M - 
COCH2CH2Br), 
265, 263 (M Ts)  
3-74 1766 3.63-3.33 (4H, m, 376.00426 (M + 1) -53.7 132.5- 94 
(C0) -C112CH2-, A2B2) [C 1 4H1 
781  BrN04S 133.5 
1727 [24.8 (C8), 37.7 (C7), MI-I 376.00424], 
(C0) 41.1 (C 3), 53.2 (CO:  374.00624 (M + 1) 
4 X CH] [C 14H1779BrNO4S 
MH 374.00621], 296 
(M - Br), 238 (M - 
COCH2CH2Br)  
3-75 1733 3.86 (1H, q, J 14.0, 377.98982 (M + i)-  100.5- 32.6 
(C0) 5-H, AB), 4.01 (1H, C 13H15 81 BrNO5 S 102 
1752 q, J 14.0, 5-H, AB), MT-I 377.98338], 
(C=O) 4.32 ( IH, s, 3-H), 375.98713 (M + 1) 
4.70 (1H, s, 2-H); C 13H1579BrN04S 
[49.5 (CH2 , C5), 53.2 MH 375.98543], 318 
(CH, C2), [(M + 1) - COCH3], 
65.8 (CH, C3)] 298 [(M - 1) - Br}+  
3-78 3260 6.70-6.34 (2H, brs, 195 (M +1), 194 130- 28.2 
(NH) 3-H, 5-H), 9.40(111, (M), 193 (M -1), 131.5 
1674 brs, NH) 179 (M - CH3), 163 
(C=O) (M- OCH3), 135 (M 
- COOCH3) 
3-79 2245 2.56 (3H, s, Ar-CH3 ), 210 (M + 1), 183 96.0- 24.2 
(CN) 2.90 (211, t, J 3), 3.48 (M - CN) 96.5 
(2H, t, J 3), 8.16-7.40 
(411, m, Ar-H, A2B2) _______  
3-80 1722 3.54 (3H, s, N-CH3 , 209 ((M + 1), 177 203- 62 
(C=O) 3.92 (3H, s, COCH3), (M - OCH3) 204 
7.26 (1H,d, J 2, 2-H), 
7.60 (1H, d, J 2, 3-H)  
3-82 3272 1.38 (3H, t, J 7), 2.96 193 (M + 1), 192 118- 70.4 
(NH) (2H, q, J 7), 6.65(IH, (M), 191 (M - 1), 120.5 
1635 d, J 1.2, 3-H), 6.68 163 (M - Et), 135 
(C=O) (IH, d, J 1.2, 5-H), (M - COEt) 
10.1 (1H, brs, NH) 
3-83 3433 205.11895 (M+1)-' -53.21 oil 90 
(OH) [C 12H16NO2 MH 
1725 206.11810], 188(M- 
(C=O) OH), 174 (M - 
CH20H)  
3-84 1755 2.06 (31-I, s, COCH3) 248.12951 (M + 1) oil 74.2 
(C=O) [C 1411 18NO3 MH 
1741 248.12867], 174(M- 
(C=O)  CH20Ac)  
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3.3. Conclusion 
(2S,4R) 4HP can be converted to its (2R, 4R) stereoisomer which is a useful 
chiral starting material in asymmetric synthesis. A route to convert the 2-
carboxylic acid function to the corresponding aldehyde has been developed 
which is valuable for extension of the side chain. Because the aldehyde is 
quite easy reacted with other reagents it should be a useful chiral 
intermediate for synthesis of other products. 
The C-5 position is difficult to react or to be activated under normal reaction 
conditions in 4HP derivative systems because both the C-2 and C-3 
positions47  are more active than the C-5 position. To synthesis 2,5-
cyclisation products, anodic oxidation 58 would probably be a more effective 
method. 
Other methods developed in this investigation may be used in the future for 
synthesis of natural products or other compounds from (2S,4R) 4HP. Some 
materials synthesised in this work will be potentially useful for future work, for 
example, in the synthesis of C-3 derivatised 2-carboxy-4-hydroxy-
pyrrolidines. 
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Chapter 4. Development of Routes for 
the Syntheses of Difluorodethiobiotin 
and Other Analogues 
of Biotin Biosynthetic Precursors 
4.1. Introduction 
4.1.1 Biotin as an essential Coenzyme 
Biotin (4-1) is an essential mammalian vitamin produced by microorganisms 
and plants. It is present in minute amounts in all living cells 101 . The function 
of biotin is as the coenzyme responsible for CO 2 transfer in carboxylation 
and transcarboxylation enzymes. 
ATP 	 ADP 
	
o 	OH 

















ts V\CO V  
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Scheme 4-1: The role of biotin in malonyl C0A synthetase 
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Unlike many coenzymes, such as thiamine and the nicotinamides (e.g. 
NADH and NADPH), which act in the free state - biotin acts as a prosthetic 
group covalently attached to its carrier protein (biotin carrier protein, BCP) as 
a 8-lysine amide. In this aspect it is similar to the lipoamide and 
pantothenoate cofactors although these play a more prosaic role in transport 
of intermediates between active sites rather than being involved directly in 
enzyme catalysis. The mechanism of biotin action is still an area of active 
research. Our current views of the mode of action of biotin in carboxylase 
activity are summarised in Scheme 4-1 which shows the essential steps 
involved in the transformation of acetyl C0A to malonyl C0A by malonyl CoA 
synthetase' °2 
4.1.2. The Biosynthesis of Biotin 
The biosynthetic pathway to biotin has been extensively studied in E. coil 
and Bacillus sphaencus and to a lesser extent in plants. The pathway is 
shown in Scheme 4-2. 
On the basis of substrate and genetic studies it is now known that at least 
four proteins are definitely involved in the E. co/i pathway: 7-keto-8-
aminopelargonic acid* synthase (AOP or KAPA synthase, EC 2.3.1.47), 7,8-
d iaminopelargonate synthase (DAPA synthase), dethiobiotin synthetase 
(DTB synthetase, EC 6.3.3.3) and the BioB protein of biotin synthase 103 . The 
pathway in Bacillus sphaericus appears to be identical and there is a high 
degree of similarity in the amino acid sequences of the proteins encoded by 
the genes from the two organisms104 . Preliminary evidence also suggests 
* . 7Keto 8 am i nopelargOflic acis (KAPA, 4-4) and 7,8-diaminopelargoflic acid (DAPA, 4-3) are historic 
names still used in the literature. The correct names are 8-amino-7-oxononanoic acid and 7,8-
diaminononanoic acid respectively. 
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that the pathway in plants involves similar enzymes 105 . Two of the enzymes 
of the B. sphaericus pathway - pimeloyl CoA synthase (not shown in Scheme 
4-1) and AOP (KAPA) synthase - have been overexpressed in E coil and 
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Scheme 4-2: The pathway of biotin biosynthesis 
DTB synthetase from Pseudomonas graveolens has been partially purified 
and characterised by lzumi and coworkers 107 and Eisenberg and his 
collaborators were able to purify the E. co/i protein in small amounts from an 
E. co/i X lysogen (incorporating Xbio256 which carries the entire b1oABFCD 
cluster of genes). These authors found that the enzyme was a dimer 
requiring ATP, Mg 2 and CO2 for activity 108 . Recently our laboratory in 
Edinburgh has published the amino acid sequence of E. co/i DTBS 109 , the 
sequence of steps involved in its catalytic mechanism' ° and the X-ray 
structure of the enzyme and the enzyme-substrate complexes 111 . The native 
61 
E. co/i DTB synthetase structure has also been elucidated independently by 
Huang eta!112 . 
Cloning and overexpression of the BioB proteins of E. co/land B. sphaericus 
in E. coil has also been achieve& 13 . Sanyal et al have reported the 
purification and characterisation of the E. co/i bloB protein and shown it to be 
a dimer containing a Fe 2S2 cluster114 . Recently it has become clear that the 
enzymatic action of bacterial biotin synthase requires at least three proteins - 
the bloB protein, flavodoxin and a pyridoxal phosphate dependent cysteine 
desulfurase. While the enzyme mechanism of this complex transition is still in 
doubt it has been shown that the formation of the tetrahydrothiophene ring 
involves the intermediacy of the primary thiol 115 and that the ring closure step 
(i.e. formation of the C-6 sulfur bond) proceeds with retention of 
stereochemistry 116 
4.1.3. Inhibition of the biosynthesis of biotin as a biocide target 
Biotin is essential for normal cell function yet its biosynthesis is strictly 
controlled by a few enzymes which - at least in microorganisms - are present 
as only a few copies per cell. Thus analogues of biotin biosynthetic 
precursors which inhibit the enzymes of its biosynthesis should be potentially 
valuable as microbial and agrochemical biocides. Indeed early research had 
shown that biotin analogues such as a-methylbiotin (4-5, Fig. 4-1) and a-
dehydrobiotin (4-6) have significant biocidal action. It is now realised that 
these function as pseudo-substrates or ligands of the biotin activating 
holoenzyme, Bir A, and that they, or their AMP anhydrides, act as 
corepressors of blo gene expression thus inhibiting synthesis of the enzymes 
themselves 117 . a-Methyldethiobiotin (4-7) has a similar action to a-
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4.1.4. Synthesis of biotin, its precursors and their analogues 
The total synthesis of biotin was firstly achieved by Harris et a! in 19438,  but 
since then a large number of synthesis have been reported by numerous 
other research groups 119 . Some analogues of DTB, DAPA and KAPA have 
also been obtained through these routes. DTB can also be prepared by 
reduction of biotin and its analogues with Raney nickel 120 . The first total 
direct synthesis of DTB was achieved by Rubin et a/in 1942121.  Since then 
various authors including Marquet, Duschinsky, and Baxter et al have also 
synthesised DTB and some of its analogues 122 . The route used by Baxter's 
group is achiral but is more useful for analogue preparation due to the fact 
that it is possible to use different acid chlorides to vary the length of the side 
chain (Scheme 4-3). DAPA is ysually obtained by hydrolysis of 
dethiobiotin 123 . So far the total syntheses of chiral DAPA and KAPA have not 
been achieved although they can be obtained by biosynthetic methods 124 . 
4.1.5. Fluorodethiobiotin and its analogues 
Fluorinated analogues of biologically important compounds are of 
considerable importance in biological chemistry. The fluorine atom has the 
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closest covalent radius to the hydrogen atom (1.35 A compared with 1.20 A) 
of all of the elements. The substitution of fluorine for hydrogen results in 
minimal change of steric bulk in the molecules thus allowing fluorinated 
precursor analogues to mimic the metabolic fate of the parent hydrogen 
compounds leading finally to their incorporation into final metabolic products 
in the organism 125 . The carbon-fluorine bond is however much stronger than 
the carbon-hydrogen bond and as a consequence, the introduction of 
fluorine makes the substrate relatively resistant to metabolic transformations 
which require manipulation of the C-F bond 126 . Taken together with other 
properties of fluorine such as its strong electronegativity and good 
lipophilicity, the use of fluorine-containing analogues of biological 
intermediates has become common in medicinal and agrochemical fields in 
the past quarter of the century. 
In the pathway of biotin biosynthesis (see section 4.1.3), the final step is 
introduction of sulfur between C-6 and C-9 of the DTB skeleton by biotin 
synthase. So a C-6 or C-9 fluorinated DTB is important for our investigation: 
Firstly, it is a useful probe in research on the biotin synthase mechanism for 
elucidation of which carbon-sulfur bond formation and would help to provide 
a definite answer to the question of.the immediate sulfur atom donor; 
Secondly, the C-6 difluoro [or (6R)-monofluoro] or a C-9 trifluoro derivative of 
DTB should be good inhibitors of biotin synthase and thus potentially 
valuable biocides in the agrochemical field. 
4.1.6. The strategies and aims 
While a convenient route for synthesis of (±) DTB and its analogues has 
been developed in our laboratory, attempts to synthesis 6,6-difluoro-DTB (4-
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Another route for synthesis of biotin biosynthetic precursors is being 
developed in Edinburgh (Scheme 4-4). This is an interesting strategy for 
racemic KAPA, DAPA and DTB synthesis, but is not particularly suitable for 
synthesis of fluorinated analogues (S. Horgen, private communication). 
The overall aim of this work was to develop a versatile route to biotin 
biosynthesis precursors which would enable the construction of analogues of 
KAPA, DAPA and DTB. Ideally such a synthetic route would be chiral and 
could also be used for preparation of fluorinated analogues. For this reason 
we decided to discard the various routes to biotin synthesis which had been 
exploited by previous investigators and to design a route based, at least in 
part, on biogenetic analogy (see Scheme 4-1). 
The retrosynthetic analysis in Scheme 4-5 shows that DTB analogue 
construction (4-10) leads to the DAPA analogue precursor (4-11) which 
should be accessible by reductive amination from the KAPA analogue 
precursor (4-12). 
From this point biogenetic analogy is not helpful since the KAPA synthase 
step (see Scheme 4-2) in the biosynthesis has few chemical analogues. 
Construction of 4-12 may be analysed in three ways: a chiral aldehyde 4-14 
could be reacted with a six carbon unit; an intermediate (4-13) prepared from 
a chiral aldehyde (4-14) and a four carbon unit could be reacted with a two 
carbon unit such as ethyl bromoacetate (via a Reformatsky reaction); or 
another intermediate (4-15) made from N-protected-L-alaninal (4-14) and 
ethyl bromoacetate or its fluorinated derivative could be reacted with a four 
carbon unit. Compounds such as 4-15 should also be accessible by reaction 
of the chiral aldehyde 4-14 with other reagents. 
Based on the above analysis, we decided to develop a broad synthetic route 
shown in Scheme 4-6 for preparation of DTB and 6,6-difluoro-DTB (4-10, R 6 
= H or F, see Scheme 4-5). By exploring the synthetic methods in this route, 
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we also hoped to synthesise some useful synthons or intermediates for 
preparation of other analogues of biotin biosynthetic precursors. 
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Scheme 4-6: Routes to 6,6-difluoro-DTB and its ana'ogues 
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4.2. Results and Discussion 
4.2.1. Preparation of(S)-N-t-Boc-alaniflal 4-18 
The retrosynthetic analysis outlined in the previous section (see Scheme 4-5) 
indicates that optically active N-protected alaninal would be the desired 
starting material for the route. Thus the first target in this project was the 
preparation of this compound. 
Optically active N-protected a-amino aldehydes are important and versatile 
chiral synthons for stereocontrolled organic synthesis and two main methods; 
reduction of esters or active amides of N-protected a-amino acids and 
oxidation of alcohols obtained from N-protected a-amino acids are normally 
used for their preparation 127 . The main problem encountered is the 
racemisation of the product. Several research groups have synthesised N-
protected L-alaninals and their results have shown that while N-[9-(9-
phenyluorenyl)]-L-alaninal (N-Phfl-L-alaninal) is configurationally stable, 
other N-protected-L-alaninals are easily racemised and it is currently 
accepted that these have to be used immediately after preparation 128 . 
However, N-Phfl-L-alanine was unsuitable as a starting material in our work 
due to the difficulty of its preparation and the prohibitively high price of the 
starting material for the protecting group. So we chose N-Boc-L-alanine 4-17 
as the starting material to prepare the corresponding aldehyde because of 
the following reasons: Firstly, N-Boc-L-alanine is commercially available and 
the price is some ten fold cheaper than that of N-Phfl-L-alanine; Secondly, 
the Boc group is easy to remove selectively, and this is important for the later 
steps in the synthesis; Finally, although N-Boc-L-alaninal may be easier to 
racemise than N-Phfl-L-alaninal, we expected that under mild conditions 
racemisation of the aldehyde in the reactions could be minimised. 
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The first method we tried for synthesis of 4-18 was reduction of a active 
amide. Thus N-Boc-L-alanine 4-17 was reacted with 3,5-dimethylpyrazole to 
give the amide 4-25 in a 87% yield and 4-25 was then reduced with LiAIH4 at 
-780C in THF to give 4-18 in 60% yield (Scheme 4-7). Spectral data showed 
that 4-18 contained a CHO group [ö 9.68 (1H, s) ppm; ir 2723, 1729 cm- 1 
(CHO)J. The structure was further confirmed by elemental analysis and MS 
data [m/z 174.11299 (M + l), C6H16NO3  MH requires: 174.11302]. 
The second route for preparation of N-Boc-L-alanine is also shown in 
Scheme 4-7. The acid 4-17 was methylated with CH2N2 to give the methyl 
ester 4-26 which was reduced with LiBH4 to give the alcohol 4-27 in an 
overall 92% yield. When 4-27 was oxidised with COCl2/DMS0 73 at -780C, a 
74.5% yield of aldehyde 4-18 was obtained. Moreover it was found that it 
was possible to crystallise the product of this reaction. The high specific 
rotation ([a]D2°  -36.590) of the crystalline product indicated that the product 
was essentially the L-isomer. Compared with the first method, this way is 
much better with a higher yield and easier purification. 
NHBoc 
a 
31 	 _____ 
.-2S COOH 
4-17 
NHBoc 	I NHBoc 
b 	
CHO 
0 	N 	 4-18 
4-25 
NHB0c 	 d 	NHBoc 
'4COOMe 	
OH 
4-26 	 4-27 
Reagents: a. DCC/CH2Cl2; b. LIAIH4JTHF; c. CH2N2/Et20; d. LiBH4/THF; e. (COCI)2/DMSO 
Scheme 4-7: Routes to N-Boc-L-alaninal 4-18 
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Although the experimental data of 4-18 implied that our product was purer 
than that prepared by other researchers (see Table 4-1), we were confused 
by one aspect of its IH NMR spectrum: Why did the CHO proton not couple 
with its neighboring proton? (i.e. The CHO proton was a single peak in its 1 H 
NMR spectrum in both CDCI3 and DMSO-d 6 .) This would imply that the 
structure of the product could only be correct if it adopted a dihedral angle of 
approximately 900 between the 1-H and 2-H protons in both solvents. 
Molecular modelling using the Alchemy III program*  (Tripos Associates, 
1994) indicates a dihedral angle of ca 400  which would suggest that a 
significant coupling between the two protons would be observed. However 
fixing of the dihedral angles to allow maximum H-bonding between the 
carbonyl oxygen and the amide hydrogen results in a 1-H12-H dihedral angle 
of 85 0  which is consistent with the observation of no coupling (Fig. 4-3). 
While this is a reasonable explanation of the facts it suggests that the N-H 
O=C H-bond is not disrupted in DMSO. Thus a doubt remained that perhaps 
the product was not the desired aldehyde. 
To answer this question, a X-ray crystallographic determination of the 
structure of the product was required. The X-ray crystal structure is shown in 
Fig. 4-4. This completely confirms the enantiomeric purity of the product and 
enables us to have confidence in its stereochemical integrity. 
It is noteworthy that the aldehyde 4-18 is easy to crystallise from Et20, 
CH2Cl2 or mixed solvents and that crystalline samples have stable optical 
activity even at room temperature. For example, a crystalline sample kept for 
20 	0 
5 months at room temperature had [aID  -36.02 (c 1.0, MeOH) which was 
almost the same as the freshly purified compound [aID2° -36.580 (C 1.0, 
MeOH). 
* It should be noted that this program is limited in that it considers only van der Waal's and charge 
contributions. Determination of the exact conformation of a compound in solution involves 
contributions from solvent molecules which require more sophisticated approaches. 
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The unusually stable characteristics of crystalline 4-18 suggest that it will be 
an useful chiral synthon in asymmetric organic synthesis* 
129 
Table 4-1: Comparison of N-Boc-L-alaninal data 
reported by different researchers 
Synthesised by M.P. °C [aID Reported data Lit. 
Baxter 89.5 - 90.5 -3 6.59° CHN analysis, 
& Wang (c 1.0, MeOH) IR 'H-NMR, 
13C-NMR, MS, 
X-ray.  
Fehrentz 88 -89 +36.7° CHN analysis, 130 
& Castro (c 1, CH2C12) JR. 'H-NMR, 
-34.1 0 TLC. 
(c 1, MeOH)  
Jurczak group 88-89 +360 not reported 129a 
(c 1, CH2C12)  
Kanellis group (2,4-DNP +1.00 JR. 1H-NMIR, 131 
derivative: (c 1, CH2Cl2) TLC. 
143-5)  
Structure 1 	 Structure 2 
Fig. 4-3: Modelling of N-boc alininal. Modelling was carried out using the Alchemy III program 
(Tripos Associates, 1994). Structure 1 was generated after 1000 iterations and shows a 2-HI 1 -H 
dihedral angle of 42°. In Structure 2 the N-C-C-O torsion angle was fixed to simulate H-bonding 
between the amide H and the aldehyde oxygen - this results in a 2-W1-H dihedral angleof 85 0 . 
. Since the purification of N-Boc-L-alaninal has been developed the Sigma-Aldrich Company has 
decided to market the compound on our behalf. 
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Fig. 4-4: The X-ray crystal structure of (S)-N-Boc-alaninal 4-18 
4.2.2. Syntheses of (S)-4-t-butoxycarbonylamino-3-oxo-pentanoic acid, ethyl 
ester (4-21) and (S)-4-t-b utoxyca rbo nyla m i no-3-oxo-2.2-difluoropentanoic 
acid, ethyl ester (4-22) 
The next two targets in our route were 4-21 and 4-22. For economic reasons, 
we decided to synthesis 4-21 first to establish the reaction conditions, then 
based on this, to make the related fluorinated product. 
The Reformatsky reaction, a general way for preparation of -hydroxy esters 
by reaction of an aldehyde or ketone with a a-hatogenated ester in the 
presence of zinc132 , seemed the most suitable method for our purpose. 
Although various conditions have been developed to improve this reaction 133 , 
two important factors had to be considered in our route; maintaining the 
chiral centre and retaining the Boc group. 
When 4-18 was reacted with ethyl bromoacetate under different conditions, 
such as Zn/THE, Zn/B(OcH 3)3rrHF 133a, Zn/C6H6, Zn/THF-C6H6, the 
desired product was not obtained. However the reaction was successfully 
achieved using 12 catalysis in Et20. The yield of the product 4-19 was 73%, 
and its structure was confirmed by its spectral data [ir. 3433 (NH), 3390 
(OH), 1713 (C=O), 1639 (C=O) cm 1 ; 8H  1.34 (3H, t, J 7.2), 1.55 (12H), 2.58 
(2H, d, J 6.5), 3.26 (2H, q, J 7.2); m/z 262.16607 (M + 1), C12H24N 05 MH 
requires: 262.165451. The alcohol 4-19 could be oxidised with Jones reagent 
but gave a quite low yield (46.6%) of the corresponding ketone 4-21. It 
proved difficult to avoid partially hydrolysis of the Boc group. Swern oxidation 
was tried but it did not afford the desired product. The ketone 4-21 prepared 
by Jones oxidation gave satisfactory spectral data [ir. 3364 (NH), 1746 
(C=O), 1714 (C=O) cm 1 ; 8H 3.62 (2H, s); m/z 260.14860 (M + 
C 12 H22N05 MH requires: 260.14980]. 
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Under the same conditions, the fluorinated alcohol 4-20 could be obtained by 
reaction of 4-18 with ethyl bromodifluoroacetate in a 65% yield [ir. 3438 (NH), 
3393 (OH), 1766 (C0), 1682 (C=O) cm-i; 8H  1.34 (3H, t, J 7.1, CH2CH3), 
4.32 (2H, q, J 7.1, CH2CH3); Ei- 73.6 (C-3, t, 2JCF  24.6, 26.4), 114.2 (C-2, q, 
1JCF 254.4, 258.9), 163.3 (C=O, q, 2JCF 30.2, 32.1); mlz 298.14621 (M + 1), 
C12H22F2N05 MH requires: 298.14660], but the corresponding ketone 
could not be prepared by oxidation of 4-22 with Jones reagent. In contrast to 
4-21, 4-22 (Scheme 4-8) could be prepared by Swern oxidation of 4-20 in a 
42.4% yield [ir. 3398 (NH), 1777 (C=O), 1766 (C=O), 1711 (C=O) cm-i; 8H 
1.30 (3H, t, J 7.1, CH2CH3), 1.37 (3H, d, J 8.9, CHCH3), 1.38 (9H, s, Boc), 
4.33 (2H, q, J 7.1, CH2CH3), 4.75 (IH, brt, J 7.2, CHCH3), 5.08 (IH, d, J 6.4, 
NH); 8c  108.3 (C-2, t, 'JCF  264.0), 160.7 (CO 3 t, 2JCF  30), 196.9 (CO 3 t, 2JCF 
27.0); m/z 296.12994 (M + 1), C12H20F2N 05 MH requires: 296.13095]. 
NHBoc 
Jones oxidation 	2 
DEt 	 ]f' C00Et 
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4-21 
NHB0c 	 NHBoc 
Zn/BrCH 2 COOEt - 
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Since our purpose was preparation of the ketones 4-21 and 4-22, the 
stereochemistry of the alcohols 4-19 and 4-20 was not studied. However on 
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the basis of the 13C NMR spectra only one main stereoisomer of 4-19 and 4- 
20 were present. Modelling studies would suggest that these were the 3S, 
20 	o 
4S diastereomers. The specific rotations of 4-20 ([a]D -3.37) and 4-22 
([a]D2° +1.370) imply that the C-4 chiral centre in these products was (at least 
partially) maintained, but it must be noted that further evidence such as chiral 
tic, hplc or X-ray would be needed to confirm whether the chiral (C-4) carbon 
in the products is totally or partially retained. 
4.2.3. Synthesis of ureido ring compound 4-24 
From the ketones 4-21, 4-22 and the alcohols 4-19, 4-20, there were several 
possible routes for preparation of the cyclic product 4-24. There are shown in 
Scheme 4-9: 
NHBoc NHB0c TsCl/Py 	 RNH2 
NHBOC 
1 
53 	\CX2COOEt - - - 	 ,,-'\CX2COOEt 	- - - CX2COOEt 
OH OTs NHR 
4-19 X = H 





2.[H]. -'  NHR 
0 
0 
N H Boc 




- - 	 HN 	NR 	- - 
CX2COOEt 
0 CX2COOEt 4-24 R=Bz,X=H 
4-21 X=H 
4-22 X = F R=HorBz 
Scheme 4-9: Possible routes to the cyclic product 4-24 
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First, we tried to tosylate the alcohols, 4-19 and 4-20, but this was not 
successful even by heating with TsCl in pyridine at 90 0C for lOh. Next, a 
method for direct preparation of the imidazolinone was tried 1 . The ketone 
4-21 was hydrolysed with CF 3COOH at 0°C to cleave the Boc group and the 
unpurified reaction product was then reacted with KOCN to produce a 
crystalline product in 25% yield. This compound contained COOEt [ir, 1735 
cm-1 (C=O), 8H 1.21 (3H, t, J 7.1), 4.13 (21-1, q, J 7.1)]; CHCH3 [H  1.36 (3H, 
d, J 6.6), 4.42 (IH, dq, J 1.7, 6.6)]; N=C; (ir 1637 cm) and CONH2, [ir, 
3321, 3270 cm- 1 (NH2); oH 6.83 (11-1, brs), 9.17 (IH, brs)] groups. These 
data suggested a structure 4-28, i.e. a dimer was produced in this reaction. 
The structure of 4-28 was further confirmed by 13C NMR and MS [mlz 370 (M 
+ 2), 369 (M + 1), 324 (M - CONH2)t 294 (M - HCOOEt)+] data. This 
result can be rationalised on the basis of the acidity of the 2-H which is 
located between two carbonyl groups. A possible reaction mechanism for 
dimer formation is shown in Scheme 4-10. 
NH 	 NH 	HN=C0 	
2 NH .2 - 	 - N=c=O 
	
11 CooEt 	 CooEt 	 COOEt 
ROH 
EtOOC 2' CONH2 
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4-28 	- 











Scheme 4-10: Possible mechanism for formation of the dimer 4-28 
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Another potential route to 4-24 was that ketone 4-21 could be reductively 
aminated with NH40Ac/NaBH3CN 135 to produce the amine 4-29, which then 
should be easily converted to the desired cyclised product (Scheme 4-I1). 
However, when 4-21 was reacted with NH40Ac/NaBH3CN, a complex 
mixture was obtained and the desired product could not be isolated. Since 
this could be due to the polar nature of the product, BzNH2 was used to 
replace NH40Ac in this reaction, and the product 4-30 was obtained in a 
24.9% yield. [6 4.37 (2H, d, J 5.9, Ar-CH2-NH), 4.56 (1H, m, BzNH); m/z 
323.19739 (M + 1), C17H27N204 MH requires: 323.19708]. Under the 
same conditions, the fluorinated ketone 4-22 gave the product 4-31 [mlz 
358.17094, M, C17H24F2N2 04 M requires: 358.17041] in a 20%yield. The 
yields in these reactions were disappointingly low, and moreover, all chirality 
was lost, neither of the products 4-30 and 4-31 having any optical rotation. 
NHBoc 	NH40Ac/NaBH 3CN/MeOH 
CX2COOEt 
\\ H2/NaBH3CN/MeOH 
4-21 X = H 
4-22 X = F NHBoc 
2 	1 
CX2COOH 
4-30 X = H 







An alternative strategy to the ureido ring compounds is shown in Scheme 4- 
12. The ketone 4-21 was heated with BzNH2/C6H6 to give an enamine 4-32 
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[ir. 3338 (NH), 1711 (C=O), 1649 (C=O), 1609 (C0) cm 1 ; 8H  1.24 (3H, d, J 
6.3), 4.16 (1H, m, 4-H), 4.48 (IH, d, J 6.1, 2-H), 4.62 (2H, d, J 14.3, Ph- 
CH2NH), 8.86 (IH, brs,BzNH); 8c 58.48 (Ph-CH 2), 79.20 (C-4), 81.46 (C-2), 
154.49 (C-3); mlz 349.21508 (M + i)', C20H29N204 MH requires: 349.21273] 
in 91% yield. 
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Scheme 4-12 
We expected that the enamine 4-32 would be reduced easily to produce the 
desired diamine product 4-35. However, 4-32 could not be reduced with 
NaBH3CN even though the reaction was continued for a long time. When 4- 
32 was hydrogenated on Adam's catalyst 136  in AcOH, a complex mixture of 
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products was obtained none of which retained the benzyl group. Reduction 
of 4-32 with LiBH4 in THF gave the cyclic amide 4-33 [ir. 3290 (NH), 1668 
(C=O), 1611 (C=C-C=O); 8H  4.22 (2H, d, J 5.6, Ph-CH2-NH), 4.44 (IH, s, 
C=CH), 6.85 (1H, t, J 5.5, BzN!-I); mlz 303.17062 (M + 1), C 17 H23 N203 MH 
requires: 303.17087] in 53% yield. Reduction of 4-32 with excess LiAIH4 in 
THE gave the acid 4-34 in 23% yield, [ir. 3340 (NH), 3308 (OH), 1720 
(C=O), 1681 (C=O), 1644 (C=N); 8H  3.50 (IH, q, J 16.9, 2-H, AB), 3.56 (1H, 
q, J 16.9, 2-H, AB), 4.44 (2H, BzCH 2); 8c 43.5 (C-2), 45.2 (PhCH2), 155.3 (C-
3), 205.9 (COOH); m/z 321.18083 (M + 1), C 17 H25N204 MH requires: 
321.18143]. 
The fact that all of the reduced products retained the enamine or imine bond 
suggest that these groups are stable to the above reduction conditions in this 
structural system. So, we tried to reduce 4-32 under acidic conditions. The 
desired product 4-35 was finally obtained in a 91% yield by using NaBH3CN 
in MeOH/HCI [ir. 3364 (NH), 3348 (NH), 1726 (C=O), 1698 (C=O); & 36.34 
(C-2), 49.01 (C-3), 58.17 (C-4); m/z 351 (M + 1)]. 
To convert 4-35 to the corresponding cyclic ureido compound it was first 
treated with CF 3COOH to hydrolysis the Boc group then with COCl 2 in 
toluene-Na2CO3 to afford a cyclic product in an overall 91% yield (Scheme 
4-12). The structure of the product is discussed in the next section. 
4.2.4. 	Structure 	elucidation 	of 	(4RS. 	5RS)-1 -benzyl-4-methyl-5- 
ethoxycarbonylmethyl-tetrahyd roimidazolid-2-one 
110 
The cyclic product derived from 4-35 reacted with N,N-dimethylamino 
cinnamaldehyde to give a pink colour on tic. This is a test for 
dihydroimidazolin-2-ones which is used in our laboratory and suggests the 
presence of the this functionality in the product. The MS data of the 
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compound was also concordant with the presence of the 
dihydroimidazolinone ring structure expected for 4-24 [mlz 277.15503 (M + 
1)+, C151-121N203 MH requires: 277.15522, 231 (M -OEt), 203 (M - 
COOEt), 189 (M - CH2COOEt) and 185 (M - Bz)J. Additionally the ir 
spectrum of the product showed that the product contained a typical carbonyl 
group of a dihydroimidazolinoné ring (1695 cm 1 ). These results implied that 
the desired cyclic product 4-24 has been produced. However the 1 H and 13C 
NMR speätra were much more complex than expected for this structure. 
Both spectra showed multiple resonances for each of the signals expected 
for the structure 4-24. The 1 H-NMR COSY of the product was also 
complicated, exhibiting cross peaks for methyl-CH coupling with methine 
signals at both 3.45 and 3.92 ppm. These data could be accommodated in 
two structures --- if the product was a 1:1 mixture of both cis and trans 
substituted dihydroimidazolinones (4-24) or if it were an dimer (4-24a or 4-
24b Fig. 4-5). Indeed evidence for a dimeric structure was suggested from 
the MS of the crude product which showed an ion at m/z 553 (59.5%). 
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Obviously further information about the structure was required and 
eventually we obtained single crystal of the product for X-ray structural 
determination. The X-ray crystal structure of the product is shown in Fig. 4-6, 
and clearly identifies that the product is the desired cyclic product 4-24 (see 
Scheme 4-12) but that this was a mixture of trans and cis substituted ring 
products (Ca. 1:1). Due to the fact that 4-24 contains two chiral carbons, we 
should say 4-24 is a mixture of four stereoisomers. 
On this basis it is relatively easy to explain the 1 H-NMR, 1 H COSY and 13C-
NMR spectra of the product as a mixture of cis and trans isomers of 4-24. 
For convenience we can designate.the isomers as X and Y. In the 1 H-NMR 
the 6 1.07-1.20 (6H) region shows 10 peaks, corresponding to the CHCH3 
and CH2CH3 signals. Five peaks come from X, another five from Y; the 6 
2.45 (2H, m) peaks is due to 2-H which produces a ABX system with 3-H; the 
3-H of one isomer (X or Y) is located at 6 3.45 (IH, m) which is coupling with 
2-H; the other isomer's 3-H (Y or X) is located at 6 3.92 which is 'a part of 
ABX system; The 6 3.45 resonance also contains the 4-H sign of the other 
isomer (Y or X) which is coupled with 4-CH3, and the 6 3.92 resonance 
contains the 4-H of the other isomer (X or Y) which also couples with 4-CH3; 
6 4.03 (3H, m) are the protons of CH2CH3 and a proton of Ph-CH2, this 
proton is the A part of the AB system of Ph-CH2; at 6 8.68 (2H, q) is the 
other proton of Ph-CH2 which is the B part of the AB system, two peaks 
come from X the others from Y; 6 5.59 (s) and 5.69 (s) are the signals of NH, 
one peak come from X, another from Y and their ratio is Ca 1:1; 6 7.26 (5H, 
m) are the Ph protons (see Appendix 2: 1 H COSY 2D spectrum of 4-24). The 
signals of the two isomers in a 1:1 ratio are also apparent in the 13C-NMR 
spectrum. 
The alcohol 4-36 (see Scheme 4-12) is produced from 4-24 in 56% yield via 













































structure follows from the structure of the ester and its spectral data [ir. 3300 
(OH), 3286 (NH) and 1689 (C=O) cm-i; oH 1.71 (21-1, m 2-H), 2.84 (IH, brs, 
OH), 3.67-3.46 (41-1, 1-H, 3-H and 4-H); 5 c 29.8, 33.9 (C-2), 44.7, 45.0 (C-I), 
49.2, 50.8 (C-3 or C-4), 55.8, 59.8 (C-4 or C-3), 58.1, 59.0 (Ph-CH2); mlz 235 
(M + 1), 219 (M - CH3)t 217 (M - OH), 203 (M - CH20H), 189 (M - 
CH2CH20H)t 143 (M - Bz)]. 
While it was disappointing that the desired products could not be prepared in 
a stereochemically controlled fashion it is noteworthy that the yields of the 
ring closure to 4-24 and its reduction to 4-36 are fairly good. Thus we now 
know that dihydroimidazolinone ring formation could be achieved by this 
route and could infer that if we were able to produce chiral diamine 
intermediates we would be able to generate the corresponding ring closure 
products. 
4.2.5. Stereocontrolled synthesis of chiral diamine intermediate 4-41 
As we have pointed out in the above section, the chiral centres of the 
products were totally lost due to racemisation of the enamine 4-32. We 
suppose one of the main reason is that the imine intermediate 4-38 is so 
easy to protonate that it racemises totally via an equilibrium process of 
deprotonation-protonation (Scheme 4-13). In this equilibrium reaction, the 
final product (4-32) we obtained is in fact the thermodynamically most stable 
compound. 
Based on this analysis, we choose BzONH2 to replace BzNH2 to prepare 
the chiral diamine because the imine intermediate produced from BzONH2 
should in principle be more difficult to protonate due to the oxygen atom 
making the nitrogen less basic. Moreover, reagents such as BH3.THF are 
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Thus 4-21 was heated with BzONH2.HCI in C6H6/Et3N  to give the imine 4- 
39 in 95% yield. The structure of 4-39 was identified by satisfactory 
spectroscopic data [ir. 3366 (NH), 1737 (C=O), 1713 (C=O) cm - I; oH 3.26 
(IH, q, J 15.9, 2-H, AB), 3.32 (IH, q, J 15,9, 2-H, AB), 5.08 (2H, s, 
PhCH20); 6c  33.1 (C-2), 60.8 (OCH2CH3), 75.9 (PhCH20), 153.5 (C0), 
154.9 (C=N), 168.5 (C=O); m/z 365.20897 (M + I), C19H29N205  MH 
requires: 365.20765]. The more valuable result is that the chiral centre we 
desired was retained ([(X]D20 -1 9.05°). 
When 4-39 was reduced with LiBH4 in THF, an alcohol 4-40 was obtained in 
92.4% yield. Satisfactory data for 4-40 confirmed its structure [ir 3428 (OH), 
3337 (NH)1688 (C=O), 1577 (C=N); 8H  2.6-2.2 (2H, m, 2-H), 3.73 (3H, m 1-H 
and OH), 5.01 (2H, s, PhCH20); Oc 30.3 (C-2), 58.6 (C-I), 74.5 (PhCH20), 
155.2 (C=O), 159.0 (C=N); m/z 323.19670 (M + I), C17H27N204  MH 
requires: 323.19708]. The chiral centre of the product was also retained 
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([a]D20  -37.10). This result also identified the fact that the imine group is quite 
difficult to reduce by normal reagents in this structural system. 
The imine 4-40 was finally reduced to give the amine 4-41 (Scheme 4-14) in 
44.2% yield using NaBH3CN in the same way as used in the preparation of 
4-23 from 4-21. The data for 4-41 confirmed its structure [ir. 3427 (OH), 3348 
(NH), 1692 (C=O); 8H 4.68 (2H, d, J 2.9 PhCH20), 4.96 (1H, brs, NH), 5.88 
(IH, brs, NH); 8c 31.19 (C-2), 48.65 (C-4), 61.27 (C1), 63.37 (C-3), 76.17 
(PhCH20), 155.56 (C=O); m/z 325 (M + !), 269 (M - 55)t 251 (M - t- 
BuO)t 225 (m - Boc)]. This amine was also optical active ([(X]D2°  1 .20). 
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Reagents: a). BzONH2.HCl/C6H6/Et3N; b). LiBH4JTHF; 
c). NaBH3CN/MeOH/HCI; d). (C0CI)2/DMS0. 
Scheme 4-14 
Even though attempts to oxidise 4-41 to give the aldehyde 4-42 (see 
Scheme 4-14) via Swern reaction have not proven successful at the time of 
It should be noted that the enantiomeric purity of 4-41 is not determined at the time of writing, 
however the specific rotation indicates that the product is not totally racemised. 
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writing, we can predict that this route is potentially very valuable for 
preparation of the chiral analogues of 4-24 and 4-36, and moreover, for 
asymmetric syntheses of dethiobiotion and other analogues in future work. 
4.2.6. Preparation of other chiral synthons 
From N-Boc-L-alaninal 4-18 other chiral synthons or intermediates can be 
prepared and some of them are in principal more useful than 4-18. Some 
examples which have been prepared in these studies are shown in Scheme 
4-15. 
When 4-18 was reacted with vinylmagnesium bromide in THE at -780C, an 
alcohol 4-43 was obtained in 100% yield [ir. 3446 (OH), 3352 (NH), 1690 
(C=O), 1509 (C=C); mlz 201.13807, M1 CI01-119NO3  M requires: 
201.13649]. The alcohol 4-43 was oxidised with Jones reagent at 0°C to 
give a ketone 4-44 in 56.6% yield (Scheme 4-15). The structure of 4-44 was 
confirmed by spectroscopic data [ir. 3332 (NH), 1707 (C0), 1698 (C0), 
1612 (C=C), cm-i; 8H  5.87 (1H, q, JAx 11.4, JBX  17.4, 2-H, ABX), 6.37 (IH, q, 
JBX 17.4, JBA  11.5, 1-H, ABX), 6.43 (IH, q, J Ax 11.4, JAB  11.5, 1-H, ABX); m/z 
200.12850 [(M + 1), C16H18NO3  MH requires: 200.12867]. 
The ketone 4-44 can be crystallised from Et20-pentane (1:3) to give crystals 
(m.p. 61-62.50C); its specific rotation (1a1D
20 
 -30.890) implies that the chiral 
centre is maintained. Comparing the chiral synthons 4-44 and 4-18, we think 
4-44 has the following advantages in asymmetric synthesis: 
a). 4-44 reacts more easily with nucleophilic reagents. For example, when 4-
18 was reacted with allylmagnesium bromide, the reaction could not 
completed at -78°C even when continued for 1 hour; but 4-44 afforded the 
optically active product 4-45 in 95% yield ([a]D2°  -26.40) under the same 
conditions in a reaction time of half an hour; 
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b). As a aj3-unsaturated ketone, 4-44 can produce two types of addition 
reactions, i.e. 1.2 and 1.4 addition, allowing the flexibility of nucleophilic 
attack at two centres. Thus, as an asymmetric synthetic building block, 4-44 
can be used in more types of reactions than 4-18. For example, 4-44 can be 
used as a typical Michael acceptor in Michael additionM.  This may be a 
valuable characteristic for future work. 
To counteract the disadvantage of that 4-44 is not directly suitable for 
preparation of C-6 fluorinated biotin precursor analogues, we designed 
another synthon which could be prepared via the route shown in Scheme 4-
15. Thus 4-18 was reacted with allymagnesium bromide in THF to give an 
alcohol 4-46 in a 57.3% yield. [ir 3434 (OH), 3350 (NH), 1681 (C=O), 1644 
(C=C) cm-i; 8H  5.02 (21-1, m, 1-H, ABX), 5.77 (1H, m, 2-H, ABX); 8 c 38.15 (C-
3), 49.93 (C-5), 73.08 (C-4), 117.63 (C-I), 134.40 (C-2); mlz 216.15996 (M + 
I), C 11 H22NO3 MH requires: 216.15997]. This alcohol 4-46 was acetylated 
with Ac20/Et3N to give an ester 4-47 in 31.3% yield. [ir, 3355 (NH), 1741 
(C=O), 1713 (C=O), cm-i; 8H  2.01 (31-1, s, Ac); m/z 258.17251 (M + 
CI3H24N04 MH requires: 258.17053]. Both 4-46 and 4-47 are optically 
active (4-46: [aID2° 5.I40; 4-47: [aID2° -27.140), which suggests that their 
chiral centres are maintained in the reactions. The 'H and 13C NMR spectra 
of 4-46 and 4-47 indicate that the Grignard reaction affords virtually a single 
diasteriomer (> 10:1). On the basis of steric approach control this should be 
the e,ythro product although at this time it has not been determined whether 
this is correct. 
The product 4-47 should be easily oxidised with 03 to give an aldehyde 4-48 
which should be a useful asymmetric building block in various reactions. The 
main advantage in this route is that BrCF2CH=CH2 reagent is commercially 
available, so the corresponding fluorinated product could potentially be 
obtained via this route. 
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Scheme 4-15: Useful synthons made from N-Boc-L-alaninal 4-18 
Finally, 4-18 can be reacted with BzNH2 in benzene to produce the imine 4-
49 in 73% yield (Scheme 4-14) [ir, 3400 (NH), 1712 (C=O), 1670 (C=N) cm-i; 
oH 4.61 (21-1, s, Ph-CH2), 7.73 (IH, brs, N=CH); m/z 263 (M + 1)+]. Although 
the optical rotation of 4-49 reveals that the chiral centre was lost, this imine is 
still a useful starting material for preparation of various diamine derivatives 
and other compounds138. An advantage of 4-49 is that this imine can be 
crystallised from Et20 at low temperature (m.p. 52-54 0C). 
4.2.7. Approaches to the synthesis of 7-keto-8-aminopelargonic acid (KAPA) 
In the retrosynthetic analysis (see section 4.1.6, Scheme 4-5), a strategy for 
synthesis of KAPA analogues was advanced where a C 6 unit nucleophilic 
reagent was reacted with aldehyde 4-18, and the product was to be 
deprotected and oxidised to afford KAPA 4-4. The only problem with this 
route now that the aldehyde is available appears to be how to prepare a C 6 
nucleophilic reagent. So, we decided to deal with this problem. 
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Preparation of a C6 nucleophilic reagent proved in fact to be a real challenge 
even though the use of the similar reagents has been reported in 
literature 139 . The difficulties in preparing this reagent are as follows: First, this 
material has to be a difunctional reagent, one functional group being used for 
conversation to a carbanion to react with the aldehyde, another being stable 
to the carbanion producing conditions and able to be converted subsequently 
to a carboxylic acid group. Second, most long chain halogeno-aliphatic 
compounds are usually unreactive and this meant that relatively vigorous 
conditions would be needed to produce the carbanions, which might result in 
destruction of the protected functionality at the same time. Finally, most of 
the commercially available difunctional C6 regents are expensive which 
restricts the methodology development. 
The first strategy for preparation of the desired C 6 reagent involved silyl ether 
methodology and is shown in Scheme 4-16. But this route had to be given up 
as the yield of 4-50 was low, and attempts to prepare the lithium reagent 4-
51 were not successful. 
However, a suitable C6 reagent, 6-benzoxyhexylmagnesium bromide 4-52, 
was finally prepared via the route shown in Scheme 4-16. Thus 1,6-
dibromohexane was reacted with NaOBz in THF to give the monosubstituted 
product 4-53 in 39.7% yield [H  1.48 (4H, m, 3-H, 4-H), 1.67 (2H, brt, J 6.5, 2-
H), 1.89 (2H, brt, J 7.0, 5-H), 3.42 (2H, t, J 6.8, 6-H), 3.51 (2H, t, J 6.4, 1-H), 
4.54 (2H, s, Ph-CH2), 7.37 (5H, m, Ar-H); 8 c 25.09, 27.65, 29.26, 32.41, 
33.52, 69.83, 72.52 (7XCH2); m/z 273.06804 (M + 1), C13H2008'Br  MH 
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Scheme 4-16: Approaches to the synthesis of KAPA 4-4 
Compound 4-53 was heated with Mg in ether at reflux to give the Grignard 
reagent 4-52, which could be stored at room temperature for future use 
To confirm that the product was in fact 4-52, a model reaction shown in 
scheme 4-16 was carried out. When 4-52 was reacted with p-anisaldehyde in 
THE, and the unseparated reaction mixture was oxidised with Jones reagent, 
the ketone 4-54 was obtained in 72% yield. 
The data on 4-54 confirmed that the desired reaction had occurred [ir, 1670 
(C=O) cm-i; 8H  1.40 (41-1, m, 4-1-1, 5-1-1), 1.63 (21-1, brt, J 6.8, 3-1-1), 1.73 (2H, 
* This reagent is quite stable at room temperature. It is also relatively unreactive and cannot be titrated 
to determine its concentration in solution using the standard literature method (ref. 140 ) because it 
does not produce desired colour with the indicator 1,1 0-phenanthroline . 
89 
brt, J 7.2, 6-H), 2.90 (2H, t, J 7.7, 2-H), 3.46 (2H, t, J 6.5, 7-H), 3.48 (3H, s, 
OCH3), 4.49 (2H, s, Ph-CH2), 6.90-7.95 (4H, q, Ar-H, A2B2),  7.32 (5H, m, 
Ar-H); 5c 198.88 (C=O); m/z 327 (M + 1), 235 (M - Bz), 219 (M -BzO or M - 
PhOCH3)]. We could thus be confident that the reagent was 4-52. 
Perversely however 4-52 refused to react with 4-18 under a variety of 
conditions which suggests that the aldehyde 4-18 is rather unreactive. 
4.3. Conclusion 
While it has not possible to achieve synthesis of the final target compounds 
outlined in the introduction to this chapter within the time scale of this thesis 
a significant amount of new chemistry has been developed which should be 
valuable both in this area and other projects. 
Based on the chiral aldehyde 4-18 and some of the compounds prepared 
from it in this work it seems likely that it will be possible to develop a number 
of routes to dethiobiotin, 6,6-difluorodethiobiotin and other analogues. The 
synthesised chiral products, aldehyde 4-18 and a,13-unsaturated  ketone 4-44 
may also prove to be versatile chiral synthons in other asymmetric organic 
synthetic fields. 
Additionally the method established for the preparation of 6-benzoxy 
hexenylmagnesium bromide 4-52 is important in that using this route the 
reagent obtained is relatively cheap, which may lead to its greater use in 
synthesis of various types of compounds such as fatty acids and 
prostaglandin analogues 139 . 
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Chapter 5. Experimental 
5.1. General Methods 
All starting materials were purchased from commercial sources (mainly from 
Sigma-Aldrich, Fluka, Fluorochem and Lancaster). Reagents were routinely 
redistilled or recrystallised before use. The following solvents used in 
reactions were dried using the reagents given in parenthesis before 
distillation: chloroform, dich loromethane and acetonitrile (phosphorous 
pentoxide); ethanol and methanol (sodium); diethyl ether, tetrahydrofuran 
and I ,2-dimethoxyethane (lithium aluminum hydride); toluene and benzene 
(sodium); dimethyl sulfoxide (calcium hydride). 
Fluka silica gel 60 (220-440 mesh) was used for column chromatography. 
Thin layer chromatography (tic) was carried out on aluminum backed sheets 
precoated with Merck Kieselgel 60 F 254 No.3545 silica. Solvent systems for 
tic were either chloroform/pentane (1:1-5), ethyl acetate/chloroform (1:3-8) 
or ethyl acetate/methanol (1:1-3) unless otherwise stated. Visualisation of 
the components was achieved by either: iodine vapour, UV absorption at 254 
nm or ninhydrin solution (0.2% in ethanol) spray. Organic extracts were 
routinely dried with anhydrous sodium sulfate prior to evaporation. 
Melting points were recorded on an electrically heated Reichert 7905 melting 
point apparatus and are uncorrected. lnfra-red spectra were recorded on a 
Biorad FTS7 Fourier Transform infra-red spectrophotometer. Samples were 
prepared as liquid films or as nujol muils unless otherwise indicated. 1H-NMR 
spectra were recorded on either a Jeol JNM-PMX 60 (60 MHz), a Bruker WP 
200SY (200MHz) or a Bruker AX 250 (250 MHz) instruments using 
tetramethylsilane (8 = 0.0) as the external standard. 13C-NMR spectra were 
recorded on a Bruker WP 200SY (50.3 MHz) instrument using 
tetramethyisilane as the external standard. Two-dimensional spectra were 
recorded on the Bruker AX 250 (250 MHz) instrument. The units of chemical 
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shift () are given in ppm, and coupling constants (J) are in Hz. Except for 
those indicated, all of the mass spectra and exact mass measurements were 
fast atom bombardment (FAB) spectra which were recorded on a Kratos MS 
50 TC instrument using either glycerol, thioglycerol or 3-nitrobenzyylalcohol 
as matrices. Electron impact (El) mass spectra were recorded on an AEI MS 
902 instrument. Optical rotations were measured on a Perkin Elmer 141 
polarimeter using 10 cm cells containing 4.8 CM3  or 1.8 cm3 of filtered 
solution and the specific rotation ([a]D)  values are given in 101  deg cm 2 g'. 
Elemental analyses are determined using a Perkin Elmer 2400 elemental 
analyzer. Radioactivity (see compound 2-13t) is determined by scintillation 
counting on a LKB RackBeta counter in Paclard scintillation fluid using 
internal standardisation to compensate for colour quenching. X-ray diffraction 
analyses are performed using a Stoe STADI-4 four circle diffractometer by 
Drs. P. 0. Gould and A. J. Blake. 
5.2. Preparations 
Preparation of berberine chloride 2-5 from 2-6 
To a suspension of 2-6 (0.091 g, 0.25 mmol) and NaH (0.097 g, 4.0 mmol) in 
dry DMF (7cm3) CH2Br2 (0.1 cm3, 1.42 mmol) was added at 80 0C under N2. 
The mixture was heated at 80-900C under N2 for 30 mm, then cooled to r.t 
and NH4CI 0  g) was added. After evaporation of the solvent under reduced 
pressure, the mixture was extracted with acetone (10 cm 3 X 6) which was 
then evaporated to give a residue. The residue was purified by column 
chromatography on A1203 which was eluted with EtOAc (200 cm3) and 
acetone (100 cm3) successively. The acetone eluate was evaporated to give 
a solid which was crystallized from acetone-MeOH (3:1) to give 2-5 as yellow 
needles (0.038 g, 40.4%). m.p. 197-1990C (lit. 141 , 2000C dec); 8H  (60 MHz, 
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DMSO-d6) 3.50-2.80 (2H, brs), 3.94 (3H, s, OCH3), 3.98 (3H, s, OCH3), 
5.04-4.6 (2H, brs), 6.08 (2H, s, -OCH20-), 6.96 (IH, s, Ar-H), 7.98 (IH, s, Ar-
H), 8.60 (IH, s, Ar-H), 8.98 (IH, s, C=CH), 9.85 (IH, s, N=CH); mlz 336 (M, 
cation). The material prepared was chromatographically identical to an 
authentic sample of berberine chloride. 
Demethylene berberine chloride 2-6 
A suspension of berberine chloride hydrate (2-5, 1.47 g, 4.0 mmol) in CH202 
(150 cm 3) was slowly dropped into a solution of BCI3 in CH2Cl2 (1.0 M, 8.3 
cm3, 8.3 mmol) at r.t. under argon over 0.5 h. After stirring under argon at 
r.t. for 25 h, MeOH (10 cm 3) was slowly added to stop the reaction. The 
mixture was evaporated to give a residue which was crystallised from MeOH 
to give 2-6 as yellow needles (1.047 g, 73.6%). m.p. > 230°C; (Found: C, 
61.80; H, 5.13, N, 3.96. C19H18NO4CI.1/2H20 requires: C, 61.88; H, 5.19; 
N, 3.80%); 8H  (60 MHz, DMSO-d6) 3.39-3.10 (4H, brs), 4.24 (3H, s, OCH3), 
4.30 (3H, s, OCH3), 5.30-5.00 (2H, brs, OH), 7.09 (IH, s, Ar-H), 7.86 (IH, s, 
Ar-H), 8.32 (2H, d, Ar-H), 8.96 (IH, s, C=CH), 10.14 (IH, s, N=CH); m/z 324 
(M, cation). 
Diacetyl demethylene berberine chloride 2-7 
Compound 2-6 (0.14 g, 0.39 mmol) was reacted with Ac20 (5 cm 3) in 
pyridine (5 cm 3) at r.t. for 20 h. The mixture was evaporated under reduced 
pressure to give a solid which was crystallised from EtOH to give the diacetyl 
product 2-7 as a pale yellow solid (0.13 g, 75 %); m.p. 192-194°C; 8H (60 
MHz, D20) 2.30 (3H, s, COCH3), 2.40 (3H, s, COCH3), 3.50-2.98 (2H, brs), 
3.98 (3H, s, OCH3), 4.12 (3H, s, OCH3), 5.00-4.35 (2H, brs), 7.30 (IH, s, Ar-
H), 7.76 (1H, s, Ar-H), 7.95 (IH, s, Ar-H), 7.98 (1H, s, Ar-H), 8.38 (IH, s, 
C=CH), 9.70 (1 H, s, N=CH); mlz 408 (M, cation). 
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Demethyl tetrahydroberberine 2-8 
A solution of 2-11 (0.687 g, 2.0 mmol) in dry THF (10 cm 3) was slowly 
dropped into a solution of (BzSe)2 (0.467 g, 1.3 mmol) and NaBH4 (0.687 g, 
18 mmol) in dry THF (30 cm3) at r.t under N2. The mixture was heated at 
reflux for 45 mm, then cooled and evaporated to give a residue which was 
extracted with aq. HCI (2M, 5 cm3 X 6). The aq. solution was extracted with 
CHCI3 (10 cm3 X 2), then basified with KOH to pH 10-12 and extracted with 
CHCI3 (10 cm 3  X 5). The combined CHCI3 extract was washed with brine (10 
cm3 X 2), dried and evaporated to give a solid which was crystallised from 
MeOH to give 2-8 as colourless crystals (0.105 g, 32%). m.p. 184.5-185.50C 
(lit. 143 , 183-1850C); 8H  (60 MHz, CDCI3) 4.5-2.3 (10H, m), 3.92 (3H, s, 
OCH3), 5.98 (2H, s, -OCH20-), 6.68 (IH, s, Ar-H), 6.79 (2H, s, Ar-H), 6.82 
(1H, s, Ar-H); 6c  (50 MHz, CDCI3), 29.4 (C-5), 36.3 (C-13), 51.2 (C-6), 53.3 
(C-8), 56.0 (10-OCH3), 59.4 (C-13a), 100.6 (C-2), 105.4 (C-14), 108.3 (C-4), 
108.8 (C-lI), 119.1 (C-12), 121.1 (C-8a), 127.7 (C-4a), 127.8 (C-12a), 130.8 
(C-13b), 141.4 (C-9), 143.9 (C-b), 145.7 (C-14a), 146.0 (C-3a); m/z 326 (M 
± 1). 
Tetrahydroberberine 2-11 
To a solution of berberine chloride hydrate (2-5, 0.372 g, 1.0 mmol) in 
MeOH (30 cm3) NaBH4 (0.045 g, 1.2 mmol) was added with vigorous stirring 
at r.t.. After stirring at r.t. for 5 h, the mixture was evaporated to give a 
residue which was extracted with CHCI3 (8 cm3 X 3). The extract was 
evaporated to give a solid which was crystallized from CHCI3 to give 2-11 as 
colourless crystals (0.302 g, 89%). m.p. 172.5-173.5 0C (lit. 142 172-173°C); 8H 
(60 MHz, CDCI3) 4.56-2.34 (9H, m), 3.92 (6H, s, 2 X OCH3), 5.98 (2H, s, - 
OCH2O-), 6.68 (1H, s, Ar-H), 6.82 ( 1H, s, Ar-H), 6.91 (2H, s, Ar-H); 8C (50 
MHz, CDCI3) 29.4 (C-5), 36.3 (C-13), 51.2 (C-6), 53.8 (C-8), 55.7 (10-OCH3), 
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59.5 (C-13a), 60.0 (9-OCH3), 100.6 (C-2), 105.4 (C-14), 108.2 (C-4), 110.8 
(C-lI), 123.7 (C-12), 127.5 (C-8a), 127.6 (C-4a), 128.5 (C-12a), 130.7 (C-
13b), 146.0 (C-3a), 150.1 (C-9); m/z 340 (M + 1). 
[8,13a - 2H21 - Tetrahydroberberine hydrochloride 2-11d 
Berberine chloride hydrate (2-5, 0.247 g, 0.66 mmol) was reduced with 
NaBD4/MeOH using the same method as in the preparation of 2-I1 to give 
2-11d as colourless crystals (0.211 g, 92.5%). oH (60 MHz, CDCI3) 4.40-
2.40 (7H, m), 3.90 (6H, s, 2 X OCH3), 5.97 (2H, s, -OCH20-), 6.66 (1H, s, Ar-
H), 6.80 (1H, s, Ar-H), 6.89 (2H, s, Ar-H); mlz 342 (M + 1), 343 (M + 2). 
Berberine iodide 2-12 
To a solution of 2-11 (0.339 g, 1.0 mmol) and KOAc (0.49 g, 5.0 mmol) in 
EtOH (50 cm3) heated at reflux a solution of 12 (1.269 g, 5 mmol) in EtOH (20 
cm3) was added slowly. After heating at reflux for 4 h, the mixture was 
cooled to r.t. and filtered. The solid was washed with water (10 cm 3) and 
acetone (10 cm3), then crystallised from hot MeOH to give 2-12 as a yellow 
solid (0.348 g, 75%). m.p. > 230°C; 0H  (60 MHz, DMSO-d6) 6.58 (2H, s, - 
OCH20-), 7.54 (IH, s, Ar-H), 8.18 (IH, s, Ar-H), 8.58 (2H, brs, Ar-H), 9.22 
(IH, s, C=CH), 10.16 (1H, s, N=CH); m/z 336 (M, cation). 
Berberine Sulfate 2-13 
To a solution of 2-12 (0.463 g, 1.0 rnmol) in MeOH (250 cm3) heated at 
reflux a solution of A92SO4 (0.187 g, 0.6 mmol) in aq. H2SO4 (0.01 M, 6 
cm3) was added slowly with vigorous stirring. After heating at reflux for 30 
mm, the mixture was coole.d to r.t., kept overnight, then filtered. The filtrate 
was evaporated to give a solid which was crystallised from water to give 2-13 
as yellow needles (0.382 g, 88%). m.p. > 230°C; 0H  (60 MHz, D20)  3.30- 
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2.90 (2H, brs), 3.98 (3H, s, OCH3) 4.09 (3H, s, OCH3), 5.00-4.30 (2H, m), 
6.00 (2H, s, -OCH20-), 6.80 (IH, s, Ar-H), 6.92 (IH, s, Ar-H), 7.66 (IH, s, Ar-
H), 7.74 (1H, s, Ar-H), 7.92 (1H, s, C=CH), 9.60 (IH, s, N=CH). 
[8 - 21-1] - Berberine sulfate 2-13d 
2-1Id (0.159 g, 0.46 mmol) was reacted with 12 then treated with A92SO4 
using the same methods as used in the preparation of 2-12 and 2-13 above 
to give 2-13d as yellow needles (0.147 g, 82%). m.p. > 230°C; 8H  (60 MHz, 
D20) 3.60-3.20 (2H, m), 4.26 (3H, s, OCH3) 4.38 (3H, s, OCH3), 5.30-4.70 
(2H, m), 6.34 (2H, s, -OCH20-), 7.14 (IH, s, Ar-H), 7.32 (IH, s, Ar-H), 8.04 
(IH, s, Ar-H), 8.16 (IH, s, Ar-H), 8.32 (IH, s, C=CH), 9.90 (-0.2H, s, N=CH); 
m/z 338 (M + 1), 337 ( M, cation). 
[8 - 31-1] Berberine sulfate 2-13t 
This compound was prepared essentially as described for 2-13d. Berberine 
chloride hydrate (0.109 g, 0.293 mmol) in MeOH (15 cm 3) was reacted with 
NaB3H4 (0.925 GBq, 18.5 GBqlmmol) first then an excess of NaBH4 (0.06 g, 
1.58 mmol) was added. The reaction was worked up using the similar 
methods as above to give 2-13t as a yellow solid. The first batch of crystals 
from water weighted 0.048 g (37.6%). radioactivity was determined by 
dilution of a sample with authentic 2-13 (1:10) and recrystallisation to 
constant specific activity. The specific activity of undiluted material was 1.72 
GBq/mmol, the radiochemical yield was 20.5%. 
I Carboxy-2-methyl-6,7-methyIeflediOXY-1 ,2,3,4-tetrahydroisoquinOlifle 
hydrochloride 2-14 
A solution of 2-25 (0.996 g, 3.78 mmol) in aq. HCI (3M, 16 cm3) was heated 
at reflux for 20 h, then evaporated to dryness under reduced pressure. The 
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residual solid was crystallised from MeOH to give 2-14 as colourless crystals 
(0.933 g, 90%). m.p. 196-198°C; (Found: C, 52.96; H, 5.22; N, 4.92. 
C12H14NO4C1 requires: C, 53.05; H, 5.19; N, 5.16%); Vmax (nujol)/cm -1 3408 
(OH), 1738 (CO), 1507; 6 (60 MHz, D20), 3.00 (3H, s, NCH3), 3.9-2.8 (4H, 
m), 4.46 (1H, brs, 1-H), 6.00 (2H, s, -OCH20-), 6.80 (1H, s, Ar-H), 6.96 (IH, 
s, Ar-H); mlz 234 (M - 1), 220 (M - CH3)t 
I -Hyd roxymethyl-2-methyl-6,7-methyleflediOXY-I ,2,3,4-
tetrahydroisoquinoline hydrochloride 2-15 
To a solution of 2-24 (1.946 g, 5mmol) in dry Et20 (100 cm3), LiAIH4 (0.38 
g, 10 mmol) was added at r.t.. After stirring at r.t. for 24 h, water (100 cm3) 
was added. The Et20 layer was separated and the aq. solution was 
extracted with Et20 (50 cm3 X 4). The combined Et20 extracts were 
extracted with aq. HCI (1 M, 10 cm3 X 5) and the aq. extract was basified with 
NaOH to pH 11-13, extracted with CHCI3 (30 cm 3 X 5) and the organic 
extract washed with brine (20cm3 X 2), dried and evaporated to give the 
product (as its free base) as a oil (0.885 g, 80%). This oil was acidified with 
conc. HCI, and crystallised from MeOH to give 2-15 as colourless crystals 
(0.979 g, 95%). m.p. 226-228°C; (Found: C, 54.80; H, 6.33; N, 5.21. 
C12H16NO3C1.1/2H20 requires: C, 54.04; H, 6.42; N, 5.25%); vmax 
(nujol)/cm- 1 3225 (OH), 1503, 1350, 1257, 1039, 898; oH (200 MHz, D20) 
2.99 (3H, s, NCH3), 3.06 (2H, t, J 5.6), 4.03-3.35 (4H, m), 4.42 (IH, brs), 
5.92 (2H, s, -OCH20-), 6.74 (2H, s, Ar-H); mlz 222 (m, cation), 206 (M - 
CH3), 190 (M - CH20H)4 . 
I Acetoxymethyl-2-methyl-6,7-methyleflediOXy-1 ,2,3,4-
tetrahydroisoquinoline hydrochloride 2-15a 
A solution of 2-15 (0.112 g, 0.43 mmol) and Ac20 (2 cm3) in pyridine (2 cm3) 
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was stirred at r.t. for 2 days, then evaporated under reduced pressure to give 
a residue which was crystallised from EtOH give 2-15a as colourless crystals 
(0.11 g, 84%). m.p. 190-192°C; (Found: C, 54.37; H, 6.14; N, 4.44. 
C14H18NO4CI.1/2H20 requires: C, 54.46; H, 6.20; N, 4.53%.); Vmax 
(nujol)/cm- 1  3375 (OH, crystal H20), 1742 (C=O), 1209, 1036, 917; oH (60 
MHz, D20), 2.08 (3H, s, COCH3), 3.02 (3H, s, NCH3), 3.9-2.8 (4H, m), 4.65-
4.40 (3H, m), 5.98 (2H, s, -OCH20-), 6.78 (2H, s, Ar-H); m/z 264 (M, 
cation), 204 (M - AcO). 
I -[N-(2-Ami noethyl)]-amidemethyl-2-methyl-6,7-methYleflediOXY-1 ,2,3,4-
tetrahydroisoquinoline hydrochloride 2-17 
A solution of (CH2NH2)2 (0.527 g, 8.77 mmol) and Al(CH3)3 (2.0 M in 
hexane, 4.4 cm3 , 8.8 mmol) in dry CH2Cl2 (30 cm3) was dropped into a 
solution of 2-25 (1.114 g, 4.23 mmol) in dry CH2Cl2 (20 cm3) under N2 at r.t.. 
The mixture was heated at reflux under N2 for 4 days, then cooled to OOC, 
and aq. HCI (0.21M, 20 cm 3) was added. After stirring at r.t. for 0.5 h, the 
mixture was filtered, the solid was washed with CHCI3 (100 cm3) and water 
(30 cm3). The combined aq. solution was extracted with CHCI3 (20 cm3 X 2). 
All of the organic solutions were combined and extracted with aq. HCI (1M, 
20 cm3 X 5) which then was basified with NaOH to pH 11-13 and extracted 
with CHCI3 (30 cm3 X 4). The combined organic extract was washed with 
brine (20 cm 3 X 2), dried and evaporated to give a residue which was 
crystallised from CHCI3-Et20 (1:3) to give 2-17 as colourless crystals (0.57 g, 
48.5%). m.p. 50.5-51.5 0C; vmax/Cm 1 3453, 3306, 2944, 2796, 1663 (C0), 
1648, 1199, 1124, 1036, 931; 0H  (60 MHz, CDCI3) 1.74 (2H, s, -NH2), 2.52 
(3H, s, NCH3), 3.70- 2.30 (8H, m), 3.91 (IH, s, 2-H), 6.00 (2H, s, -OCH20-), 
6.66 (1H, s, Ar-H), 7.18 (IH, s, Ar-H), 7.7-7.3 (1H, brs, CONH-); Oc  (50 MHz, 
CDCI3) 28.9 (C-4), 41.2 (C-15), 41.5 (C-3), 44.3 (C-12), 50.4 (C-14), 69.9 (C- 
98 
1), 100.5 (C-lI), 106.4 (C-8), 107.7 (C-5), 125.1 (C-b), 126.7 (C-9), 145.8 
(C-7), 146.3 (C-6),173.3 (C-13) (see ref. 146); m/z 278.15047 [(M + 1)+, 
C14H20N302 MH requires: 278.15046]; 264, 234 [(M + 1) - CH2CH2NH2], 
190 (M - CONHCH2CH2NH2). 
2-(3,4-Methylenedioxyphenyl)-ethanthiol 2-19 and its Dimer 2-32 
A solution of 2-31 (0.738 g, 3.29 mmol) and KOH (0.5 g, 8.9 mmol) in MeOH 
(20 cm3) was stirred at r.t. under argon for 24 h, then filtered. The solid was 
washed with with acetone (5 cm 3), then crystallised from MeOH to give the 
disulfide 2-32 as colourless crystals (0.072 g, 6%). m.p. 78.0-78.5°C; 
(Found: C, 58.33, H, 4.89, C18H1804S2.1/2H20 requires: C, 58.20, H, 
5.16%); Vmax (nujol)/cm- 1 1245, 1191, 1037, 922, 875, 817; 6H  (60 MHz, 
CDCI3) 3.04 (8H, s, 2 X -CH2CH2-), 6.08 (4H, s, 2 X -OCH20-), 6.84 (6H, s, 
Ar-H); mlz 362 ( M), 226 (M -C8H702),181, 149, 135. The combined 
filtrate and washings were evaporated to give a residue which was dissolved 
in water (30 cm3), acidified with aq. HCI (1M) to pH 4-5, then extracted with 
CHCI3 (10 cm3 X 4). The CHCI3 solution was washed with brine (8 cm3 X 3), 
dried and evaporated to give the thiol 2-19 as a pale yellow oil (0.427 g. 
71%). vmax/Cm 1 2893, 1500, 1489, 1443, 1245, 1187, 1039, 934, 811; 8H 
(60 MHz) 3.0 -2.0 (4H, brd, -CH2CH2-, A2132), 5.72 (2H, s, -OCH20-), 6.90 
(3H, brs, Ar-H); m/z 182.04014 [( M) 1- , C9H1002S M requires: 182.04015], 
181 (M - 1), 149, 135. 
2-(3,4-Methylenedioxyphenyl) ethylamine 2-21 
A solution of 3,4-methylenedioxyphenyl acetonitrile (16.16 g, 100 mmol) in 
dry Et20 (150 cm3) was dropped into a mixture of LiAIH4 (4.93 g, 130 mmol) 
and AICI3 (20.0 g, 150 mmol) in Et20 (200 cm 3) with vigorous Stirring at r.t.. 
After stirring at r.t. for 10 h, water (500 cm3) was added and stiring for lh. 
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The aq. layer was separated and the Et20 layer was extracted with aq. HCl 
(1M 60 cm 3  X 2). The combined aq. solution was basified with NaOH to pH 
11-13, then extracted with CHCI3 (100 cm3 X 6) which was washed with 
brine (50 cm3 X 2), dried and evaporated to give 2-21 as a colourless oil 
(14.289 g, 86.5%). b.p. 102-104°C12 mbar; vmax/cm 1 3370, 3286, 
2926,1606, 1501, 1488, 932, 853, 808; oH (60 MHz) 0.78 (2H, t, J 10, NH2), 
2.8-2.0 (4H, m, -CH2CH2-, A2132), 5.58 (2H, s, -OCH20-), 6.8-6.1 (3H, m, Ar-
H); m/z 166 (M + 1)+, 149 (M - NH2)+, 136 (M - CH2NH2). The HCI salt of 2- 
21 was prepared by treating the compound with dil. methanolic HCI. This 
crystaleised from MeOH as colourless crystals. m.p. 208-2100C (lit. 1 , 210- 
211°C). 
Ethyl oxyalyl 2-(3,4-methylenedioxy)phenyl ethylamide 2-22 
To a solution of 2-21 (16.521 g, 100 mmol) and pyridine (20 cm3) in dry 
CHCI3 (250 cm3) ethyl oxalyl chloride (17.75 g, 130 mmol) was slowly added 
with stirring at r.t. over 2 h. After stirring at r.t. for 10 h and evaporation of the 
CHCI3, the mixture was filtered and washed with water to remove pyridine. 
Evaporation of the CHCI 3  solution gave a solid which was crystallised from 
EtOH to give 2-22 as colourless crystals. (23.874 g, 90%); m.p. 135-
136.50C; (Found: C, 58.77; H, 5.67; N, 5.13. C13N15N05 requires: C, 58.86; 
H, 5.70; N, 5.28%); vmax (nujol)/cm- 1 3381, 1705 (C=O); 0H  (60 MHz, CDCI3) 
1.48 (3H, t, J 7, -CH2CH3), 2.90 (2H, t, J 6, ArCH2-), 3.62 (21-1, t, J 6, N-CH2), 
4.48 (2H, q, J 7, -OCH2CH3), 6.08 (2H, s, -OCH20-), 6.82 (311, brs, Ar-H), 
7.4 (1H, brs, CONH); m/z 226 (M + 1), 192 (M -EtOCO), 149 (M - 
EtOCONH). 
I Ethoxylcarbonyl6,7methyIenediOXy-3,4-dihYdrOiSOclUif 1 0 1 tfle 2-23 
To a mixture of POCI3 (10 cm3, 0.1 mol), P205 (15 g, 0.1 mol) and Celite (8 
100 
g) in CH3CN (150 cm 3) heated at reflux a solution of 1-22 (7.958 g, 30 mmol) 
in CH3CN (100 cm 3) was dropped with vigorous stirring. After continued 
heating at reflux for I h, the mixture was filtered and the solid washed with 
CHCI3 (50 cm3 X 3) and aq. HCI (1M, 150 cm3). The combined filtrate and 
washings were evaporated to give a residue which was dissolved in CHCI3 
(100 cm3) and extracted with aq. HCI (IM, 20 cm 3 X 6). All of the aq. 
solutions were combined and basified with NaOH to pH 11-13, then 
extracted with CHCI3 (50 cm3 X 6) which was washed with br!ne (30 cm 3 X 
2), dried and evaporated to give a solid which was crystallised, from Et20 to 
give 2-23 as colourless needles (4.525 g, 61%). m.p. 78.0-79.0°C; (Found: 
C, 63.35; H, 5.35; N, 5.66. C13H13N04 requires: C, 63.15, H, 5.30, N, 
5.66%); vmax (nujol)/cm -1  1724 (0=0), 1585, 1093, 1029; oH (60 MHz, Cd4), 
1.34 (3H, t, J 7.5, -CH2CH3), 2.56 (2H, dd, J 9, 10, Ar-CH2), 3.68 (2H, dd, J 
9, 10, NCH2), 4.28 (2H, q, J 7.5, -OCH2CH3), 5.96 (2H, s, -OCH20-), 6.58 
(1H, s, Ar-H), 7.12 (IH, s, Ar-H); mlz 24 (M+1), 220, 174(MEtOCO)F, 144. 
I -Ethoxylcarbonyl-2-methyl-6,7-methyleflediOXY-3,4- 
dihydroisoquinoline iodide 2-24 
To a solution of 2-23 (2,473 g, 10 mmol) in acetone (50 cm3) iodomethane (5 
cm3 , 80 mmol) was added with stirring. The mixture was stirred at r.t. for 30 
h, then filtered. The residual solid was crystallised from acetone to give 2-24 
as a yellow microcrystalline solid (3.191 g, 82%). m.p. 139.5-140.5°C; 
(Found: C, 43.38; H, 4.20; N, 3.56. C14H16N041 requires: C, 43.21; H, 4.14; 
N, 3.60%); vmax (nujol)/cm- 1  1742 (C=0), 1651 (C=N), 1287, 1243, 1099, 
1031; OH (60 MHz, ODd3) 1.60 (3H, t, J 7.5, -CH2CH3), 3.62 (2H, t, J 8.5, 
Ar-CH2), 4.12 (3H, s, NCH3), 4.70 (2H, t, J 8.5, NCH2-), 4.83 (2H, q, J 7.5, - 
OCH2CH3), 6.34 (2H, s, -OCH20-), 6.98 (1H, s, Ar-H), 7.14 (IH, s, Ar-H); 




To a solution of 2-24 (3.892 g, 10 mmol) in MeOH (100 cm3) was added 
NaBH4 (0.757 g, 20 mmoi). The mixture was stirred at r. t. for 8 h, then 
evaporated to dryness. The residue was extracted with CHCI3 (20 cm3 X 5) 
which was then extracted with aq. HC1 (1M, 20 cm3 X 5). The aq. solution 
was basified with dii. aq . NaOH to pH 11-13, then extracted with CHCI3 (30 
cm3  X 4) which was washed with brine (15 cm 3 X 2), dried and evaporared 
to give 2-25 as a oil (2.462 g, 93.5%). vrnaxlcm 1 2977, 2906, 2798, 1727 
(C=O), 1503, 1484, 1245, 1038, 932; 8H  (60 MHz, CDC13) 1,23 (3H, t, J 7, - 
CH2CH3), 2.46 (3H, s, NCH3), 3.5-2.3 (4H, m), 4.25 (IH, s, 1-H), 4.28 (2H, q, 
J 7, -OCH2CH3), 5.83 (2H, s, -OCH20-), 6.55 (IH, s, Ar-H), 7.96 (IH, s, Ar-
H); m/z 264.12358 [(M + 1), C14H18N04 MH requires: 264.12357], 263 
(M), 234 (M - Et), 190 (M - COOEt). The hydrochioride salt of 2-25 
crystaliised as colàurless crystals from EtOH. m.p. 162-1640C. 
2-(3.4-Methylenedioxyphenyl) ethanol 2-29 
A solution of (3,4-methyienedioxyphenyl) acetic acid (4.96 g, 27.5 mmol) in 
dry Et20 (100 cm 3) was dropped into a solution of LiA1H4 (1.05 g, 27.7 
mmol) in dry Et20 (50 cm 3) at r. t. with vigorous stirring. After stirring at r. t. 
for 10 h, water (50 cm3) was slowly added to the reaction mixture. The 
ethereal layer was separated and the aq. layer was extracted with Et20 (50 
cm3 X 4). The combined Et20 extracts were washed with brine (20 cm 3 X 2), 
dried and evaporated to give 2-29 as a pale yellow oil (4.363 g, 95%). 
vmax/cm 1  3356 (OH), 2883, 1503, 1489, 1441, 1246, 1188, 1040, 933, 809; 
oH (60 MHz, Cd4) 2.65 (2H, t, J 7, -CH2-), 3.65 (2H, t, J 7, -CH2-), 3.73 (IH, 
s, OH), 5.82 (2H, s, -OCH20-), 6.65 (3H, s, Ar-H); mlz 166 (M), 149 (M - 
OH), 135 (M - CH20H). 
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2-(3,4-Methylenedioxyphenyl) ethanol toluene sulfonate 2-30 
Solid TsCI (5.02 g, 26.3 mmol) was added to a solution of 2-29 (3.919 g, 
23.6 mmol) in dry pyridine (15 cm3) which was stirred at r.t. for 1 day. After 
evaporation of the solvent under reduced pressure, the residue was 
dissolved in Et20 (100 cm 3) and washed with aq. Na2CO3 (5%, 10 cm3 X 2) 
and brine (10 cm3 X 2), then dried and evaporated to give a solid which was 
crystallised from Et20 to give 2-30 as colourless crystals (3.80 g). From the 
mother liquors 1.52 g (9.1 mmol) of 2-29 was recovered. The yield of 2-30 
was 82%. m.p. 55-55.50C; (Found: C, 60, 61, H, 4.98, C16H1605S requires: 
C, 59.99, H, 5.03%); vmax (nujol)/cm 1346, 1244, 1066, 1037, 970, 932, 
902, 807; oH (60 MHz, CDCI3) 2.46 (3H, s, Ar-CH3), 3.88 (2H, t, J 7, -CH-), 
4.22 (2H, t, J 7, -CH-), 5.94 (2H, s, -OCH20-), 6.8-6.6 (3H, m, Ar-H), 7.9-7.2 
(4H, q, Ar-H, A2132); m/z 320 (M)+, 165 (M - Ts), 149 (M - TsO), 135. 
2-(3,4-Methylenedioxylphenyl)ethanthiol acetate 2-31 
A solution of 2-30 (1.693 g, 5.28 mmol) and potassium thioacetate (1.208 g, 
5.38 mmol) in dry acetone (15 cm3) was heated at reflux for 2 h, then cooled 
to r.t. and filtered. The solid was washed with acetone (10 cm 3 X 2) and 
filtered. The combined filtrate was evaporated to give a residue which was 
extracted with Et20 (10 cm 3  X 6). The ethereal extracts were evaporated to 
give a oil which was distilled under reduced pressure to give 2-31 as a pale 
yellow oil (0.793 g, 66.9%). b.p. 240 °C/0.3mbar; vrnaxlcm 1 1689 (C0), 
1503, 1489, 1443, 1245, 1134, 1039, 935; 0H  (60 MHz) 2.00 (3H, s, 
COCH3), 3.00-2.20 (4H, m, -CH2CH2-, A2132), 5.62 (2H, s, -OCH20-), 6.78 
(3H, s, Ar-H); m/z 224.05074 [(M ), C11H1203S M requires: 224.05071], 223 
(M - 1), 181 (M - Ac), 149 (M - AcS), 148, 135. 
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cis-4-Hydroxy-D-proline 3-10 
A solution of 3-21 (0.318 g, 1.89 mmol) in water (8 cm) was dropped slowly 
into a saturated aq. solution of silver carbonate (300 cm 3) at 800C with 
vigorous stirring. The mixture was stirred at 60 °C for 30 mm. and at r.t. for 10 
h, then centrifuged at 0 °C to remove the solid. The liquid was lyophilised to 
give a solid which was crystallized from MeOH to give 3-10 as colourless 
crystals (0.209 g, 84.4%). m.p. 236-238 °C (lit. 56 , 2430C); [a]D20  54.90 (C, 1.18, 
H20) [(lit. 56 , [a]D2°  58.00 . (C, 2, H20)]. 
cis-4-Hydroxy-D-prol me hydrochloride 3-21 
A solution of trans-4-Hydroxy-L-proline (13.131 g, 0.10 mol) and acetic 
anhydride (60 g, 0.58 mol) in acetic acid (180 cm) was heated at reflux for 6 
h, then cooled to r.t.. After removal of the solvents, the mixture was dissolved 
in aq. HCI (2M, 200 cm 3) and heated at reflux for 3 h. The mixture was 
evaporated under reduced pressure to give a solid which was recrystallized 
from MeOH to give 3-21 as colourless needles (9.499 g, 56.5%). m.p.158-
159.50C (lit. 543 , 161-1630C); [a]D20  19.30 (C 2.01, H20) (not previously 
reported). 
cis-4-Hydroxy-D-prol me, ethyl ester hydrochloride 3-22 
Dry HCI was passed through a solution of 3-21 (8.97 g, 53.5 mmol) in anhyd. 
EtOH (60 cm) slowly until the slurry changed to a homogeneous solution. 
The mixture was heated at reflux for 2 h, then evaporated to remove the 
solvent giving a solid which was crystallized from EtOH to give 3-22 as 
colourless crystals (7.981 g, 76.5%). m.p. 154-155 °C (lit., 155-156 0C); 
[a1 D20  20.80 (C 2.07, H20) (not previously reported); oH  (60 MHz, D20) 1.30 
(3H, t, J 7.5, CH 2CH), 2.66-2.30 (2H, m, 3-H), 3.50 (2H, brd, 5-H), 4.32 (2H, 
q, J 7.5, CH2CH3), 4.90-4.58 (2H, m, 2-H, 4-H). 
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cis-4-Hydroxy-D-proline, ethyl ester 3-23 
A solution of 3-22 (0.889 g, 4.54 mmol) in MeOH (30 cm) was dropped 
slowly into a saturated aq. solution of silver carbonate (350 cm3) at 80°C with 
vigorous stirring. The mixture was stirred at r.t. for 12 h., then filtered to 
remove the solid. The filtrate was diluted with acetone (350 cm 3) and kept at 
0°C overnight, then centrifuged to remove the precipitate. The solution was 
evaporated at r.t. to remove acetone, then lyophilised to give 3-23 as an oil 
(0.587 g, 81%). [a]D2°  43.90 (C, 2.0, H20) [lit., [a] 20 28.50 (c, 2, H20)]. 
N-Tosyl-trans-4-hydroxy-L-prolifle 3-24 
p-Toluenesulfonyl chloride (9.152 g, 48.0 mmcl) was added to a solution of 
trans-4-hydroxy-L-proline (3-9, 5.245g, 40.0 mmol) in water (80 cm). The 
mixture was kept at pH 9-10 by dropping aq. Na 2CO3 (2 M, 50 cm3 , 100 
mmcl) into the reaction during stirring at r.t. for 20 h. After extraction with 
ether (50 cm), the mixture was acidified to pH 2-3 with conc. HCI, then 
extracted with EtOAc (50cm 3 X 4) which was washed with brine (30 cm 3 X 2), 
dried and evaporated to give a residue which was crystallized from EtOAc to 
give 3-24 as colourless crystals (9.70g, 85%). m.p. 156-158 °C (lit. 146 , 153- 
1550C); [cx] D20 -1030 (c, 1.04, MeOH) [.lit. 146 , [cx]D21  -1 05.4° (C, 2, EtOH)]; vmax 
(nujol)/cm 3448 (OH), 1755 (C=O) 1595, 1344, 1326, 1265, 1180, 1072, 
998; 8H  (60 MHz, acetone-d6) 1.9-1.5 (2H, m, 3-H), 1.98 (3H, s, Ar-CH3), 3.4- 
2.7 (2H, m, 5-H), 4.2-3.7 (2H, 2-H, 4-H), 5.1 (2H, brs, OH, COOH), 7.4-6.8 
(4H, q, Ar-H, A2 132); m/z 286 [(M +1), 76.5%], 270 [(M -15), 13.6], 240 [(M - 
COOH), 75], 222 [(M - COOH-H20), 16.2], 194 (32.3), 155 (62.3), 130 
(57.1), 91(99.0). 
N-Boc-trans-4-hyd roxy-L-prol I ne 3-25 
A solution of 3-9 (1.316 g, 10.04 mmol) and di-t-butyl-dicarbonate (2.98 g, 
105 
13.66 mmol) in THF-H 20 (2:1, 20 cm) was stirred at r.t. for 20 h. The pH of 
the mixture was kept at 9-10 by adding aq. NaOH (10%) during the reaction. 
After evaporation of the THE, the aqueous solution was extracted with Et20 
(10 cm), then acidified with aq. HCI (2M) to pH 2-3 and extracted with 
EtOAc (10 cm 3 X 3). The extract was washed with brine (6 cm 3 X 3), dried 
and evaporated to give 3-25 as a colourless oil (2.319 g, 99%). A portion of 
the product was crystallized from EtOAc to give colourless crystals. m.p. 
128.5-1300C; [a]D2° -68.360 (C, 1.00, MeOH) (ljt.Ma62,  not reported); vmaxlcm 
1 3427 (OH), 1724 (C=O), 1673 (CO 3 Boc), 1477, 1419, 1253, 1160; 8H  (60 
MHz, DMSO-d 6) 1.22 [9H, brs, C(CH 3) 31, 2.2-1.7 (2H, m, 3-H), 2.3 (IH , brs, 
OH), 3.44-3.31 (2H, m, 5-H), 4.38-3.84 (2H, m, 2-H, 4-H), 4.98 (IH, brs, OH); 
m/z 232 (M + 1), 214 (M - OH), 186 (M -COOH), 176 (M - 55), 132 [(M + 
1)-Boc], 130, 114. 
N-Benzoyl-trans-4-hydroxy-L-proline 3-26 
A mixture of 3-9 (2.031 g, 15.49 mmol), benzoyl chloride (2.664 g, 18.95 
mmol) and K2CO3 (4.217 g, 30.5 mmol) in MeOH (50 cm) was stirred at r.t. 
for 20 h, then filtered and the solid was washed with acetone (15 cm 3 X 3). 
The combined filtrate and washings were evaporated to give a residue which 
was dissolved in water (50 cm 3) and extracted with ether (20 cm). The 
aqueous phase was acidified with aq. HCI (6M) to pH 2-3 and extracted with 
EtOAc (20 cm 3 X 4). The organic extract was washed with brine (10cm 3 X 3), 
dried and evaporated to give 3-26 as a colourless solid (2.829 g, 77.75%). 
Vmax (nujol)/cm 3390 (OH), 1728 (C=O); oH (60 MHz, acetone-d6), 2.1-1.7 
(2H, m, 3-H), 3.58-2.8 (2H, m, 5-H), 4.06 (IH, m, 4-H), 4.34 (IH, t, J 8.4, 2-
H)', 5.6-4.9 (2H, brs, OH, COOH), 7.06 (5H, s, Ar-H); m/z 236 [(M + 1) 
100%], 217 (M - H 2O), 190 (M - COOH), 105. 
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trans-4-Hyd roxy-L-proline, ethyl ester hydrobrom ide 3-27 
Dry HBr was passed through a solution of 3-9 (13.032 g, 99.4 mmol) in 
anhyd. EtOH (200 cm 3) at r.t. for 0.5 h, then the mixture was stirred at r.t. for 
1 h and the solvent evaporated. The residue was crystallised from acetone 
to give 3-27 as colourless crystals (18.06 g, 75.7%). m.p. 173-174.5 °C; []D20 
-23.430 (c, 0.50, MeOH); vmax/cm 1 3341 (OH), 1733 (C=O), 1276, 1238; 8H 
(60 MHz, D20), 1.29 (3H, t, J 7.2, CH 2 CH3), 2.4-2.2 (2H, m, 3-H), 3.6-3.4 
(2H, m, 5-H), 434 (2H, q, J 7.2, CH2CH 3), 4.85-4.50 (2H, m, 2-H, 4-H); m/z 
160 (M, Cation 100%). 
N-Tosyl-4-hydroxy-L-proline, methyl ester 3-28 
To a solution of 3-24 (1.143 g, 4.0 mmol) in acetone (8cm 3), a solution of 
diazomethane in ether (-0.25 M, 40 cm 3, 10 mmol) was added and the 
mixture stirred at r.t. for 4 h. The mixture was evaporated to give a residue 
which was crystallized from ether to give 3-28 as colourless crystals (1.11 g, 
92%). m.p. 92-93.5 °C (EtOAc); [a]02° -116.30 (C, 1.08, MeOH); vmax/Cm 1 
3513 (OH), 1740 (C=O), 1597, 1438, 1288., 1201, 1155, 1097, 1022; 6,. (60 
MHz, CDCI) 2.3-2.0 (2H, m, 3-H, ABX), 2.44 (1H, s, OH), 2.46 (3H, s, Ar-
CH3), 3.6-3.0 (2H, m, 5-H), 3.76 ( 3H, s, OCH 3), 4.28 (2H, m, 2-H, 4-H), 7.9-
7.3 (4H, q, Ar-H, A2 B2); m/z 300 [(M + I ), 93.7%], 282 [(M - OH), 12.7], 281 
[(M - H2O), 4.3], 240 [(M - COOCH3), 89.8], 222 (32.4) 208 (7.1), 144 
(82.4) 155 (83.0). Compound 3-28 was also prepared using the following 
method (MeOH/HCI) in a 82% yield. 
N-Boc-trans-4-hydroxy-L-proline, methyl ester 3-29 
To a solution of 3-25 (5.030 g, 21.75 mmol) in acetone (20 cm 3) was added a 
solution of ethereal diazomethane (0.13 M, 200 cm 3 , -26 mmol). The mixture 
was stirred at r.t. for 20 h, then evaporated to give 3-29 as a colourless oil 
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(4.736 g, 88.7%). [ctJD2° -77.430 (C, 0.41, MeOH); vmax/cm 3437 (OH), 1750 
(C=O), 1678 (CO 3 Boc), 1413, 1204; 8H  (60 MHz, CDCI3), 1.23 [9H, s, 
C(CH3)31, 2.6-1.96 (2H, m, 3-H), 3.58 (2H, brs, 5-H), 1.79 (3H, s, COOCH3), 
4.64-4.2 (3H, m, 2-H, 4-H, OH); m/z 246 [(M + l), 43.1%], 214 (M - OCH 3), 
189 (M - 56), 186 (M - CO 2CH3), 172 (M - toB u )4  144 (M - Boc), 130. 
N-Tosyl-4-oxo-L-proline 3-30 
Jones reagent147 (1 cm3 , 8 mmol) was dropped into a solution of 3-24 
(0.285g, 1.0 mmol) in acetone (10 cm) with vigorous stirring at 0 °C. After 
stirring at 0 °C for 20 mm. and at r.t. for 2 h, the mixture was cooled to 0 °C 
and MeOH (2 cm) was added and the solution was then stirred at r.t. for 0.5 
h. After evaporation, the residue was dissolved in water (20 cm), extracted 
with EtOAc (10 cm
3  X 4), washed with brine (10 cm
3  X 2), dried and 
evaporated to give a solid which was crystallized from EtOAc to give 3-30 as 
colourless crystals (0.24g, 91%). m.p.185-186 °C (lit. 61 , 176-1780C); [a]D20 - 
29.80 (C, 1.01, MeOH) [lit. 61 , - 1.20 (c, 1, EtOH)]; vmax (nujol)/cm 1 3136 (OH), 
1767 (C=O), 1727 (C=O); 5H  (60 MHz, acetone-d 6) 1.88 (3H, s, Ar-CH3) 2.4-
2,0 (2H, m, 3-H, ABX), 3.22 (2H, s, 5-H), 4.5-4.2 (1H, q, J 4, J 8, 2-H, 
ABX) 6.65 (1H, brs, OH, exchanged by adding D 20)7.5-6.8 (4H, q, Ar-H, 
A2B2); mlz 284 [(M +1), 100%], 283 (M 16.9), 268 [(M -15 ), 10.2], 238 [(M 
-COOH), 90.3], 192 (9.1), 155 (93.2), 128 (41.8). 
N-Boc-4-oxo-L-proline 3-31 
3-25 (1.888 g, 8.16 mmol) was converted to 3-31 (1.639 g, 87.5%) using the 
same method of preparation used for conversion of 3-24 to 3-30. m.p. 162-
162.50C (CHCI3); [a]D2° -15.880 (C, 1.06, MeOH), vmax/cm 1 1767 (C0), 
1749 (C=O), 1647 (C=O, Boc), 1283, 1261, 1193, 1180, 1138; oH [60 MHz, 
CDCI3-CD3CN (4:1)], 1.58 [9H, s, C(CH 3)31, 3.12-2.78 (2H, q, JAB  7.2, JAx 9.6, 
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JBX 4.8, 3-H, ABX), 3.92 (2H, s, 5-H), 4.82 (1H, q, JAx 9.6, JBX 4 .8, 2-H, ABX), 
5.77 (1H, brs, COOH); mlz 230 (M + 1), 176, 174, (M - 56), 128 (M - Boc). 
N-Benzoyl-4-oxo-L-proline 3-32 
3-26 (2.631 g, 11.18 mmol) was converted to 3-32 (2.275 g, 87.23%) as a 
pale yellow oil using the same method as that for preparation of 3-30 from 3-
24. vmax/cm 1  3359 (OH), 1765 (C=O), 1733 (C=O), 1642, 1598, 1497, 1416, 
1264, 1181; oH (60 MHz, CDCI 3) 3.16-2.72 (2H, m, 3-H), 4.08 (2H, brs, 5-H), 
5.36 (IH, brs, 2-H), 7.56 (5H, s, Ar-H), 10.36 (1H, s, CO 2H); mlz 234 (M+1). 
N-Tosyl-4-oxo-L-proline, methyl ester 3-33 
Compound 3-30 (0.567g, 1.906 mmol) was converted to 3-33 using the 
above method. (0.443g, 74.6%). m.p. 101 .5-1 02.5 °C (EtOAc); [a]D2°  -52.40 (C, 
1.01, MeOH); 8H  (60 MHz, CDCI 3) 2.50 (3H, s, Ar-CH 3), 3.85-3.65 (2H, m, 3-
H, ABX), 3.68 (3H, s, OCH 3), 3.86 (2H, s, 5-H), 4.95-4.74 (IH. q, i AX  4, J BX' 
2-H, ABX), 7.88-7.34 (4H, q, Ar-H, A 2B2); m/z 298 [(M + 1), 82.8%], 238 [(M 
- COOMe), 84.8], 155 (99.7), 142 (55.0). 
N-Boc-4-oxo-L-proline, methyl ester 3-34 
3-31 (0.521 g, 2.27 mmol) was converted to 3-34 as a colourless oil (0.548 g, 
99%) using the above method. [aID 2° -43.770 (c, 0.52, MeOH); vmax/cm 1 
1766 (C=O), 1740 (C=O, Boc), 1396, 1257, 1199; 0H  (60 MHz, CDCI 3) 1.20 
[9H, 5, C(CH 3) 31, 3.02-2.59 (2H, q, JBX  4.8, JAx 9.6, JAB  14.4, 3-H, ABX), 3.66 
(3H, s, CO 2CH 3), 3.80 (2H, s, 5-H), 4.66 (IH, q, JBX  4.8, JAx 9.6, 2-H, ABX); 
mlz 244 (M+1), 188 (M-55), 186 (M-57), 170 (M- t OBu), 142 (M-Boc). 
N-Tosyl-4-hydroxy-L-proline, ethyl ester 3-35 
A). 	Dry HCl was passed slowly through a solution of 3-24 (25.23 g, 88.4 
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mmol) in anhyd. EtOH (120 cm) for 0.5 h. The mixture was stirred at r.t. for 
12 h, heated at reflux for 0.5 h, then evaporated to remove the solvent. The 
residue was dissolved in EtOAc (150 cm), washed with aq. HCI (IM, 
30cm), aq. Na 2CO3 (5%, 30 cm3) and brine (20 cm 3 X 2) successively, then 
dried and evaporated to dryness. The residue was purified by distillation 
under reduced pressure to give 3-35 as a colourless oil (20.05 g, 71%). b.p. 
252°CI 0.2 mm. 8H  (60 MHz, CDCI3) 1.22 (3H, t, J 7.0, CH2CH), 2.3-1.9 (2H, 
m, 3-H), 2.40 (2H, s, Ar-CH), 3.02 (IH, s, OH), 3.76-3.34 (2H, m, 5-H), 4.60-
4.18 (2H, m, 2-H, 4-H), 4.20 (2H, q, J 7.0, CH2CH3), 7.86-7.38 (4H, q, Ar-H, 
A2 B2); m/z 240 [(M - COOEt), 100%], 158 (4.1), 155 (44.9). 
B). 3-27 (1.20g, 5.0 mmol), TsCI (o.97g, 5.1 mmol) and Na 2CO3 (1.20g, 11.3 
mmol) in acetone (100 cm) was stirred for 20 h at r.t.. The mixture was 
worked up using the same method as that of preparation of 3-37 from 3-27 to 
give 3-35 as a colourless oil (1.348g, 86%). 
N-Benzoyl-trans-4-hyd roxy-L-proline, ethyl ester 3-36 
A mixture of 3-27 (2.413 g, 10.05 mmol), benzoyl chloride (16.96 g, 12.06 
mmol) and K2CO3  (2.41 g, 17.43 mmol) in acetone (50 cm) was stirred at r.t. 
for 24 h, then filtered and the solid was washed with acetone (10 cm 3 X 2). 
The combined filtrate and washings were evaporated to give a residue which 
was dissolved in EtOAc (80 cm 3) and washed with aq. HCI (2M, 15 cm), aq. 
Na2CO3 (5%, 20 cm3 ) and brine (20 cm 3 X 2), dried and evaporated to give 
a solid which was crystallised from EtOAc to give 3-36 as colourless crystals 
(2.059 g, 77.8%). m.p. 93.5-94.5 °C; [a]D2° -1 38.25° (C, 0.51, MeOH); vmax/cm 
1 3424 (OH), 1741 (C=O), 1613 (C=O), 1574, 1417, 1373, 1274, 1194; oH (60 
MHz, CDCI 3), 1.38 (3H, t, J 6, CH2 CH3), 2.6-1.96 (2H, m, 3-H), 4.34 (2H, q, J 
6, CH2CH 3), 4.6-3.4 (4H, m, 5-H, 4-H, OH), 4.85 (IH, t, J 7, 2-H), 7.56 (5H, 
s, Ar-H); m/z 246 [(M + 1), 100%], 190 (M - COOEt), 105. 
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N-Benzyl-trans-4-hyd roxy-L-prol me, ethyl ester 3-37 
A mixture of 3-27 (10.85 g, 45.19 mmol), benzyl bromide (8.484 g, 49.6 
mmol) and K2CO3  (9.345 g, 67.6 mmol) in EtOH (160 cm) was stirred at r.t. 
for 2 days, then filtered. The solid was washed with acetone (50 cm 3 X 3). 
The combined filtrates were evaporated to give a residue which was 
dissolved in CHCI 3  0 00 cm3), and extracted with aq. HCl (2M, 30cm 3 X 4). 
The acidic aqueous solution was basified with Na 2CO3 to pH 9-11 and 
extracted with EtOAc (50 cm 3 X 4). The organic extract was washed with 
brine (20 cm 3 X 3), dried and evaporated to give 3-37 as a pale yellow oil 
(8.231 g, 73.06%). [U]D 20 -49.940 (c, 0.53, MeOH); vmaxlcm 1 3325 (OH), 1714 
(C=O), 1453, 1373, 1273, 1186, 1087, 1030; 6H  (60 MHz, CDCI 3) 1.32 (3H, t, 
J 7.2, CH2CH3), 2.64-2.08 (3H, m, 2-H, 3-H), 2.78 (1H, s, OH), 3.86 (2H, q, J 
7.2, CH2CH 3), 4.72-3.04 (5H, m, 5-H, 4-H, PhCH 2), 7.40 (5H, s, Ar-H); m/z 
250 (M + 1), 176 (M - COOEt), 158 [(M - COOEt) - H201 or(M - Bz ), 91. 
N-Benzoyl-trans-4-oxo-L-proline, ethyl ester 3-38 
3-36 (1.356 g, 5.15 mmol) was converted to 3-38 as a colourless oil (1.271 g, 
94.4%) using the same method as that of preparation of 3-30 from 3-24. The 
product was an oil. [cx]D2°  -71.570 (c, 0.43, MeOH); vmax/cm 1 1766 (C0), 
1741 (C=O), 1645 (C=O), 1490, 1343, 1267, 1187, 1141, 1030; 8H  (60 MHz, 
CDCI 3), 1.36 (3H, t, J 7.2, CH2 CH3), 3.06-2.8 (2H, q, 3-H) 4.16 (2H, s, 5-H), 
4.32 (2H, q, J 7.2, CH2CH 3), 7.58 (5H, s, Ar-H); m/z 262 (M + 1). 
N-Tosyl-4-oxo-L-proli ne, ethyl ester 3-39 
A solution of 3-30 (0.568g, 2.0 mmol) and thionyl chloride (5 cm) in benzene 
(10 cm) was heated at reflux for 4 h. The mixture was evaporated to give a 
white solid which was dissolved in anhyd. EtOH (20 cm 3) and heated at 
reflux for 0.5 h. After evaporation of the solvent, the residue was crystallised 
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from EtOAc to give 3-39 as colourless crystals (0.51g, 81.7%). m.p. 129-
131 °C; [a]D2° -54.20 (C, 1.01, MeOH); vmax (nujol)/cm 1 1765 (C0), 1752 
(C0), 1599, 1346, 1291, 1257, 1197, 1164, 1902, 1017; 8H  (60MHz, CDC13) 
1.20 (3H, t, J 7, CH 2CH), 2.48 (3H, s, Ar-CH), 2.8-2.6 (2H, m, 3-H, ABX), 
3.82 (2H, s, 5-H), 4.10 (2H, q, J 7, CH2CH 3 ), 4.92-4.72 (IH, q, JAX4, J 8, 2-BX 
H, ABX), 7.9-7.3 (4H, q, Ar-H, A 2B2); mlz 312 [(M -i-1), 100%], 266 [(M - 
OEt), 58.5], 238 [(M - COOEt), 84.4],156(59.5), 155 (86.5). 
N-Tosyl-trans-4-acetoxy-L-PrOl i ne 3-40 
A mixture of 3-24 (5.69 g, 19.9 mmol), acetic anhydride (40 cm 3) and 
pyridine (25 cm) was stirred at r.t. for 2 days, then dropped into ice-water 
(300 cm) with vigorous stirring. The mixture was filtered with a Buchner filter 
to collect the solid which then was crystallized from CHCI 3 to give 3-40 as 
colourless crystals (5.138 g, 78.7%). m.p. 124.5-125.5 °C; [aID -90.30 (C, 
0.51, MeOH); (Found: C, 48.70; H, 5.53; N, 3.86. C 14 H 17N06S•H 20 requires: 
C, 48.69; H, 5.54; N, 4.06%); vmax(nujol)/cm 1 3389 (OH), 1714 (C=O), 1706 
(C=O), 1262, 1092; 8H  (60 MHz, CDCI 3) 1.62 (3H, m, COCH 3), 2.45-2.25 
(2H, m, 3-H), 2.48 (3H, s, Ar-CH 3), 3.70 (2H, m, 5-H), 460 (1H, t. J 8, 2-H), 
5.24 (IH, brs, 4-H), 6.30 (3H, s, COOH, H 20, exchaged with D 20 , 8.10-7.32 
(4H, q, Ar-H, A2 B2); m/z 329 (M + 2), 312 [(M + 2) - OH]., 286 [(M + 2) - 
COCH31., 268 (M - OCOCH3)., 240, 222, 174, 155. 
N-Boc-trans-4-acetoxy-L-proline 3-41 
3-25 (1.293 g, 4.73 mmol) was converted to 3-41 (0.923 g, 71.7%) using the 
same method as that used to prepare of 3-40 from 3-24. m.p. 110-111 °C 
(CHCI3); [aID2° -47.28° (C, 0.50, MeOH); Vmax (nujol)/cm 1 1739 (C=O), 1638 
(C=O, Boc), 1255, 1234, 1139, 1070; oH (60 MHz, CDCI3), 1.60 [9H, s, 
C(CH3)31, 2.21 (3H, s, COOCH3), 2.31-2.8 (2H, m, 3-H), 3.82 (2H, d, 5-H), 
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4,60 (1H, m, 2-H), 5.44 (1H, m, 4-H), 10.63 (IH, s, COOH); m/z 274 (M + l), 
228 (M - COOH ),218 (M - 57), 174 [(M + I)- Boc], 158, 128, 112. 
N-Benzyl-trans-4-acetoxy-L-prol i ne 3-42 
3-37 (0.333 g, 1.336 mmol) was converted to 3-42 as an oil (0.229 g, 
58.99%) using the same method as that used in the preparation of 3-40 from 
3-24. 3-42 was an oil. [ct]D20 -41 .04° (C, 0.675, MeOH); vmaxlcm 1 1739 (C=O), 
1494, 1453, 1370, 1241, 1184, 1075, 1030; 6H  (60 MHz, CDCI3) 1.32 (3H, t, 
J 7.2, CH2 CH3), 2.08 (3H, s, COCH 3), 2.8-2.16 (3H, m, 2-H, 3-H), 3.64-3.38 
(2H, m, 5-H), 3.73 (IH, t, J 8.4, PhCH 2 , AB), 3.90 (IH, t, J 8.4, PhCH 2, AB), 
4.26 (2H, q, J 7.2, CH2CH 3), 5.32 (1H, m, 4-H), 7.42 (5H, s, Ar-H); m/z 292 
(M + 1), 231 (M - AcOH), 218 (M - COOEt) 158 [(M - COOEt) - AcOH ]. 
N-Boc-trans-4-acetoxy-L-prol i ne 3-43 
3-41 (0.923 g, 3.38 mmol) was converted to 3-43 as a colourless oil (0.930 g, 
95.8%) using the same method as that for preparation of 3-29 from 3-25. 3-
43 was a colourless oil. [a]D2°  -56.51 0 (C, 0.47, MeOH); vmaxlcm 1 2976, 1744 
(C=O), 1703 (C=O, Boc), 1400, 1367, 1238, 1126; 8H  (60 MHz, CDCI 3) 1.42 
[9H, s, C(CH 3)31, 203 (3H, s, COCH 3), 2.32 -2.16 (2H, m, 3-H), 3.65 (2H, s, 5-
H), 3.76 (3H, s, OCH 3), 4.38 (1H, t, JAx 8.4, JBX  8.4, 2-H, ABX), 5.3 (1H, m, 
4-H); m/z 288 (M + 1), 272 (M - CH 3), 232 (M - 55), 214 [M -OC(CH3)31, 
188, 186(M - Boc), 172 (M - 56 - COOCH 3), 144, 126, 112, 68. 
N-Tosyl-4-hydroxy-2(4-pentenoyl) pyrrolidine 3-44 
A solution of vinylmagnesium bromide in THF (1.0 M, 20 cm 3, 20 mmol) was 
dropped into a solution of 3-35 (2.68 g, 8.55 mmol) in THE (50 cm 3) at -78°C 
under N2 with vigorous stirring. The mixture was stirred at -78 °C for I h, 0°C 
for 2 h and at r.t. for 20 h, then sat. aq . NH4CI (50 cm) was dropped into the 
113 
mixture at -78 °C and the stirred mixture allowed to come to r. t. over 3 h. The 
organic layer was separated and the aqueous layer was extracted with 
EtOAc (50 cm 3 X 3). The combined organic solution was evaporated to give - 
a residue which was dissolved in EtOAc (50 cm) then passed through a 
silica gel column. The combined EtOAc (50 cm 3) eluate was evaporated to 
give 3-44 as a pale yellow oil (2.318 g, 83.8%). [cx] 020 -93.20 (C, 2.15 , CHCI 3); 
vmaxlcfll 1 3518 (OH), 1713 (C=O), 1641 (C=C), 1236; 6. (60MHz, CDCI 3) 3.4-
1.7 (6H, m, 5-H, 8-H, 7-H), 2.42 (3H, Ar-CH 3), 3.75-3.35 (2H, m, 3-H), 4.65-
4.15 (2H, m, 2-H, 4-H), 6.4-4.85 (4H, m, OH, CH=CH 2), 8.0-7.3 (4H, q, Ar-H, 
A2B2); m/z 324 [(M + 1), 75.8%), 306 (M - OH), 240 (M - COC4H7), 222 (M 
- COC4H7 - H2O), 168 (M - Ts) 155, 150 (M - Is -H2O). 
N-Tosyl-4-oxo-2-(4-pentenoyl) pyrrolidine 3-45 
A). Jones reagent (8cm 3 , —64 mmol) was dropped into a solution of 3-44 
(2.318 g, 7.17 mmol) in acetone (70 cm 3) at 0 °C with vigorous stirring. The 
mixture was stirred at 0 °C for 1 h and r.t. for 6 h, then MeOH (20 cm) was 
added and stirring continued for 0.5 h. After dilution with water (100 cm), the 
mixture was evaporated to remove the organic solvents and the aqueous 
solution was extracted with EtOAc (30 cm 3 X 4) which was then washed with 
aq. sodium carbonate (5%, 30 cm 3) and brine (30cm 3 X 2), dried and 
evaporated to give a solid which was crystallised from ether to give 3-45 as 
colourless needles (0.875 g, 38%). m.p. 122-123 °C; 126-127 °C (EtOH); 
[aID2°  -83.30 (C, 0.20, MeOH), (Found: C, 59.06; H, 6.0; N, 4.31. C 16 H 19N04S 
requires: C, 59.79; H, 6.96, N, 4.36 %); vmax (nujol)/ cm 1 1767 (C=O), 1723 
(C=O), 1641 (C=C); ö (60MHz, CDCI 3) 2.54 (3H, s, Ar-CH 3), 2.6-2.2 (4H, m), 
3.2-2.7 (2H, m), 3.80 (2H, s, 5-H), 4.80 (IH, q, 2-H), 6.3-4.9 (3H, m, 
CH=CH 2 , ABC), 7.7 (4H, q, Ar-H, A 2 B2); H  (200 MHz, CDCI 3) 2.30 (1H, q, J 
j 18.8, 3-H, ABX), 2.58-2.32 (2H, m, 7-H or 8-H), 2.53 (IH, q, J. x 3.8,AB 
114 
AB 
18.5, 3-H, ABX), 2.96-2.72 (2H, m, 8-H or 7-H), 3.68 (2H, q, J 18.3, 5-H, 
AB), 4.63 (IH, q, J AX  9.4, J BX  3.8, 2-H, AB.X), 5.09-4.95 (2H, m, CH=CH 2 , A), 
5.88-5.68 (IH, m, CH=CH 2 , ABC), 7.71-7.31 (4H, q, Ar-H, A 2B2); 6 (50 MHZ, 
CDCI3) 21.5 Ar-CH 3), 27.1 (C-8), 38.0 (C-7), 38.1 (C-3), 53.0 (C-5), 62.9 (C-
2), 115.7 (C-b), 127.4 (2 X Ar-CH), 130.1 (2 X Ar-CH), 133.2 (Ar-C), 136.3 
(C-9), 144.9 (Ar-C), 206.0 (C-6), 206.7 (C-4); m/z 322.11132 [(M + 1), 
C 16H 20N04S MH requires: 322.11129], 294 (M - CH=CH 2), 265 (M - 
CH 2CH 2CH=CH2), 238 ( M - COC 4H 7), 210, 166 (M -Ts), 155, 139, 110. 
B). A solution of 3-48 (0.14 g, 0.38 mmol) and toluene-4-sulphonic acid 
(0.01 g, 0.005 mmol) in acetone (5 cm) was heated at reflux for 2 h. The 
mixture was evaporated to give a residue which was extracted with CHCI 3 
(10cm3  X 5). The extract was washed with aq. HCl (IM, 10 cm), aq. Na 2CO3 
(5%,10 cm3) and brine (10 cm 3 X 2), then dried and evaporated to give a 
solid which was cystallized from EtOH to give 3-45 as colourless crystals 
(0.039 g, 31.7%). 
N-Tosyl-4,4-ethylenedioxy-L-PrOlifle, ethyl ester 3-47 
A solution of 3-39 (1.783g, 5.0 mmol), toluene-4-sulphonic acid (0.102g, 
0.536 mmol), and 1,2-ethandiol (10 cm) in benzene (50 cm) was heated at 
reflux for 6 h using a Dean Stark apparatus to remove the water produced in 
the reaction. The mixture was diluted with CHCI3 (100 cm), washed with aq. 
HCI (IM, 30 cm), aq. Na2CO3 (5%, 40 cm3) and brine (30 cm3 X 2) 
successively, dried and evaporated to give 3-47 as a colourless oil (1 .895g, 
94%). 8 H (60 MHz, CDCI 3) 1.26 (3H, t, J 7, CH 2CH), 2.6-2.16 (2H, m, 3-H, 
ABX), 2.42 (3H, s, Ar-CH 3), 3.42 (2H, s, 5-H), 3.86 (4H, brs, -OCH 2CH 2O-), 
4.32 (2H, q, J 7, CH2CH3), 4.4-3.9 (IH, m, ABX), 7.8-7.2 (4H, q, Ar-H, A 2B2); 
mlz 282 [(M - COOEt), 24%], 200 [M - Ts), 60.7], 171 [(M - Ts-
COOEt), 100]. 
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N-Tosyl-4,4-ethylenedioxy-2(4-PeflteflOYl) pyrrolidi ne 3-48 
A solution of vinylmagnesium bromide in THF (1.0 M, 1.2 cm 3, 1.2 mmol) 
was slowly dropped into a solution of 3-47 (0.314 g, 0.88 mmol) in dry THF 
at -78°C over N2. The mixture was stirred at -78 °C for 0.5 h., at 0 °C for 2 h 
and at r.t. for 8 h., then cooled to -78 °C and sat. aq . NH4CI (10cm3) was 
dropped into the reaction which was then stirred at -78 °C for 10 mm., and at 
r.t. for 2h. The mixture was diluted with aq. NH 4CI (20 cm3), evaporated to 
remove THE and extracted with CHCI 3 (30 cm 3 X 4) which was then washed 
with aq. HCl (1M, 20 cm), aq. Na 2CO3 (5%, 20 cm 3) and brine (15 cm 3 X 2), 
dried and evaporated to give 3-48 as a pale yellow oil (0.205 g, 68 %). 8H (60 
MHz, CDCI3) 2.4-1.8 (4H, m), 2.45 (3H, s, Ar-CH 3), 3.2-2.8 (2H, m, 3-H), 3.6-
3,3 (2H, d, 5-H), 3.9-3.7 (4H, brs, -OCH 2CH20-), 4.3-4.0 (1H, m, 2-H), 6.3-
4,8 (3H, m, CH=CH2, ABC), 7.95-7.25 (4H, q, Ar-H, A2 B2); m/z (e.i.) 282 [(M-
COCH2CH2CHCH2) + , 100%1, 155, 126, 91, 83 [(COCH2CH2CHCH2), 
2.4], 55. 
N-Tosyl-trans-4-acetoxy-2-pyrrolidifle carboxylic acid chloride 3-50 
A solution of 3-40 (0.981 g, 2.996 mmol) and thionyl chloride (5 cm) in 
benzene (80 cm) was heated at reflux for 3 h using a Dean Stark apparatus 
to separated the water produced, then evaporated to give a solid which was 
crystallized from dry CHCI 3  to give 3-50 as colourless crystals (0.893 g, 
86.2%). m.p. 150.5-152.5 °C; [a]D2° -87.80 (c, 1.21, CHCI3); (Found: C, 48.86; 
H, 4.78; N, 3.91. C 14 H 16N05C1S requires: C, 48.63; H, 4.66; N, 4.05%); Vmax 
(nujol)/ cm 1  1822 (C=O), 1741 (C=O), 1239, 1091; 8H  (60 MHz, CDCI3) 2.72 
3H, s, COCH 3), 2.8-2.2 (2H, m, 3-H), 2.50 (3H, s, Ar-CH 3), 3.72 (2H, d, 5-H, 
AB), 4.72 (1H, t, J 8, 2-H), 5.62 (1H, m, 4-H),, 7.92-7.32 (4H, q, Ar-H, A 2 132); 
m/z 349 [M(37C1) + 2], 347 [M( 35C1) + 2] (349/347 ca 3:1), 283 [(M + 1) - 
COCl], 240, 222. 
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N-Tosyl-4-acetoxy-L-proline amide 3-51 
Compound 3-50 (110 mg, 0.318 mmol) and vinylmagnesium bromide (0.965 
M*, 1.0 cm 3, 0.965 mmol in THF) were reacted using the same method as 
that used in preparing 3-44 to give 3-51 as a colourless crystals (37 mg, 
35%). m.p. 163-164.5°C (Et20); [aID2°  -109
0 
 (C, 1.00, MeOH); (Found: C, 
51.58; H, 5.88; N, 8.45. C 14 H 18N205S requires: C, 51.52; H, 5.56; N, 8.58%); 
vmaxlCm 1 3429, 3211 (NH 2), 1724 (C0), 1673 (C=O); 6H  (200 MHz, CDCI3) 
1.53 (3H, s, COCH3), 2.27 (2H, q, J 8.3, 3.6, 3-H), 2.43 (3H, s, Ar-CH 3), 3.56 
(IH, q, JAB  7.3, JAx 0.8, 5-H, ABX), 3.74 (IH, q, JAB  7.3 JBX  2.2, 5-H, ABX), 
4.18 (1H, t, J 8.3, 2-H), 5.04 (IH, dq, J 3.6, J Ax 0.8, JBX  2.2, 4-H, ABX), 5.68 
(1H, brs, NH 2), 6.77 (1H, brs, NH 2), 7.76-7.34 (4H, m, Ar-H, A 2 132); ö (50 
MHz, CDCI3) 20.2 (COCH 3), 21.4 (Ar-CH 3), 36.7 (C-3), 54.8 (C-S), 61.3 (C-
2)., 72.2 (C-4), 128.2 (2 X Ar-CH,), 129.8 (2 X Ar-CH), 132.9 (Ar-C), 144.3 
(Ar-C), 169.7 (C-7), 173.4 (C-6); mlz 328 (M + 2), 312 (M - NH 2), 285 [(M + 
2) - COCH 31, 267 (M - COOCH 3), 240 [(M + 1) - COCH 3 - CONH 2], 222 (M-
CONH2 - CH3COOH), 173 [(M +2) - Ts], 155. 
N-Tosyl-4-hyd roxy-2-[3-(3-hydroxypentyl-1 ,4-d iyne)] pyrrolidine 3-52 
A solution of ethynylmagnesium bromide in THF (0.5 M, 18 cm 3, 9 mmol) 
was added slowly into a cooled solution of 3-28 (0.90 g, 3 mmol) in dry THF 
(15 cm3) at -78°C. The mixture was stirred at -78 °C for I h, at r.t. for 1 h, then 
diluted with sat. aq . NH4CI (10 cm3) and extracted with ether (30 cm3 X 3). 
The extract was washed with aq. HCI (1M, 20 cm), aq. Na 2CO3 (5%, 20 
cm3) and brine (20 cm 3  X 3), then dried and evaporated to give a solid which 
was crystallized from CHCI 3 to give 3-52 as colourless crystals (0.347 g, 
36%). m.p. 138-139.5°C; [a]020 - 42.50 (C 1.01, MeOH); (Found: C, 60.16, H, 
. The reagent purchased from Aldrich was titrated using literature method (ref. 140) before use. 
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5.40, N, 4.21, C 16H 17N04S, requires: C, 60, 17, H, 5.36, N, 4.38%); vmaxlcm 1 
3407 (OH), 3265, 3216, 2105, 1599, 1333, 1205, 1155, 1050, 983; 6H  (60 
MHz, CDCI3) 2.0 (1H, brs, OH, replaced by adding D 20), 2.6-2.3 (2H, m, 3-
H), 2.52 (3H, s, Ar-CH 3), 2.70 (2H, s, CCH), 3.82 (2H, brs, 5-H) 4.30 (IH, t, J 
8, 2-H), 4.52 (IH, brs, 4-H ), 5.64 (IH, brs, OH, replaced by adding D 20), 
8.1-7.4 (4H, q, Ar-H, A 2 132); mlz 320 (M +1), 302 (M - HO), 240 [M - 
COH(CCH)21. 
NTosyl4,4ethylenedioxy-2-hydrOXYmethYIPYrrOlidi ne 3-54 
A solution of LiAIH 4 (1.793 g, 45 mmol) in THF (80 cm 3) was slowly dropped 
into a cooled solution of 3-55 (15.155 g, 40.8 mmol) in dry THE (100 cm 3) at 
0°C over 1.5 h. After stirring at 0 °C for 20 h., water (50 cm) was dropped 
slowly into the mixture and stirred for I h. After the THE was evaporated, the 
aqueous solution was extracted with EtOAc (60 cm 3 X 5) which was then 
washed with aq. HCI (2M, 60 cm), aq. Na 2CO3 (5%, 60 cm 3) and brine (40 
cm3  X 3), dried and evaporated to give 3-54 as a colourless oil (11.35 g, 
88.7%). [ct] D2° 3.670 (c,1.01, MeOH); vmax/cm 1 3517 (OH), 2890, 1597, 1493, 
1335, 1011, 909, 816; oH (60 MHz, CDCI3) 2.32-1.90 (2H, m, 3-H), 2.56 (3H, 
s, Ar-CH 3), 2.80 (IH, brs, OH, exchanged with D20), 3.52 (2H, d, 5-H, AB), 
4.2-3.7 (7H, m, 2-H, CH 20H, -OCH2CH20-), 8.04-7.34 (4H, q, Ar-H, A 2 132); 
mlz 314.10624 [(M + 1), C 14H20N05S MH requires: 314.10621), 282 (M - 
CH20H), 159 [(M + 1) - Ts], 128 [(M + 1) -Ts - CH 20H]. 
N-Tosyl-4,4-ethylenedioxy-L-prOlifle 2-hydroxyethyl ester 3-55 
A solution of 3-30, 1,2-ethandiol (100 cm 3) and toluene-4-sulphonic acid 
(0.511 g, 2.68 mmol) in benzene (300 cm) was heated at reflux for 5 h. A 
Dean Stark apparatus was used to separate the water produced during the 
reaction. After the solvents were evaporated, the residue was dissolved in 
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EtOAc (150 cm 3), washed with aq, Na2CO3 (5%, 30 cm), brine (30 cm 3 X 3), 
dried and evaporated to give 3-55 as a colourless oil (10.756 g, 95%). [a]D2° 
-53.680 (C, 1.51, MeOH); vmajcm 1  3537 (OH), 1746 (C=O), 1597, 1157, 
1012, 816, 707; 8,, (60 MHz, CDCI 3) 2.32 (2H, d, J 8, 3-H), 252 (3H, s, Ar-
CH), 2.84 (1H, brs, OH, replaced by adding D 20), 3.50 (2H, d, 3-H, AB), 
3.94 (6H, -OCH 2CH20-, COCH2), 4.38 (2H, m, -CH20H), 4.46 (1H, t, J 8, 2-
H), 8.0-7.3 (4H, q, Ar-H, A 2 B2); mlz 372.11174 [(M + 1), C 16H22N07S MH 
requires: 372.11169], 354 (M - OH), 328 [(M +1) -CH 2CH2OH], 282 (M - 
COOCH 2CH 2OH). 
N-Tosyl-4,4-ethylenedioxy-2-formYlPYrrOlidifle 3-56 
A solution of 3-54 (11.316 g, 36.1 mmol) in dry CH 2Cl2 (80 cm) was slowly 
dropped into a solution of oxalyl chloride (11.64 g, 91.7 mmol) and dry 
DMSO (16 cm 3 , 225.47 mmol) in dry CH2Cl2 (100 cm3) at -78°C over N 2 . 
After stirred for 25 mm. at -78 °C, NEt3 (40 cm) was added and stirring 
continued at r.t. for 15 mm.. The mixture was diluted with water (100 cm) 
and the organic phase was separated. The aqueous solution was extracted 
with CHCI3 (80 cm3  X 3). The combined organic extracts were washed with 
aq. HCI (1M, 80 cm), aq. Na 2CO3 (80 cm3) and brine (80 cm 3 X 2), then 
dried and evaporated to give a residue which was purified by silica gel 
column chromotography eluted with CHCI 3 and CH2Cl2-EtOAc (4:1) 
successively. Fractions containing 3-56 were evaporated to give the product 
as a viscous oil (10.75 g, 95%). A portion of the product was crystallised from 
Et20 to give colourless crystals. m.p. 64.5-65.5 C; [a]D20 -39.50 (C, 8.3, 
CHCI3); Vmax/ cm 1 2982, 2830, 1728 (C=O); 8H  (200 MHz, CDCI3) 1.89 (IH, 
q, JAB 13.1, JAx 9.2, 3-H, ABX), 2.07 (IH, q, JAB 13.1, JBX  5.7,3-H, ABX), 2.34 
(3H, s, Ar-CH 3), 3.09 (IH, q, J 10.3, 5-H, AB), 3.42 (IH, q, J 10.3, 5-H, AB), 
3.67-3.78 (4H, m, -OCH 2CH20-, A2 132), 3.85 (IH, q-d, J 3.3, J Ax 9.2, JBX  5.7, 
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2-H, ABX), 7.27-7.63 (4H, q, Ar-H, A 2B2), 9.58 (1H, d, J 3.3, 6-H); mlz 
312.09055 [(M + 1), C 14 H 18N05S MH requires: 312.09056], 282 (M - CHO), 
156 (M-Ts), 155,127. 
N-Tosyl-4,4-ethylened ioxy-2-(3-hyd roxyal lyI)pyrrolidine 3-57 
A solution of vinylmagnesium bromide in THF (0.975 M, 40 cm 3 , 39 mmcl) 
(titration using the method in reference 98) was dropped into a cooled 
solution of 3-56 (9.793 g, 31.45 mmol) in dry THF at -78 °C under N2 . After 
stirring at -78 °C for 1.5 h, a further portion of vinylmagnesium bromide 
solution (10 cm 3 , 9.75 mmol) was added and the solution stirrred at -78°C for 
4 h, then at 4°C for 10 h. Water (50 cm 3) was added slowly to end the 
reaction. The mixture was acidified with conc. HCl (to pH 1-3), extracted with 
CHCI3 (60 cm3 X 4) and the organic extract washed with aq. Na 2CO3 (5%, 50 
cm3) and brine (50 cm 3 X 3), then dried and evaporated to give a residue. 
The residue was chromatographed on a silica gel column which was eluted 
with CHCI3 and CHCI3-EtOAc (4:1) successively. After evaporation, the 
product 3-57 was obtained from the CHCI 3-EtOAc eluate as a viscous oil 
(9.689 g, 90%). A sample of the product was crystallised from a CHCI 3-Et20 
(1:5) to give colourless crystals. m.p. 113-114 °C; vmaxlcm 1 3497 (OH), 1643 
(C=C), 1597, 1493, 1335, 928; oH (60 MHz, CDCI 3) 1.4-2.4 (2H, m, 3-H), 
2.52 (3H, s, Ar-CH 3), 3.36 (IH, brs, OH, replaced by adding D 20), 3.53 (2H, 
s, 5-H), 4.3-3.6 (4H, m, -OCH 2CH20-, A2 B2), 4.80 (IH, brs, 6-H), 6.32-5.16 
(3H, m, CH=CH 2 , ABC), 8.2-7.3 (4H, q, Ar-H, A2B2); 0H  (200 MHz, CDCI 3) 
1.73 (1H, q, JAB  13.4, JAx 8.3, 3-H, ABX), 2.14 (IH, q, JAB  13.4, JBX  7.9 3-H, 
ABX), 2.38 (3H, 5, Ar-CH3), 3.12 (1H, brs, OH), 3.33 (2H, s, 5-H), 3.82-3.37 
(5H, m, 2-H, -OCH 2CH20), 4.62 (1H, brs, 6-H), 5.37-5.11 (2H, m, CHCH2, 
ABC), 5.83-5.67 (IH, m, CH=CH 2 , ABC), 7.70-7.24 (4H, q, Ar-H, A2B2); m/z 
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340.12184 [(M + 1), C 16 H22N05S MH requires: 340.12186), 322 (M - OH), 
282 (M - CHOHCH=CH2)+  
N-Tosyl-4-oxo-2-(3-hydroxyallyl)PYrrOlidi ne 3-58 
Perchioric acid (70%, 3cm) was dropped slowly into a solution of 3-57 
(1.077 g, 3.17 mmol) in THF (50 cm) with stirring at 0 °C. After stirring at r.t. 
for 3 days, the mixture was cooled to 0°C, diluted with water (30 cm 3) and 
CHCI3 (50 cm 3) and stirred for a further hour. After the organic phase was 
separated, the aq. phase was extracted with CHCI 3 (20 cm3 X 3) and the 
combined organic solutions were washed with aq. Na 2CO3 (5%, 30 cm) and 
brine (30cm3 X 2), dried and evaporated to give a solid which was 
crystallized from Et20 to give 3-58 as colourless crystals (0.476 g, 50.7%). 
m.p. 154.5-156.0 °C. (Found: C, 56.96; H, 5.79; N, 4.78. C 14H 17N04S requires: 
C, 56.93; H, 5.80; N, 4.74%); Vm (nujol)/cm 1 3493 (OH), 1746 (C=O), 1594 
(C=C), 1376, 1338, 1157, 931. 816; 6H  (60 MHz, CDCI 3) 2.8-2.2 (3H, m, 3-H, 
OH, replaced by adding D 20), 2.52 (3H, s, Ar-CH 3), 3.86 (2H, d, 5-H, AB), 
4.32 (IH, m, 2-H), 4.80 (IH, brs, CHOH), 6.1-5.2 (3H, m, CHCH 2, ABC), 
8.1-7.3 (4H, q, Ar-H, A2B2); H  (200 MHz, CDCI 3) 2.03 (IH, q, J 9.5, JAB  18.2, 
3-H, ABX), 2.38 (IH, q, J 2.2, J AB  18.2, 3-H, ABX), 2.39 (3H, s, Ar-CH 3),AX 
2.82 (1H, brs, OH), 3.64 (1H, q, J 18.0, 5-H, AB), 3.82 (1H, q, J 18.0, 5-H, 
AB), 4.18 (1H, q, J 9.5, J 8 2.2, 2-H, ABX), 4.64 (IH, brs, CHOH), 5.39-5.18AX 
(2H, m, CH=CH 2, ABC), 5.83-5.67 (1H, m, CH=CH 2, ABC), 7.72-7.29 (4H, q, 
Ar-H, A2 B2); o (50 MHz, CDCI3), 21.4 (Ar-CH 3 ), 36.4 (C-3), 53.9 (C-5), 60.9 
(C-2), 74.8 (C-6), 117.1 (C-8), 126.9 (2XAr-CH), 130.0 (2XAr-CH), 134.4 (Ar-
C), 135.8 (C-7), 144.2 (Ar-C), 208.5 (C-4); m/z 296.09640 [(M + 1), 




Jones reagent (0.1 cm 3 , —0.8 mmol) was slowly dropped into a vigorously 
stirred solution of 3-58 (0.106 g, 0.36 mmol) in acetone (8 cm 3) at -150C. 
After 2.5 h, MeOH (1 cm) was added and stirring continued at 0 °C for I h. 
The mixture was diluted with water (10 cm), evaporated at r.t. to remove the 
organic solvents and extracted with CHCI 3 (15 cm3 X 3). The organic extract 
was washed with aq. Na 2CO3 (5%, 15 cm), brine (15 cm 3 X 2), dried and 
evaporated to give a solid which was cystallized from CHCI 3-Et20 (1:5) to 
give 3-59 as colourless crystals (0.098 g, 93%). m.p. 145-146°C; [a]D20  -85.3 0 
(C, 0.40, MeOH); (Found: C, 57.79; H, 5.19; N, 4.89. C 14H 15N04S requires: C, 
57.32; H, 5.15; N, 4.89%); vmax (nujol)/cm -1  1757 (C=O), 1711 (C=O), 1689 
(C=C), 1613, 1596, 1376, 1343, 1151, 980; 8H  (60 MHz, CDCI3) 2.6-2.3 (2H, 
m, 3-H, ABX), 2.50(3H, s, Ar-CH 3), 3.80 (2H, s, 5-H), 5.08 (IH, q, JAx 7, J.x  
5, 2-H, ABX), 6.30-5.90 (IH, d-d, CH=CH 2 , ABX), 7.26-6.34 (2H,m, CHCH2, 
ABX), 8.04-7.30 (4H, q, Ar-H, A2B2); oH  (200 MHz, CDCI 3) 2.32 (IH, q, J 9.1, 
AB 
 18.3, 3-H, ABX), 2.43 (3H, s, Ar-CH 3 ), 2.56 (IH, q, JBx AB  18.3, 3-H, 
ABX), 3.65 (IH, q, J 18.0, 5-H, AB), 3.74 (1H, q, J 18.0, 5-H, AB), 4.93 (1H, 
q, J BX'  3.7, J 9.1, 2-H, ABX), 5.98 (1H, q, JBX  10.5, JAB  1.3, CHCH2,AX 
ABX), 6.50 (1H, q, JAx 17.5, JAB  1.3, CHCH2 , ABX), 6.78 (1H, q, J 17.5, 
BX 
 10.5, ABX), 7.71-7.31 (4H, q, Ar-H, A2 B2); Oc  (50 MHz, CDCI 3) 21.5 (Ar-
CH3), 38.5 (C-3), 53.0 (C-5), 61.2 (C-2), 127.5 (2 X Ar-CH), 130.1 (2 X Ar-
CH), 131.7 (C-7), 131.8 (C-8), 133.4 (Ar-C), 144.8 (Ar-C),195.0 (C-6), 206.7 
(C-4); mlz 249.08000 [(M + 1), C 14H 16N04S MH requires; 294.08001], 238 
(M - COCH=CH 2). 
NTosyI4,4ethylenedioxy-2-acrylOylpyrrOIidifle 3-60 
A). A mixture of 3-57 (1.122 g, 3.2 mmol) and manganese dioxide 83 (12.5 
g, 143.8 mmol) in CH 2Cl2 (50 cm) was stirred ar r.t. for 8 h, then filtered. The 
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solid was washed with CH 2Cl2 (10 cm3 X 3) and filtered. The combined 
filtrates were evaporated to give a residue which was purified by silica gel 
column chromatography eluting with petrolum ether (60-80 °C) and 
CHCI3 :EtOAc:petrolum ether (4:1:1) successively. After evaporation, 3-60 
was obtained from the second elutate as a viscous oil (0.599 g, 53.7%). This 
product was crystallized from Et20 to give colourless crystals. m.p. 76-78 °C; 
[ct]02° -23.970 (c, 0.566, MeOH); vmaxlcm 1 1697 (C=O), 1612, 1598, 1347, 
1161, 1091, 906, 817; oH (60 MHz, CDCI 3) 2.16 (2H, d, J 7.5, 3-H), 2.46 (3H, 
s, Ar-CH 3), 3.35 (1H, q, J 9.6, 5-H, AB), 3.57 (1H, q, J 9.6, 5-H, AB), 4.16-
3.12 (4H, m, -OCH 2CH20-, A2 132), 4.34 (1H, t, J 7.5, 2-H), 7.2-5.8 (3H, m, 
CH=CH2, ABX), 8.1-7.3 (4H, q, Ar-H, A 2 132); mlz 338.10623 [(M + 1), 
C16 H20N05S MH requires: 338.10621], 282 (M - COCHCH2), 183 [(M + 1) 
-Ts], 155. 
B). 	Jones reagent (5cm 3) was dropped slowly into a solution of 3-57 
(2.91 Ig, 8.57 mmol) in acetone (80cm) with vigorous stirring at 0 °C. The 
mixture was stirred at 0 °C for 20 mm., then worked up using the same 
method as that used in the preparation of 3-59 from 3-58 to give 3-60 as 
colourless crystals (2.307g, 79%). 
N-Benzoyl-4,4-ethylenedioxyproline, 2-hydroxyethyl ester 3-61 
3-32 (4.198 g, 18.0 mmol) was converted to 3-61 (4.737 g, 81.9%) using the 
same method as that for preparation of 3-55 from 3-30. The product was 
crystallised from EtOAc. m.p. 62-64 °C; [a]D2° -68.060 (c, 0.74, MeOH); 
vmax/cm 1  3403 (OH), 1745 (C=O), 1630 (C=O), 1448, 1420, 1189, 1120, 
1084, 1015; 0H  (60 MHz, CDCI3) 2.30 (2H, q, J Ax 8.4, JBX  8.4, JAB  2.4, 3-H, 
ABX), 3.86 (2H, brs, 5-H), 4.6-3.2 (IOH, m), 4.92 (1H, t, J Ax 8.4, JBX  8.4, 2-H, 
AB), 7.62 (5H, s, Ar-H); m/z 322 (M + 1), 304 (M - OH) + , 232 (M - 
COOCH 2CH20H). 
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N-Benzoyl-4,4-ethyleflediOXy-2-hyd roxymethylpyrrolidi ne 3-62 
To a solution of 3-61 (0.908 g, 2.827 mmol) in THF (8 cm) was added LiBH 4 
(0.25 g, 11.48 mmol) at 0 °C with vigorous stirring. After stirring at r.t. for 20 h, 
water (0.8 cm) was added and the solution stirred at r.t. for 5 h. The mixture 
was filtered and the solid was washed with acetone (10cm 3 X 3). The 
combined filtrate and washings were evaporated to dryness. The residue 
was dissolved in EtOAc (50 cm), washed with aq. Na 2CO3 (5%, 10 cm), aq. 
HCI (IM, 10 cm 3) and brine (10 cm 3 X 3), dried and evaporated to give a 
solid which was crystallised from CHCI 3 to give 3-62 as colourless crystals 
(0.564 g, 75.84%). m.p. 138.5-140 °C; [a]D20  -111.590 (C, 0.26, MeOH); 
(Found: C, 63.20, H, 6.62, N, 5.57, C 14 H 17N04  requires: C, 63.87, H, 6.51, N, 
5.32); vmax/Cm 1  3405 (OH), 1612 (C=O), 1575, 1426, 1118, 1014; 6H  (200 
MHz, CDCI3), 1.97 (IH, q, JAB  13.2, JAx 	3-H, ABX), 2.21 (1H, q, JAB 13.2, 
JBX 8.1, 3-H, ABX), 3.41 (1H, q, J 11.4, 5-H, AB), 3.56 (IH, q, J 11.4, 5-H, 
AB), 3.96-3.70 (6H, m, 6-H, -OCH 2CH20-), 4.52 (IH, q, J Ax 8.4, JBX  8.1 1  2-H, 
ABX), 4.50 (IH, brs, OH), 7.48-7.30 (5H, m, Ar-H); 8 c (50 MHz, CDCI 3) 36.74 
(C-3), 57.33 (C-4), 59.52 (C-2), 64.37, 64.98 (OCH 2CH20), 65.69 (C-6), 
111.83 (C-4), 127.95 (2 X Ar-CH), 128.19 (2 X Ar-CH), 130.14 (Ar-CH), 
135.81 (Ar-C), 171.86 (C=O); mlz 264.12326 [(M + 1), C 14H 18N04 MH 
requires 264.12358], 246 (M - OH )', 232 (M - CH 20H), 160, 128. 105. 
NBenzoyI4,4-ethyIenedioxy-2-fOrmylPYrrOlidifle 3-63 
3-62 (0.223 g, 0.85 mmol) was converted to 3-63 (0.173 g, 78.16%) using 
the same method as that for preparation of 3-56 from 3-54. 3-63 was a 
viscous oil; vmaxlcm 1  2890, 2832, 1730 (C=O), 1631 (C=O), 1576, 1447, 
1273, 1120, 1031; oH (200 MHz, CDCI 3) 2.18 (IH, q, JAB 13.2, JAx 5.5, 3-H, 
ABX), 2.32 (1H, q, JAB 13.2, JBX 9.4, 3-H, ABX), 3.58 (1H, q, J 11.1, 5-H, 
AB), 3.64 (1H, q, J 11.1, 5-H, AB), 4.01-3.77 (4H, m, -0CH 2CH20-, A2 132), 
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4.68 (IH, 7 peaks, J4.x 5.5, JBX  9.4, J 2, 2-H, ABX), 7.57-7.36 (5H, m, Ar-H) 
9.62 (IH, d, J 2, CHO); 6c  (50 Hz, CDCI 3 ) 35.61 (C-3), 56.60 (C-5), 63.23 
(C-2), 64.13, 64.85 (-OCH 2CH2O-), 112,80 (C-4), 127.24 (2 X Ar-CH), 
128.28 (2 X Ar-CH), 130.60 (Ar-CH), 134.78 (Ar-C), 170.24 (C=O), 199.64 
(C=O); m/z 262.10731 [(M + 1), C 14 H 16N04 MH requires: 262.10793], 232 
(M - CHO). 
NBenzyl4,4-ethyIenedioxy-2-hydrOXYmethYIPYrrOl idine 3-64 
To a solution of 3-61 (23.072 g, 71.80 mmol) in THF (200 cm) solid LiAIH4 
(5.75 g, 151.56 mmol) was added at 0 °C with vigorous stirring. After stirring 
at r.t. for 20 h, water (12 cm) was added and the suspension stirred at r.t. for 
3 h. The mixture was filtered and the solid was washed with acetone (50 cm 3 
X 3). The combined filtrate and washings were evaporated to give a residue 
which was dissolved in EtOAc (100 cm), washed with aq. Na 2CO 3 (5%, 20 
cm3), aq. HCl (1M, 20cm), brine (20 cm 3 X 3), dried and evaporated to give 
a residue which was purified by column chromatogragh on silica gel. The 
column was eluted with CHCI 3 and CHCI 3-EtOAc (3:1) successively. After 
evaporation of the CHCI3-EtOAc eluate, 3-64 was obtained as a pale yellow 
oil (14.34 g, 80.11%). A portion of the product was crystallised from Et20 to 
give colourless crystals. m.p. 63-65 °C; [a]02° -87.390 (C, 0.31, MeOH); 
vmax/cm 1 3438 (OH), 2946, 2880, 2803, 1494, 1452, 1364, 1162, 1096, 
1073, 1019, 947; oH (200 MHz, CDCI 3) 2.13 (2H, d, J 8.2, 3-H), 2.47 (IH, q, J 
10.3, 5-H, AB), 2.96 (IH, q, J 10.3, 5-H, AB), 2.77 (1H, brs, OH); 3.31 (IH, q, 
J 13.1, ph-CH, AB), 4.00 (1H, q, J 13.1, ph-CH, AB), 3.47-3.41 (IH, d-d, 6-
H), 3.95-3.70 (6H, m, 2-H, 6-H, -OCH 2CH 20-), 7.30-7.22 (5H, m, Ar-H); Oc 
(50 Hz, CDCI 3) 38.0 (C-3), 57.7 (C-5), 60.4 (Ph-CH 2), 61.9 (C-6), 62.9 (C-2), 
64.2, 64.2 (OCH 2CH 20), 113.3 (C-4), 126.9 (Ar-CH), 128.1, 128.4 (4XAr- 
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CH), 138.1 (Ar-C); m/z 250.14484 [(M + l), C14H20NO3 MH requires: 
250.14432], 232 (M - OH), 218 (M - CH 2COH), 172 (M - Ph), 160, 128. 
N-Benzyl-4,4-ethylenedioxy-2-formylpyrrolidine 3-65 
3-64 (0.500 g, 2.0 mmol) was converted to 3-65 (0.342 g, 69.07%) using the 
same method as that used in the preparation of 3-56 from 3-54. The product 
was obtained as a pale yellow oil. vmaxlcm 1 2883, 2807, 2718, 1727 (C=O), 
1491, 1453, 1362, 1163, 1097, 1018; 61-1  (60 MHz, CDCI 3) 2.32-2.18 (2H, m, 
3-H, ABX), 2.70 (1H, q, J 10.5, 5-H, AB), 3.25 (IH, q, J 10.5, 5-H, AB), 3.6-
3.12 (IH, m, 2-H, ABX), 3.84-3.80 (2H, brs, Ph-CH 2, AB), 3.96 (4H, brs, - 
OCH2CH20-, A2 B2), 7.48 (5H, s, Ar-H), 9.65 (1H, d, J 4, CHO); mlz 248 (M + 
1), 218 (M - CHO), 128 (M - CHO - PhCH2). 
N-Benzoyl-4,4-ethylenedioxy-2-(3-hydroxyprOpiOflyl)pyrrOlidifle 3-66 
3-63 (0.149 g, 0.57 mmol) was converted to 3-66 (0.079 g, 47.97%) using 
the same method as that for preparation of 3-57 from 3-56. The product was 
a viscous oil. vmaxlcm 1 3365 (OH), 1680 (C=C), 1612 (C0), 1673, 1447, 
1429, 1342, 1278, 1116, 1029, 1016; 8H  (60 MHz, CDCI3) 2.50-2.06 (2H, m, 
3-H), 3.60 (2H, s, 5-H), 3.94 (4H, brs, -OCH 2CH20-), 5.04-4.30 (3H, m, 2-H, 
6-H, OH), 6.40-5.20 (3H, m, CH=CH 2, ABC), 7.56 (5H, s, Ar-H); oH (200 
MHz, CDCI3) 1.99 (IH, m, 3-H, ABX), 2.13 (IH, m, 3-H, ABX), 3.44 (IH, q, J 
11.6, 5-H, AB), 3.55 (1H, q, J 11.6, 5-H, AB), 3.96-3.40 (4H, m, -OCH 2CH20- 
A2 B2), 4.36 (IH, m, 6-H), 4.55 (IH, m, 2-H, ABX), 4.91 (IH, brs, OH), 5.92-
5.19 (3H, m, CH=CH 2 , ABC), 7.48-7.36 (5H, m, Ar-H); Oc  (50 MHz, CDCI 3) 
36.8 (C-3), 57.2 (C-5), 61.1 (C-2), 64.4, 65.0, (-OCH 2CH20-), 76.5 (C-6), 
111.9 (C-4), 117.6 (C-8), 127.1, 128.2, 130.3 (5 X Ar-CH), 135.6 (Ar-C), 
137.0 (C-7), 172.8 (C=O); mlz 29013985 [(M + 1), C 16H20N04 MH requires: 
290.13923], 272 (M - OH), 232 (M - CH(OH)CH=CH2], 154, 128. 
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N-Benzyl-4,4-ethylenedioxy-2-(3-hydrOXyprOPiOflYl)PYrrOlidifle 3-67 
3-65 (0.231 g, 0.93 mmol) was converted to 3-67 (0.130 g, 50.45) using the 
same method as that for preparation of 3-57 from 3-56. The product was a 
pale viscous oil which was crystallised from Et 20 to give colourless crystals. 
m.p. 80-82°C; vmax/cm 1 3453 (OH), 1633 (C=C), 1493, 1452, 1365, 1281, 
1161, 1094, 1071, 1015, 994, 924; 8H  (200 MHz, CDCI 3), 1.99 (IH, m, 3-H, 
ABX), 2.23 (IH, q, 3-H, ABX), 2.55 (IH, q, J 11.5, 5-H, AB), 2.94 (IH, q, J 
11.5, 5-H, AB), 3.04 (1H, m, 2-H, ABX), 3.52 (1H, m, 6-H), 3.37 (1H, brs, 
OH), 3.52 (IH, q, J 13, PhCH, AB), 4.10 (IH, q, J 13, PhCH, AB), 3.96-3.78 
(4H, m, -OCH 2CH20-, A2 B2), 5.99-5.13 (3H, m, CH=CH2, ABC), 7.29 (5H, m, 
Ar-H); 8 (50 MHz, CDCI 3) 38.2 (C-3), 60.6 (C-5), 60.7(PhCH2), 64.2 
(OCH 2CH20), 66.4 (C-2), 73.0 (C-6), 114.4 (C-4), 115.5 (C-8), 126.9 (Ar-
CH), 128.2 (2 X Ar-CH), 128.4 (2 X Ar-CH), 138.8 (Ar-C), 139.0 (C-7); m/z 
276.15962 [(M + 1), C 16H22 NO3 MH requires: 276.15997], 258 (M - OH), 
218 (M - CHOHCH=CH2). 
N-Tosyl-4-hyd roxy-2-hydroxymethylpyrrolidine 3-68 
A solution of L1AIH4 (1.2 g, 30 mmol) in THE (50 cm) was dropped into a 
solution of 3-24 (5.607 g, 19.65 mmol) in THE (30 cm 3) at 0°C with vigorous 
stirring. After stirring at 0 °C for I h and at r.t. for 20 h, the reaction was 
terminated by adding water (2 cm 3) and stirring for 3 h. The mixture was 
filtered, the solid was washed with acetone (30 cm3 X 2) and filtered. The 
combined filtrate was evaporated to give a residue which was crystallized 
from MeOH to give 3-68 as colourless crystals (2.26 g, 42.3%). m.p. 134.5-
136.50C (lit.5"46 , 130-131 °C, 131-1330C); [a]D2° -51.60 (C, 1.04, MeOH) 
[lit." 46 -46.80 (C, 1.86, EtOH), -42.8 0 (C, 1.96, EtOH); vmax(nujol)/cm 1 3394 
(OH), 3295 (OH), 1596, 1442, 1338, 1155, 1089; oH (60 MHz, CDCI 3) 1.98 
(2H, m, 3-H), 2.8-2.4 (2H, brs, OH, replaced by adding D 20), 2.50 (3H, s, Ar- 
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CH 3), 3.50 (2H, m, 5-H), 3.80 (2H, m, 6-H), 4.45 (1H, m, 2-H), 8.02-7.32 (4H, 
q, Ar-H, A2 B2); m/z 272 [(M + 1), 80.5%], 254 (M - OH), 240 (M - CH 20H), 
155, 116. 
N-Tosyl-4-oxo-2-(3-tosyloxypropiflOYl)PYrrOlid me 3-69 
A solution of Cs 2CO3 (30 mg, 0.09 mmol) in CH 3CN (60 cm 3) was 
dropped into a solution of 3-59 (0.130 g, 0.44 mmol) in CH 3CN (50 cm 3) over 
30 mm. at r.t. .The mixture was stirred at r.t. for 20 h, then evaporated to 
remove the solvent. The residue was dissolved in CH 2Cl2 (20 cm 3), washed 
with aq. HCI (1M, 8 cm), aq. Na 2CO3 (5%, 8 cm3) and brine (8 cm 3 X 3), 
dried and evaporated to give a solid which was crystallised from CHCI 3-Et20 
(1:5) to give 3-69 as colourless crystals (0.082 g, 41.4%). m.p. 135.5-
136.5°C; [cx]02° 0 0  (c, 0.51, MeOH); Vmax (nujol)/cm 1 1762 ( C=O), 1720 
(C=O), 1352, 1154; 8H  (200 MHz, CDCI 3) 2.30 (IH, q, JAB 10.4, J Ax 5.2, 3-H, 
ABX), 2.42 (3H, s, Ar-CH 3), 2.44 (3H, s, Ar-CH 3), 2.63 (IH, q, JAB 10.4, JBX 
2.6, 3-H, ABX), 3.53-3.18 (4H, m, -CH 2CH2-, A2132), 3.64 (IH, q, J 10.1, 5-H, 
AB), 3.71 (IH, q, J 10.1, 5-H, AB), 4.58 (IH, q, J Ax 5.2, JBX2.6, 2-H, ABX), 
7.38-7.34 (4H, q, Ar-H, A2 132), 7.79-7.76 (4H, q, Ar-H, A2 B2); m/z 450 (M + 
1), 294 (M - Ts), 265, 238, 139, 109, 91. 
A solution of Lil (16.3 mg, 0.12 mmol) in DME (5 cm) was dropped 
into a solution of 3-59 (0.084 g, 0.28 mmcl) in DME (5 cm 3) at r.t.. The 
mixture was stirred at r.t. for 18 h, then worked up using the same method as 
above to give 3-69 (0.062 g, 48.7%). 
NTosyI4,4ethyIenedioxy-2-(3-aCetOXYaIIYI)PYrrOlidifle 3-70 
Compound 3-70 was obtained from 3-57 using the same method as that of 
preparing 3-71 from 3-57 in 77.3% yield. Colourless crystals m.p. 113- 
114.50C (Et20); vmaxlcm 1 1744 (C=O), 1643, 1238; oH (60 MHz, CDCI 3) 2.08 
128 
(3H, s, COCH 3), 2.4-1.78 (2H, m, 3-H), 2.50 (3H, s, Ar-CH 3), 3.64- 3.18 (2H, 
m, 5-H, AB), 4.30-3.64 (5H, m, 2-H, -OCH2CH20-), 6.14-5.12 (4H, m, 6-H, 
CH=CH2), 8.04-7.24 (4H, q, Ar-H, A 2 132); m/z 382.13245 [(M + 1), 
C18H24N06S MH requires: 382.13242], 337 [(M - 1) - COCH 3], 323 [(M + 1) - 
OCOCH 3], 218. 
N-Tosyl-4-oxo-2-(3-acetoxyallYI)PYrrOlidifle 3-71 
A mixture of 3-58 (0.298 g, 1.01 mmol), acetic anhydride (3cm 3) and pyridine 
(2 cm) was stirred at r.t. for I day, then dropped into ice water (50 cm 3) and 
stirred at r.t. for 3 h. The liquid was removed by filtration and the solid was 
recrystallized from Et20 to give 3-71 as colourless crystals (0.290 g, 85%). 
m.p. 126.5-127.5°C; Vmax (nujol)/cm 1 1771 (C0), 1738 (C=O), 1375, 1349, 
1234, 1154; 8H  (60 MHz, CDCI 3) 2.08 (3H, s, COCH 3), 3.7-2.3 (2H, m, 3-H), 
3.54 (3H, s, Ar-CH 3), 3.80 (2H, d, 5-H, AB), 4.62 (IH, m, 2-H), 6.2-5.14 (4H, 
m, 6-H, CH=CH 2), 8.1-7.3 (4H, q, Ar-H, A 2 132); m/z 338.10623 [(M + 1), 
C16 H 20N05S MH requires: 338.10621], 278 (M - OCOCH3), 238 (M - 
CHOAcCH=CH2), 184 [(M + 1) - Ts). 
N-Tosyl-4,4-ethylenedioxy-2-(3-ethylthioPrOPiOflYl)PYrrOlidifle 3-72 
A mixture of 3-60 (0.489 g, 1.45 mmol) and NaOMe (Ca. 20 mg) in EtSH (5 
cm3) was stirred at r.t. for 2 days and the solvent removed by evaporation. 
The residue was distributed between aq. HCI (2M, 10 cm 3) and CHCI 3 (30 
cm3). After separation of the organic phase, the aqueous solution was 
extracted with CHCI 3 (20cm3 X 3). The combined organic extract was 
washed with aq. Na2CO3 (20 cm3) and brine (1 5cm 3 X 3), then dried and the 
solvent evaporated. The residue was dissolved in CH 2Cl2 (10 cm 3) and 
passed through a short silica gel column eluted with CH 2Cl2 (20 cm). The 
combined eluate was evaporated to give 3-72 as a viscous oil (0.383 g. 
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66%). An aliquot of the product was crystallized from ether to give colourless 
crystals. m.p. 61.6-62.5
0C; [aID2° -52.60 (C, 0.41, MeOH); vmax/cm 1 2965, 
2895, 1715 (C=O), 1697, 1347, 908, 816; oH (200 MHz, CDCI3) 1.23 (3H, t, J 
7.5, CHCH3); 1.89 (IH, q, JAB 13.3, J Ax 9.5, 3-H, ABX), 2.09 (IH, q, JAB 
13.3, JBX 5.0, 3-H, ABX), 2.14 (3H, s, Ar-CH 3), 2.53 (2H, q, J7.5, CH2CH 3), 
2.72 (IH t, J 6.9, 5-H, AB), 2.76 (IH, t, J 6.9, 5-H, AB), 3.30-2.99 (4H, m, 
CH2CH2, A2 132), 3.89-3.71 (4H, m, -OCH 2CH20-, A2 132),4.02 (1H, q, JAX  9.5, 
JBX 5.0, 2-H, ABX), 7.67-7.29 (4H, q, Ar-H, A 2 132); Oc  (50 MHz, CDCI3) 14.5 
(C-b), 21.4 (Ar-CH3), 24.8 (C-9), 25.8 (C-8), 38.2 (C-Il), 38.3 (C-21), 54.8 
(C-7), 64.7 (C-3), 64.9 (C-5), 65.7 (C-2), 112.0 (C-4), 127.6 (2 X Ar-CH), 
129.7 (2 X Ar-CH), 132.3 (Ar-C), 144.2 (Ar-C), 207.5 (C-6); m/z 400.12524 
[(M + 1), C 18 H 26N05S2 MH requires: 400.12523], 338 (M - -SEt), 282 (M - 
COCH 2CH2SEt), 245 [(M + 1) - Ts], 182 (M - Ts - EtSH), 128 [(M + 1) - Ts 
- COCH2CH2SEt]. 
3-73 
Dry HBr was passed through a cooled solution of 3-60 (0.651 g, 1.928 mmcl) 
in CH2Cl2-Et20 (1:6, 35cm3) at -15 °C for 2 h. The mixture was stirred at.0 °C 
for 4 h, then evaporated to give a residue which was crystallized from 
CH 2Ct2-Et20 (1:10) to give 3-73 as colourless crystals (0.465 g, 57.8%). m.p. 
119-120.5°C; [aID2°  -37.05 (C, 0.70, MeOH); Vmax (nujol)/cm 1 1716 (C0), 
1595, 1343, 1258, 1156, 1011, 929, 905; O (60 MHz CDC13) 2.40-2.04 (2H, 
m, 3-H, ABX), 2.60 (3H, s, Ar-CH3), 3.64-3.18 (2H, q, 5-H, AB), 3.9-3.6 (4H, 
m, CH2CH2, A2132), 4.96-3.92 (4H, m, -OCH 2CH20-, A2 132), 4.20 (1H, q, JAx  
7.5, JBX  5.0, 2-H, ABX), 8.10-7.44 (4H, q, Ar-H, A2 132); m/z 420.03046 [(M + 
1), C 16 H21 81 BrNO5S MH requires: 420.03045], 418.03246 [(M + 1), 
C16H21 7913rN05S MH requires: 418.03242], 338 (M - Br), 282 (M - 
COCH2CH2Br), 265, 263 (M - Ts). 
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NTosyl-4-oxo-2-(3-bromOPrOPiOflYl)PYrrOIidifle 3-74 
Compound 3-59 (0.387 g, 1.3 mmol) was converted to 3-74 (0.467 g, 94%) 
using the same method as that used for the preparation of 3-73 from 3-60. 
m.p. 132.5-133.5°C (Et20); [a]D2° -53.70 (C, 0.5, MeOH); Vmax (nujol)/cm 1 
1766 (C=O), 1272 (C0), 1153, 1065, 984, 722; 6H  (200MHz, CDCI3) 2.26 
(IH, q, JAB 18.6, JAx 9.4, 3-H, ABX), 2.65 (IH, q, JAB  18.6, JBX  4.8, 3-H, 
ABX), 2.42 (3H, s, Ar-CH 3), 3.63-3.31 (4H, m, CH 2CH2, A2 132), 3.63 (IH, q, J 
18.5, 5-H, AB), 3.71 (1H, q, J 18.5, 5-H, AB), 4.53 (1H, q, JAx  9.4, JBX  4.8, 2-
H, ABX), 7.75-7.28 (4H, q, A2132); öc (50 MHz, CDCI 3) 21.5 (Ar-CH 3), 24.8 (C-
8), 37.7 (C-7), 41.1 (C-3), 53.2 (C-5), 63.2 (C-2), 122.8 (2 X Ar-CH), 127.6 (2 
X Ar-CH), 130.2 (Ar-C), 132.3 (Ar-C), 203.5 (C-6), 206.5 (C-4); m/z 
376.00426 [(M + 1), C 14 H 1781 BrNO4S MH requires: 376.004241, 374.00624 
[(M + 1), C 14 H 1779BrNO4S MH requires: 374.00621], 296 (M - Br), 238 (M - 
COCH2CH2Br). 
N-Tosyl-4-oxo-trans-3-bromo-L-PrOlifle, methyl ester 3-75 
A solution of bromine in acetic acid (4%, 0.54 cm 3 , 1.35 mmol) was dropped 
into a mixture of 3-33 (0.337 g, 1.13 mmol) and aq. HBr (48%, -0.01 cm) in 
acetic acid (8 cm 3) at 0°C. After stirring at r.t. for 0.5 h, the mixture was 
diluted with Et20 (50 cm 3) and the precipitated solid was crystallized from 
MeOH-Et20 (1:5) to give 3-75 as colourless crystals (0.138 g, 32.6%). m.p. 
100.5-102°C; vmax/cm 1  1773 (C=O), 1752 (C=O), 1435, 1352, 1223, 1157, 
816, 664; oH (60 MHz, CDCI 3) 2.44 (3H, s, Ar-CH 3), 3.78 (3H, s, COCH3), 4.0 
(2H, brs, 5-H), 4.39 (1H, s, 3-H), 4.79 (IH, s, 2-H), 8.0-7.3 (4H, q, Ar-H, 
A2 B2); 0H  (200 MHz, CDCI 3) 2.42 (3H, s, Ar-CH 3), 3.68 (3H, s, COCH3), 3.86 
(IH, q, J 14.0, 5-H, AB), 4.01 (1H, q, J 14.0, 5-H, AB), 4.32 (IH, s, 3-H), 4.70 
(1H, s, 2-H), 7.85-7.20 (4H, q, Ar-H, A 2 13 2); oc (50 MHz, CDCI3) 21.5 (Ar-
CH 3), 43.7 (COCH3), 49.5 (C-5), 53.2 (C-2), 65.8 (C-3), 127.4 (2 X Ar-CH), 
131 
129,8 (2 X Ar-CH), 134.1 (Ar-C), 144.6 (Ar-C), 168.2 (C-6), 195.5 (C-4); m/z 
377.98982 [(M + 1), C 13H 1581 BrNO5S MH requires: 377.98338], 375.98713 
[(M + 1), C 13H 1579BrNO5S MH requires: 375.98543], 318 [(M + 1) - 
COOCH 3], 298 [(M + 1) - Br], 238. 
3-Tosyl propionitrile 3-79 and 
4-(N-pyrrolid inyl)-2-methoxycarbonyl pyrrole 3-78 
A solution of 3-33 (1.421 g, 4.78 mmol) and pyrrolidine (1.5 cm 3, 17.8 mmol) 
in benzene (80 cm 3) was heated at reflux for 2 h, then evaporated to remove 
the solvents. The residue was dissolved in acetonitrile (10 cm 3) and heated 
at reflux for I h. After evaporation of the solvent, the residue was dissolved 
in CHCI3 (30 cm3) and extracted with aq. HCI (2 M, 8 cm 3 X 3). The CHCI3 
solution was washed with aq. Na 2CO3 (5%, 8 cm), brine (8 cm 3 X 2), dried 
and evaporated to give a solid which was crystallized from ether to give 3-79 
as colourless crystals (0.242 g, 24.21%). m.p. 96.0-96.5 °C (Et20); 
vmax(nujol)/cm 1  2245 (CN), 1594, 1421, 1303, 1244, 1168, 1139, 1084; 8H 
(60 MHz, CDCI 3), 2.56 (3H, s, Ar-CH 3), 2.90 (2H, t, J 3, CH 2CN), 3.48 (2H, t, 
J 6, TS-CH 2), 8.16-7.40 (4H, q, Ar-H, A 2 132); m/z 210 [(M + 1), 29.5%], 183 
[(M - CN), 4.8], 139, 123, 91, 54. 
The acidic extract from above was basified with Na 2CO3 to pH 9-11 and 
extracted with EtOAc (10 cm 3 X 3). The organic extract was washed with 
brine (10 cm 3 X 2), dried and evaporated to give a solid which was 
crystallized from ether to give 3-78 as pale yellow crystals (0.262 g, 28.22%). 
m.p. 130-131.5°C; Vmax (nujol)/cm 1 3260 (NH), 1674 (C0), 1580, 1395, 
1294, 1115; 8H(60  MHz, CDCI3)2.0 (4H, m, 8-H, 9-H), 3.15 (4H, m, 7-H, 10-
H), 3.90 (3H, s, COOCH 3), 6.70-6.34 (2H, 3-H, 5-H), 9.40 (IH, brs, NH); m/z 
195 [(M + 1), 94.3%], 194 (M, 100), 193 [(M - 1), 31.7], 179 [(M - CH 3), 
2.6], 163 [(M - OCH 3), 31.3], 135[(M - COOCH 3), 14.3]. 
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N-Methyl-4-(N-pyrrolidinyl)-2-methoxycarbonyl pyrrole 3-80 
A solution of 3-33 (0.299 g, 1.0 mmol) and pyrrolidine (0.5 cm) in Et20 (20 
cm3) was heated at reflux for 1 h, then evaporated to dryness. The residue 
and CH 3I (0.5 cm) were dissolved in a mixture of CH 2Cl2-Et20 (1:1, 10 cm) 
and heated at reflux for I h, and then evaporated to dryness. The residue 
was dissolved in CHCI 3 (20 cm3) and extracted with aq. HCI (2 M, 5 cm 3 X 4). 
The acidic extract was basified with aq. Na 2CO3 (10%) to pH 9-11, extracted 
with EtOAc (10 cm 3 X 4) and the extract was washed with brine (5 cm 3 X 2), 
dried and evaporated to give 3-80 as a pale yellow solid (0.129 g, 62%). m.p. 
203-204°C; vmax/cm 1 1722 (C=O), 1688, 1485, 1480, 1433, 1375, 1353, 
1291, 1215; 8H  (60 MHz, D20) 2.34 (4H, m, 8-H, 9-H), 3.54 (3H, s; N-CH 3), 
3.92 (3H, s, COOCH 3), 4.06 (4H, m, 2-H, 10-H), 7.26 (IH, d, J 2, 5-H), 7.60 
(IH, d, J 2, 3-H); m/z 209 [(M + 1), 60.7%], 177 [(M - OCH 3), 18.4], 150, 
135, 109, 91. 
4-(N-pyrrolidinyl)-2-propionylpyrrole 3-82 
A solution of 3-58 (0.201 g, 0.68 mmol) and pyrrolidine (1.0 cm) in benzene 
(20 cm) was heated at reflux for I h, then evaporated to remove the 
solvents. The residue was dissolved in ether (30 cm 3) and extracted with aq. 
HCI (2 M, 5 cm 3 X 3). The acidic extract was basified with Na2CO3 to pH 9-
11, extracted with CHCI 3 (10 cm 3 X 3). The organic extract was washed with 
brine (8 cm 3 X 2), dried and evaporated to give a solid which was crystallized 
from ether to give 3-82 as colourless crystals (0.092 g, 70.49%). m.p. 118.0-
120.50C; vmaxlcm 1  3272 (NH), 1635 (C=O), 1581, 1487, 1406, 1215, 916; 8H 
(60 MHz, CDCI 3) 1.38 (3H, t, J 7, CH2CH3), 2.12 (4H, m, 10-H, 11-H), 2.96 
(2H, q, J 7, CH2CH3), 3.28 (4H, m, 9-H, 12-H), 6.65 (IH, d, J 1.2, 3-H), 6.68 
(1H, d, J 1.2, 5-H), 10.10 (1H, brs,NH), mlz 193 [(M + 1), 83.2%], 192 (M, 
100), 191 [(M - 1), 87.8], 163 [(M - Et), 8.8), 135 [(M - COEt), 23.3]. 
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NBenzyl-4-oxo-2-hydroXymethylPYrrOIidine 3-83 
Dry HBr was passed through a solution of 3-64 (4.727 g, 18.96 mmol) in 
MeOH (30 cm 3) at r.t. for 20 mm.. The mixture was heated at reflux for I h, 
then evaporated to give a residue which was dissolved in water (50 cm 3) and 
extracted with ether (10 cm 3  X 2). The aqueous layer was basified with aq. 
Na2CO3  (10%) to pH 9-11 and extracted with EtOAc (20 cm 3 X 3). The 
extract was washed with brine (15 cm 3 X 2), dried and evaporated to give 3-
83 as a pale yellow oil (3.58 g, 90%). [a]D2° -53.2 10  (c, 0.39, MeOH); vmax/cm 
1 (OH), 1725 (C0), 1494, 1435, 1400, 1186, 1137, 1055, 1030; 8H (60 
MHz, CDCI 3) 2.66-2.46 (2H, m, 3-H, ABX), 2.82 (1H, s, OH), 2.86 (IH, q, J 
15.0, 5-H, AB), 3.37 (IH, q, J 15.0, 5-H, AB), 3.2 (IH, m, 2-H, ABX), 3.47 
(IH, q, J 13.5, ph-CH, AB), 4,23 (1H, q, J 13.5, Ph-CH, AB), 3.94-3.70 (2H, 
d-d, J 3.0, 10.0, 6-H), 7.40 (5H, s, Ar-H); 8c(SO MHZ, CDCI 3) 39.7 (C-3), 57.5 
(C-5), 59.9 (PhCH 2), 61.7 (C-6), 62.0 (C-2), 127.5, 128.3, 128.5 (5 X Ar-CH), 
138.8 (Ar-C), 212.8 (C=O); m/z 206.11895 [(M + 1), C 12 H 16NO2 MH 
requires: 206.11810], 188 (M - OH), 174 (M - CH 20H). 
N-Benzyl-4-oxo-2-acetoxypyrrOlidifle 3-84 
3-83 (0.402 g, 1.96 mmol) was converted to 3-84 (0.359 g, 74.25%) using 
the same method as that for preparation of 3-40 from 3-24. The product was 
a pale yellow oil which changed to a brown colour on standing. vmax/cm 
1755 (C=O), 1741 (C=O), 1494, 1453, 1432, 1387, 1369, 1230, 1185, 1141, 
1042; oH (60 MHz, CDCI3) 2.06 (3H, s, COCH3), 2.49-2.30 (2H, , 3-H, ABX), 
2.74 (1H, q, J 17.7, 5-H, AB), 3.32 (1H, q, J 17.7, 5-H, AB), 3.31 (1H, m, 2-H, 
ABX), 3.44 (IH, q, J 12.6, Ph-CH, AB), 4.19 (IH, q, J 12.6, Ph-CH, AB), 4.4-
4.2 (2H, d-d, J 1.6, 5, 6-H), 7.30 (5H, s, Ar-H); mlz 248.12951 [(M + 
C14H 18NO3 MH requires: 248.12867], 174 (M - CH 20Ac). 
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(S)-N-Boc-Alaninal 4-18 
A.) A solution of 4-27 (24.769 g, 141.35 mmol) in CH 2Cl2 (120 cm) was 
dropped slowly into a solution of oxalyl chloride (18.10 g, 142.60 mmol) and 
DMSO (22.3 g, 285.4 mmol) in CH 202 (240 cm3) at -78°C under argon with 
vigorous stirring. After stirring at -78 °C for 5 mm, Et3N (45 cm) was slowly 
added with stirring, the temperature allowed to rise to r.t. and water (100 
cm3) was added. The organic layer was separated, washed with aq. HCl 
(0.5M, 50 cm 3 X 2), aq. Na2CO3 (5%, 50 cm3 X 2) and brine (50 cm3 X 2), 
then dried and evaporated to give a residue which was dissolved in EtOAc 
(100 cm3) and passed through a short silica gel column which then washed 
with EtOAc (30 cm). The total eluate was evaporated to give a residue 
which was crystallised from Et 20 to give 4-18 as colourless crystals (18.243 
g, 74.5%). m.p. 89.5-90.5 0C; (Found: C, 55.69, H, 9.02, N, 8.54, C 8 H 15NO3 
requires: C, 55.47, H, 8.73, N, 8.09%); [aID2° -36.590 (C, 1.01, MeOH), vmax 
(nujol)/cm 1 3331 (NH), 2723, 1729 (C=O), 1680 (C=O), 1534, 1368, 1313, 
1251, 1167, 1059; 5 H  (60 MHz, CDCI3), 1.38 (3H, d, J 7Hz, CH-CH), 1.50 
(9H, s, Boc), 4.24 (IH, dq, J 7, 7, NH-CH-CH 3), 5.23 (IH, brs, NH), 9.68 (IH, 
s, CHO); oH (200 MHz, CDCI3) 1.25 (3H, d, J 7.4, CHCH3), 1.37 (9H, s, Boc, 
3 X CH3), 4.12 (1H, brt, J 7.1, CHCH3), 5.24, (IH, brs, NH), 9.48 (1H, s, 
CHO); 0c  (50 MHz, CDCI3) 14.63 (CH 3), 28.11 (3XCH 3 , Boc), 55.34 (CH), 
79.89 (C, Boc), 146.74 (C=O, Boc), 199.69 (CH=O); m/z 174.11299 [(M+1), 
C8 H 16NO3 MH requires:174.11302], 174 [(M+1), 61.1%], 118 [(M-55), 80.6]. 
B). To a solution of 4-25 (0.301 g, 1.12 mmol) in dry THE (10 cm 3) was 
added LiAIH4 (0.028 g, 0.74 mmol) with stirring under argon at -78 °C. The 
mixture was stirred for 3 h at -78 °C, quenched by adding water (5 cm 3) then 
diluted with CH 2Cl2 (50 cm3) and warmed to r.t.. The organic phase was 
washed with aq. HCl (1M, 10 cm 3 X 2), aq. Na2CO3 (5%, 10 cm3 X 2) and 
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brine (10 cm 3 X 3), dried and evaporated to give a residue which was 
crystallised from Et 20 to give 4-18 as colourless crystals (0.117 g, 60%). 
(3RS,4S)-4-t-Butoxycarbonylamino-3-hydroxypentaflOiC acid, ethyl ester 
4-19 
A solution of 4-18 (0.152 g, 0.879 mmol) and ethyl bromoacetate (0.584 g, 
3.49 mmol) in Et20 (5.5 cm
3
) was slowly dropped into a suspension of Zn 
powder (0.236 g, 3.61 mmol) and 12 (- 10 mg) in dry Et20 (1 cm3) at r. t. 
under argon with efficient stirring. The mixture was warmed to 30-35 °C for 
0.5-1 h, then cooled to 0 °C, diluted with Et20 (15 cm 3) and stirred with aq. 
H2SO4 (10%, 5 cm3) at r.t. for lh. The Et20 layer was seperated, then 
washed with aq. HCI (2 M, 5cm 3), aq. Na2CO3 (10%, 5 cm 3 X 2) and brine (5 
cm3 X 3), dried and evaporated to give a residue which was purified by 
column chromatograph on silica gel. The column was washed with CHCI 3 (80 
cm3), then CHCI 3-EtOAc (4:1) from which 4-19 was obtained as a colourless 
oil (0.167 g, 73%). vmax/cm 1 3433 (NH), 3390 (OH), 2977, 2933, 1713, 
(C=O), 1639 (C=O), 1617, 1515, 1360, 1246, 1169, 1028; 8H  (60 MHz, 
CDCI3), 1.34 (3H, t, J 7.2,-CH2 CH3), 1.7-1.4 (12H, t, Boc, CH-CH3), 2.58 
(2H, d, J 6.5, 2-H), 3.96-3.5 (2H, m, OH, 3-H), 3.26 (2H, q, J 7.2, CH2CH3)
1 
 
4.3-4.0 (IH, m, 4-H), 5.05 (IH, d, J 9.5, NH); 8 c (50 MHz, CDCI 3) 13.91 
(CH 3), 14.87 (CH 3), 28.15 (3XCH 3, Boc), 38.60 (CH 2), 49.57 (CH), 60.60 
(CH 2), 70.35 (CH), 79.14 (C, Boc), 155.71 (C=O, Boc), 172.88 (C=O); m/z 
262.16607 [(M4-1), C 12 H 24N05 MH requires: 262.16545], 261 (M, 37.2%), 
206 [(M - 55 ), 71.9], 188 [(M - t-BuO)+, 48.7], 186 [(M - Bu - H2O), 56.5], 
160 [(M - Boc), 58.8]. 
136 
(3RS,4S)4-t-Butoxycarbonylamino-2,2-diflUOrO-3-hydrOXyPefltaflOiC 
acid, ethyl ester 4-20 
A solution of 4-18 (0.520 g, 3.0 mmol) and ethyl bromodifluoroacetate (1.738 
g, 8.56 mmol) in dry Et20 (15 cm3) was slowly dropped into a suspension of 
zinc powder (0.784 g, 12 mmol) and 1 2  (- 20mg) in dry Et20 (5 cm ) at r. t. 
under argon with efficient stirring. The mixture was warmed to 30-35 °C for 
10-20 mm, then worked up using the same method as that used in the 
preparation of 4-19 from 4-18 to give 4-20 as a colourless oil (0.581 g, 65%). 
vmax/cm 1  3438 (NH), 3393 (OH), 2980, 2937, 1766 (C0), 1682 (C=O), 
1510, 1453, 1392, 1370, 1320, 1306, 1165, 1085, 1015; 8 H  (60 MHz, CDCI 3) 
1.8-1.4 (12H, brs, Boc, CHCH3), 4.42 (2H, q, J 7.2, CH2 CH3), 4.68-3.8 (2H, 
m, OH, CHCH3), 4.84 (IH, d, J 6.2, 3-H), 5.32 (IH, d, J 8.5, NH); oH  (200 
MHz, CDCI3) 1.34 (3H, t, J 7.1, CH2 CH3)
1 
 1.41 (9H, s, Boc, 3XCH 3), 1.43 
(3H, d, J 8.1, CHCH), 4.01-3.87 (2H, m, 3-H, 4-H), 4.32 (2H, q, J 7.1, 
CH2CH3), 4.84 (H, d, J 8.0, NH); O (50 MHz, CDCI 3) 13.6 (CH2CH3), 18.0 
(CHCH), 28.0 (Boc, 3XCH 3), 45.7 (CH-CH 3), 62.8 (CH2CH 3), 73.6 (C-3, t, 
CF' 24.6, 26.4), 79.9 (Boc, C), 114.2 (C-2, q, 1CF, 254.4, 258.9), 156.1 
(C=O), 163.3 (C=O, q, CF, 30.2, 32.1); m/z 298.14621 [(M + 1), 
C 12 H22 F2N05 MH requires: 298.14660], 298[(M + 1)t 51.6%], 280 [(M - 
OH), 3.3], 242 [(M -55), 88.6], 224 [(M - OBut)+, or (M - COOEt), 13.8], 
280 [(M-OH), 3.3], 198 (94.7), 180 (7.9), 196 [(M - Boc)t 14.1], 153 (12.1), 
92 (17.2), 60 (100). 
(S)-4-t-Butoxycarbonylamino-3-OXOPefltaflOiC acid, ethyl ester 4-21 
Jones reagent (1 cm3 , —8 mmol) was slowly added to a solution of 4-19 
(0.234 g, 0.895 mmol) in acetone (40 cm 3) at r.t with stirring. After stirring at 
r.t. for 2 h, MeOH (10 cm 3) was added and the mixture was stirred for 0.5 h, 
then evaporated to remove the solvents. The residue was dissolved in water 
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(20 cm3), then extracted with EtOAc (10 cm 3 X 3). The combined extract was 
washed with aq. Na 2CO3 (8 cm3) and brine (8 cm 3 X 2), then dried and 
evaporated to give a residue which was purified by silica gel column 
chromatography eluting successively with CHCI 3 and CHCI3-EtOAc (8:1). 
After evaporation, 4-21 was obtained from the CHCI 3-EtOAc eluate as a 
colourless oil (0.508 g, 46.67%). [a]020 -3.370 (C, 2.07, CHCI3); vma1cm•1 
3364 (NH), 2979, 2935, 1746 (C=O), 1714 (C=O), 1509, 1367, 1249, 1166, 
1026; 8H  (60 MHz, CDCI 3) 1.32 (3H, t, J 7.2, CH2 CH3), 
1.70-1.40 (12H, brs, 
Boc, CHCH), 3.62 (2H, s, 2-H), 4.26 (2H, q, J 7.2, CH2CH 3), 4.6-4.3 (IH, m, 
CHCH3), 5.44 (IH, brd, J 9.5, NH); & (50 MHz, CDCI 3) 13.83 (CH 3), 16.68 
(CH 3), 28.05 (3XCH 3 , Boc), 45.59 (CH 2), 55.19 (CH), 61.25 (CH), 79.81 (C, 
Boc), 155.00 (C=O, Boc), 166.79 (C=O, COOEt), 202.42 (C=O); m/z 
260.14860 [(M+1), C 12 H 22N05 MH requires: 260.14980], 260 [(M + 1), 
42.2%], 204 (M - 55), 93.9], 186 [(M - t-BuO)+, 17.8], 160 (89.4), 158 [(M - 
Boc), 21.7]. 
(S)4NtButoxycarbonylamino-3-oxo-2,2-diflUOrOPefltaflOiC acid, ethyl 
ester 4-22 
A solution of 4-20 (1.957 g, 6.58 mmol) in dry CH 2Cl2 (30 cm3) was slowly 
dropped into a solution of oxalyl chloride (0.7 cm 3, 8.02 mmol) and DMSO 
(1.4 cm3, 19.72 mmol) in dry CH 2Cl2 (30 cm3) at -78°C under argon with 
vigirous stirring. After stirring at -78 °C for 30 mm, Et 3N (2.5 cm3) was added 
and the mixture was allowed to warm to r.t. with stirring, then washed with 
aq. Na2CO3 (5%, 20 cm3 X 2), aq. HCI (1M, 20 cm 3 X 2) and brine (20 cm 3 X 
3), then dried and evaporated to give a residue which was purified on a silica 
gel column eluted with CHCI 3 and CHCI3-EtOAc successively. 4-22 was 
obtained as a colourless oil after evaporation of the CHCI 3-EtOAc eluate. 
(0.824 g, 42.4%). [aID 1.37
0 
 (C, 1.22, CHCI3); vma1cm1 3398 (NH), 1777 
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(C=O), 1766 (C=O), 1711 (C=O), 1512, 1506, 1454, 1369, 1310, 1249, 
1154, 1090, 1055, 1012; 8 H  (200 MHz, CDCI 3) 1.30 (3H, t, J 7.1, CH 2 CH3), 
1.37 (3H, d, J 8.9, CHCH), 1.38 (9H, s, Boc, 3XCH 3), 4.33 (2H, q, J 7.1, 
CH2CH3), 4.75 (IH, t, J 7.2, CHCH), 5.08 (IH, d, J 6.4, NH); ö (50 MHz, 
CDCI 3) 13.6 (CH2 CH3)
1 
 16.9 (CHCH), 28.0 (3XCH 3 , Boc), 51.5 (CHCH3), 
63.8 (CH2CH3), 80.3 (C, Boc), 108.3 (CF 2 , , 'CF' 264.0), 154.6 (C=O, Boc), 
160.7 (C=O, 	'CF -30], 196.9 (C=O, 	CF, 27.0); mlz 296.12994 [(M + 
C 12 H20F2N05  MH requires: 296.13095], 296 [( M + 1), 32.5%], 240 [(M - 
55)t 84.8], 222 [(M - t-BuO)+, 16.7], 196 (80.0), 194 [(M - Boc), 10.6], 178 
(11.1), 89(16.0), 60(100). 
(4RS,5RS)-1 -Benzyl-4-methyl-5-ethoxyCarbOflYlmethYl- 
tetrahyd roimidazolid-2-one 4-24 
A solution of 4-35 (0.264 g, 0.753 mmol) in trifluoroacetic acid (1 cm 3) was 
stirred at 0 °C for 10 mm, then evaporated under reduced pressure to remove 
the solvent. The residue was dissolved in toluene (10 cm 3) and stirred with 
aq. Na2CO3 (10%, 5 cm 3) and COd 2 (0.5 cm3 , 20% in toluene, ca I mmol) at 
r. t. for 10 h, then diluted with EtOAc (20 cm 3). The mixture was washed with 
aq. Na2CO3 (5%, 8 cm 3 X 2), aq. HCI (1 M, 8 cm 3 X 3), brine (10 cm 3 X 3), 
dried and evaporated to give a residue which was crystallised from Et 20 to 





0.406, MeOH); vmalcm1 3252 (NH) ; 1728 (C=O), 1695 (C=O), 1446, 1253. 
6H (200 MHz, CDCI 3) 1.20-1.07(6H, m, 4-CH 31  CH2CH), 2.58-2.41 (2H, m, 6-
CH 21  ABX), 3.48-3.45 (IH, m, 5-H or 4-H, ABX), 3.99-3.89 (IH, m, 4-H or 5-
H), 4.08-4.00 (2H, m, CH 2CH 3), 4.72-4.00 (2H, m, Ar-CH 2 , AB), 5.69-5.59 
(IH, d, NH), 7.26 (5H, m, Ar-H). oc  (50 MHz, CDCI 3) 13.86, 13.90 (CH2CH), 
15.88, 21.41 (C-8, CH 3), 32.47, 36.94 (C-6, CH 2), 45.08, 44.81 (CH2CH3), 
48.72, 51.29 (C-4 or C-5), 54.77, 58.74 (C-S orC-4), 127.22, 127.44, 127.57, 
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128.43 (5XPh-CH), 137.07 (Ph-C), 160.84, 161.93 (C=O), 170.33, 170.55 
(C=O). m/z 277.15503[(M + l)t C 15 H21 N203 MH requires: 277.15522], 231 
(M - OEt), 203 (M - COOEt)t 189 (M - CH2COOEt), 185 (M -Bz). 
(S)-1-(N-Boc-alanyl)-3,5-dimethylpyrazole 4-25 
A solution of N-Boc-L-alanine 4-17 (0.379 g, 2.0 mmol), 1,3-
dicyclohexylcarbodimide (DCC) (0.436 g, 2.12 mmol) and 3,5-
dimethylpyrazole (0.201 g, 2.1 mmol) in CH 2Cl2 (8 cm3) was stirred at r.t. for 
three days, then filtered and the solid was washed with Et 20 (20 cm 3) and 
filtered. The combined filtrate was filtered again, then washed with aq. 
Na2CO3 (5%, 5 cm3) and brine (5 cm 3 X 2), dried and evaporated to give 4- 
25 as a colourless oil (0.468 g, 87.4%). [a]D20  -12.90 (C, 1.01, MeOH); 
vma1cm1 3364 (NH), 1712 (broad C=O), 1586, 1515, 1504, 1453, 1388, 
1367, 1247, 1169; & (60 MHz, CDCI 3) 1.6-1.2 (12H, Boc, CH 3), 2.18 (3H, s, 
3-CH 3), 2.48 (3H, s, 5-CH 3),5.80-5.28 (2H, m, NH, CHCH3), 5.92 (IH, s, 4-
H); mlz 268 [(M + 1), 46.6%], 267 (M, 10.6), 266 [(M - 1), 16.6), 252 [(M - 
CH3), 4.2)], 212 [(M - 55), 44.3], 211 [(M - 56), 10.1], 210 [(M - 57), 
11.5), 194[(M -t-BuO)+, 24.4], 166[(M - Boc)t 15.7]. 
(S)-N-Boc-Alanine, methyl ester 4-26 
A solution of CH 2 N2  [ made from Diazald (50.8 g, 237 mmol)] in Et 20 (300 
cm3) was added to a solution of 4-17 (26.44 g, 139.75 mmol) in acetone (30 
3 	o 
cm ) at -78 C with stirring. The mixture was stirred at -78 C for 2 h, r.t. for 20 
h, then evaporated to give 4-26 as a colourless oil (28.33 g, 99.7%). The 
product was crystallised from Et 20 to give colourless crystals. m.p. 32- 
32.5
0
C; (Found: C, 53.25, H, 8.33, N, 7.08, C 9H 17N04 requires: C, 53.19, H, 
8.43, N, 6.89%); 1aID20  -44.83 (C, 1.01, MeOH); vmaIcm1 3323 (NH), 2978, 
1745 (C=O), 1713 (C=O), 1517, 1453, 1366, 1249, 1166, 1068; 8H  (60 MHz, 
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CDCI3) 1.60-1.35 (12H, d, J 7.2, Boc, CHCH), 3.80 (3H, s, COOCH), 4.26 
(1H, q, J 7.2, CHCH 3), 5.10 (1H, brs, NH); & (50 MHz, CDCI 3) 18.42 (CH 3), 
28.11 (3XCH 3, Boc), 48.95 (OCH3), 52.11 (CH), 79.62 (C, Boc), 154.92 
(C=O, Boc), 173.68 (C=O); mlz 204.12393 [(M+1), C 9 H 18N04 MH requires: 
204, 123581, 204 [(M+1), 80%1, 148 [(M-55), 100]. 
(S)-2-t-Butoxycarbonylaminopropanol 4-27 
To a solution of 4-26 (28.33 g, 139.39 mmol) in THF (200 cm 3), LiBH4 (1.93 
g, 84.18 mmol) was added with stirring at 0 °C. The mixture was stirred at 
0°C for 10 h, then water (18 cm 3) was added and stirring continued for 8 h. 
The mixture was diluted with Et20 (100 cm3), then filtered. The solid was 
filtered and washed with acetone (50 cm 3 X 2). The combined filtrate and 
washings were evaporated to give a residue which was disolved in CH 2Cl2 
(50 cm 3) and passed through a short silica gel column which was washed 
with EtOAc (80 cm
3 
 ). The combined eluate was evaporated to give a residue 
which was crystallised from Et20 to give 4-27 as colourless crysyals (22.558 
g, 92.3%). m.p. 59.5-60.5 °C; (Found: C, 54.75; H, 9.58; N, 8.45. C 8H 17NO3 
requires: C, 54.84; H, 9.78; N, 7.99%); [aID20  -7.720 (C, 1.0, MeOH); Vmaxlcm 
3391 (NH), 2975, 2932, 2876, 1687(C=O), 1523, 1366, 1249, 1171, 1065; 8H 
(60 MHz, CDCI 3) 1.26 (3H, d, J 7, CHCH3), 1.56 (9H, s, Boc), 3.44 (1H, brs, 
OH), 4.1-3.5 (3H, m, CHCH3, CH20H), 5.08 (IH, brs, NH), (peaks at 3.44 
and 5.08 were exchanged by adding D 20); ö (50 MHz, CDCI3) 17.14 (CH 3), 
28.20 (3XCH3, Boc), 48.33 (CH), 66.68 (CH 2), 79.41 (C, Boc), 156.14 (C=O, 
Boc); m/z 176.12918 [(M+1), C 8H 18NO3 MH requires: 176.12867], 176 
[(M+1), 81.9%], 144(M-CH20H)t 120 [(M-55), 90.8], 103 [(M - t-BuQ)+, 
9.2]. 
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2,5-Di(2'-carboxyethylacetamide)-3,6-d imethyl-3,6-dihydro-1 ,4-diazine 
4-28 
A solution of 4-21 (0.523 g, 2.01 mmol) in trifluoroacetic acid (3 cm 3) was 
stirred at OOC for I h, then evaporated to remove the solvent. The residue 
was dissolved in a solution of potassium cyanate (0.324 g, 4.0 mmol) in 
water (8 cm3) and the solution was adjusted to pH 4-6 with aq. HCl (2 M), 
then stirred at r.t. for 6 h and heated at reflux for 1 h. The mixture was cooled 
to r.t., diluted with water (10 cm3) and extracted with EtOAc (10 cm3 X 4), 
which then was washed with brine (8 cm3 X 2), dried and evaporated. The 
residue was crystallised from Et20 to give 4-28 as crystals (0.093 g, 25%). 
m.p. 119.5-120.0°C; [ct]D20 00  ( c, 0.506, MeOH ) vmaxlcm 1 3321, 3270 
(NH2), 1735 (C=O), 1681 (C=O), 1637 (C=N), 1443, 1278, 1206, 1152, 1045; 
oH (200MHz, CDCI3) 1.21 (3H, t, J 7.1, CH2CH3), 1.36 (3H, d, J 6.6, 
CHCH3), 4.13 (2H, q, J 7.1, CH2CH3), 4.42 (1H, dq, J 6.6, CHCH3), 4.84 
(IH, d, J 1.7, 2'-H), 6.83 (IH, brs, NH2), 9.17 (IH, brs, NH2); Oc  (50 MHz, 
CDCI3) 14.19 (CH2CH3), 21.07 (CHCH3), 52.76 (CHCH3), 59.62 (CH2CH3), 
85.44 (C-2'), 158.40 (C=N), 159.05 (C=O), 168.16 (C=O); mlz 370 [(M + 2), 
37.6%], 369 [(M + 1), 7.1], 368 (M, 9.4), 324 [(M + 1) - EtO or M - 
CONH2], 294 (M - HCOOEt), 217, 185, 155, 139, 123. 
(3RS,4RS)3-BenzyIamino-4-N-t-butoxycarbonyIamiflOPefltaflOiC acid 
4-30 
Compound 4-21 (0.529 g, 2.04 mmol), benzylamine hydrochloride (1.5 g, 
10.4 mmol), benzylamine (0.5 cm 3 4.58 mmol) and NaBH 3CN (0.251 g, 3.99 
mmol) in MeOH (30 cm3) were heated at reflux for 5 h, then evaporated to 
remove the solvent. The residue was dissolved in water (30 cm 3), adjusted to 
pH 6-8 with conc. HCI, then extracted with EtOAc (10 cm 3 X 4). The 
combined extract was washed with brine (5 cm 3 X 2), dried and evaporated 
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to give a residue which was crystallised from Et 20 to give 4-30 as colourless 
crystals (0.164 g, 24.9%). m.p. 148.5 - 150.0 °C; [a]D2° 00 (C, 0.39, MeOH). 
Vmax (nujol)/cm 1  3325 (NH) 1680 (C=O) 1645 (C=O). 8H  [200 MHz, CDCI 3-
(CD3)2C0] 109 (3H, d, J 6.8, CH3), 1.37 (9H, s, Boc), 2.36 (2H, m, ABX), 
3.58(IH, m, CHCH), 3.89 (IH, m, H-3, ABX), 4.37 (2H, d, J 5.9, Ar-CH 2- 
NH), 4.56 (IH, m, Bz -NH), 5.39 (IH, d, J 7.6, B0cNH), 7.22 (5H, m, Ar-H), 
7.47 (IH, brs, COOH). 8C [50 MHz, CDCI3-(CD3)2C0] 13.67 (C-5), 26.52 
(Boc, 3xCH 3), 37.62 (C-2), 41.37 (ArCH 2), 48.83 (C-3), 69.84 (C-4), 77.04 
(Boc, C), 125.38, 125.86, 126.73 (Ar, 5XCH), 136.92 (Ar, C), 154.10 (Boc, 
C=O), 170.54 (COOH). mlz 323.19739 [(M + 1), C 17H27 N204 MH requires: 
323.19708], 279, 267 (M-56), 249 [M - t-BuQ]+, 223[(M - Boc) + 2), 206, 
178, 160, 133. 
(3RS,4RS)3-Benzylamino-4-N-t-butoxycarbOflyIamiflO-2,2- 
difluoropentanoic acid 4-31 
A solution of 4-22 (0.291 g, 0.98 mmol) and benzylamine (0.215 cm3, 1.97 
mmol) in benzene (20 cm3) was heated at reflux for 3 h, then evaporated to. 
remove the solvent. The residue and NaBH 3CN (0.20 g, 5.3 mmol) in MeOH 
(15 cm
3 
 ) were stirred ar r.t. for 20 h, then evaporated to give a residue which 
was dissolved in water (30cm 3) and stirred at r.t. for I h. The solution was 
adjusted to pH 6-8 with aq. HCI (2 M) and extracted with EtOAc (10 cm 3 X 3). 
The extract was washed with brine (10 cm3 X 2), dried and evaporated to 
give a residue which was crystallised from Et 20 to give 4-31 as colourless 
crystals (0.071 g, 20%). m.p. 167-168.5 °C; vm8x(nUjol)/Cm 1 3342 (NH), 1687 
(C=O), 1678 (C=O). 6H  (200 MHz, CD 3COCD3) 1.2 (2H, d, J 6.8, CHCH), 
1.39 (9H, s, Boc, 3XCH3), 3.94 (IH, m, H-4), 4.19 (IH, m, H-3), 4.43 (IH, q, 
J 15.0 ArCH2 AB), 4.50(1H, m BzNH), 4.54 (1H, q, J 15.0, ArCH 2 AB), 7.27- 
7.33 (7H, m, 5XAr-H, BocNH, COOH). & (50 MHz, CDCI 3) 14.12 (C-5), 
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26.75 (Boc, 3XCH 3), 41.50 (BzCH2), 45.00 (C-4), 70.80 (C-3, q, CF' 22.8, 
26.1), 77.18 (Boc, C), 112.89 (CF 2, q, 1JCF,  259.4, 280.2), 125.91, 126.32, 
127.40 (5XArCH), 136.98 (Ar-C), 154.02 (Boc, C=O), 162.51 (C-i, 
28.0). m/z 358.17094 (M, C 17H24 F2 N204 M requires: 358.17041), 302 (M - 
56), 284 (M - t-BuQ)+, 259 (M - Boc + 2), 241, 198. 
(RS)-3-Benzylamino-4-N-t-butoxycarbonylamiflO-2-efle-PefltaflOiC acid, 
ethyl ester 4-32 
Compound 4-21 (0.484 g, 1.90 mmol) and benzylamine (1 cm 3, 9.15 mmol) 
in benzene (20 cm 3) were heated at reflux for 6 h, then cooled to r.t. and 
diluted with EtOAc (30 cm). The mixture was washed with sat. aq . NH4CI 
(10 cm
3 
 X 3), water (10 cm
3 
 X2), dried and evaporated to give a residue 
which was crystallised from Et 20 to give 4-18 as colourless needles (0.61 g, 
91%). m.p.93.5-94.5 0C; [a]D20 00 (C , 054, CHCI3  ). vmajcm l  3338 (NH), 
2978, 1711 (C=0), 1649 (C=C), 1609 (C=0), 1497, 1366, 1250, 1171; oH 
(200 MHz, CDCI 3) 1.23 (3H, t, J 7.1, CH2 CH3), 1.24 (3H, d, J 6.3, CHCH3), 
1.40 (9H, s, Boc, 3XCH 3), 4.08 (2H, q, J 7.1, CH2CH3), 4.16 (IH, m, 4-H), 
4.48 (1H, d, J 6.1, 2-H), 4.62 (2H, d, J 14.3, Ar-CH2), 4.68 (1H, brs, NHBoc), 
7.29 (5H, m, Ar-H), 8.86 (IH, brs, NHBz). o (50 MHz, CDCI 3) 14.37 
(CH2 CH3), 20.19 (CHCH), 28.13 (Boc, 3XCH 3), 46.33 (CH2CH3), 58.48 (Ph-
CH2), 79.20 (C-4), 79.72 ( Boc-C), 81.46 (C-2), 126.97, 127.27, 128.59 
(5XAr-CH), 138.20 (Ar-C), 154.49 (C-3), 166.30 (C0), 170.79 (C0). m/z 
349.21580 [(M + 1), C20H29N204 MH requires: 349.21273], 303 (M - OEt)t 
293 (M -55), 275 (M -t-BuO)+, 247 (M - Boc), 231, 203, 186, 158. 
5-Methyl-4-benzylamino-1 -N-t-butoxycarbonyl-3-pyrrolin-2-one 4-33 
To a solution of 4-32 (0.568 g, 1.63 mmol) in Et 20 (15 cm 3) solid NaBH4 
(0.086 g, 3.94 mmol) was added at r.t. and the mixture was stirred for 20 h, 
144 
then water was added and stirring continued for 3 h. The mixture was filtered 
3 
and the solid was washed with Et 20 (8 cm x 2). The combined filtrate and 
washings were evaporated to give a residue which was dissolved in CH 2Cl2 
(20 cm
3  ) and passed through a silica gel column eluted with Et20 (10 cm
3
). 
The combined eluate was evaporated to give a residue which was 
crystallised from CH 2Cl2-Et20 (1:1) to give 4-33 as colourless crystals (0.214 
g, 53%). m.p. 154.5-155.5°C; [a]02° 00 (C, 1.02, CHCI3); vmaxlcm-1 3290 
(NH), 1743 (C=O), 1668 (C=C), 1611 (C=O), 1453, 1355, 1318, 1253, 1162, 
1101, 1085; 8 H  (200 MHz, CDCI 3) 1.45 ( 9H, s, Boc, 3 X CH 3
), 1.46 (3H, d, J 
6.5, CHCH), 4.22 (2H, d, J 5.6, CH2Ph), 4.44 (1H, s, C=CH), 4.45 (1H, q, J 
5.5, CHCH), 6.85 (1H, t, J 5.5, NHCH 2Ph), 7.18-7.13 (5H, m, Ar-H); 8 c (50 
MHz, CDCI3) 19.2 (5-CH 3), 28.0 (3 X CH 3, Boc), 48.0 (CH2Ph), 55.8 (C-5), 
81.2 (C, Boc), 86.3 (C-3), 127.0, 127.1, 128.3 (5 X Ar-CH), 137.2 (C, Ph), 
149.2 (C-4), 167.4 (C=O, Boc), 170.9 (C=O, C-i); m/z 303.17062 [(M + 1), 
C 17 H 23N 203  MH requires: 303.17087], 303 [(M + i), 42.4%1, 247 [(M - 55), 
65.0], 229 [(M - t-BuO)+, 50.7], 212 [(M - 91), 62.1], 202 [(M - Boc)t 46.3]. 
(RS)3BenzyIimino4N-t-butoxyCarbOflYlamiflOPefltaflOiC acid 4-34 
To a solution of 4-32 (0.656 g, 1.88 mmol) in dry THE (25 cm 3) solid LiAIH4 
(0.131 g, 3.4 mmol) was added at r.t and the mixture was stirred for 20 h, 
then water (0.2 cm 3) was added and stirring continued for I h. The mixture 
was filtered and the solid was washed with acetone (10 cm 3 X 2). The 
combined filtrate and washings were evaporated to give a residue which was 
purified by silica gel column chromatography eluting with CHCI 31  CHCI3- 
EtOAc (6:1) and CHCI 3-EtOAc (3:1) successively. 4-34 was obtained from 
the CHCI3-EtOAc (3:1) eluate as colourless crystals. (0.144 g, 23.87%). m.p. 
143.5-145.0°C; [a]020 0
1 
 (C, 1.03, CHCI3); vmax/Cm 1  3340 (NH), 3308 (OH), 
1720 (C=O), 1681 (C=O), 1644 (C=N), 1553, 1530, 1369, 1321, 1525, 1164, 
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1056; 8. (200 MHz, CDCI 3) 1.30 (3H, t, J 7.2, 5-CH 3), 1.40 (9H, s, Boc, 3 X 
CH 3), 3.50 (1H, q, J 16.9, 2-H, AB),3.56 (1H, q, J 16.9, 2-H, AB), 4.24 (1H, 
overlapping dq, J 7.1, 6.1, 4-H), 4.44 (2H, d, J 5.7, CH2Ph), 5.18 (IH, d, J 
6.1, NH), 7.32-7.24 (6H, m, COOH, Ar-H); & (50 MHz, CDCI3) 16.4 (C-5), 
28.1 (3 X CH 31  Boc), 43.5 (C-2), 45.4 (CH2Ph), 55.9 (C-4), 80.3 (C, Boc), 
127.2, 127.6, 128.5 (5XAr-CH), 137.6 (C, Ph), 155.3 (C-3), 165.1 (C=O, 
Boc), 205.9 (C-i); m/z 321.18083 [(M + 1), C 17 H 25N204 MH requires: 
321.18143 ], 321 [(M + 1), 44.9% ], 265 [(M - 55), 58.6 ], 247 [(M - t-
BuO)t 8.1], 219 [(M - Boc)t 11.8]. 
(3RS,4RS)-3-Benzylamino-4-t-butoxycarbOflylamiflOPefltaflOiC 	acid, 
ethyl ester 4-35 
Compound 4-32 (0.104 g, 0.299 mmol), NaBH 3CN (0.20 g, 3.18 mmol) and 
conc. HCI (0.1 cm 3) in MeOH (8 cm 3) were stirred at r.t. for 2 h, then water 
(10cm 3)  was added and stirred for I h. The mixture was evaporated to 
remove MeOH, diluted with aq. HCl (2 M, 10 cm 3) and extracted with Et20 
(10 cm3 X 2). The aq. phase was basified with Na 2CO3 to pH 10-12 and 
extracted with CH 2Cl2 (15 cm3X3). The combined CH 2Cl2 extract was 
washed with brine (10cm3 X 2), dried and evaporated to give 4-35 as a 
courless oil (0.095 g, 91%). [a]D20 00 (C, 0.40, MeOH); vmax/Cm 1 3364(NH), 
3348 (NH), 2976, 2931, 1726 (C=O), 1698 (C=O), 1496, 1366, 1246, 1169. 
H 
 (200 MHz, CDCI3) 1.07-1 .26 (6H, m, CH2CH3, CHCH), 1.41 (9H, d, Boc, 
3xCH 3), 1.50 (1H, brs, NH), 2.38-2.45 (2H, m, 2-H), 3.00-3.08 (IH, m, 3-H), 
3.69-3.80 (3H, m, Ar-CH 2, 4-H), 4.12 (2H, dq, CH 2CH3), 4.83 (IH, brs, NH), 
7.23-7.30 (5H, m, Ar-H). o (50 MHz, CDCI 3) 13.96 (CH 2CH), 17.81 
(CHCH), 28.17 (3XCH 3, Boc), 36.34 (C-2), 49.01(C-3), 52.40(CH2CH 3), 
58.17(C-4), 60.36 (PhCH2), 78.90 (Boc-C), 126.81, 127.98, 128.13 (5XAr- 
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CH), 140.15 (Ar-C), 155.36 (Boc, C0), 172.10 (C=O). m/z 351 (M + l), 
295 (M - 55), 275 (M - t-BuO + 2)t 248 (M - t-BUQH)+, 213, 186. 
(4RS,5RS)-1 BenzyI-4-methyI-5-(2-hydroxyethYI)-tetrahYdrO-imidaZOl id- 
2-one 4-36 
To a solution of 4-24 (0.0869 g, 0.31 mmol) in dry THF (8 cm 3) solid L1BH 4 
(0.014 g, 0.64 mmol) was added at r. t. with stirring. After stirring for 10 h, 
water (10 cm3) was added and the mixture was evaporated to remove the 
THE. The aq. solution was extracted with EtOAc (10 cm 3 X 4) and the 
organic extract was washed with aq. HCI (11M, 5 cm 3 X 2), aq. Na 2CO3 (5 cm 3 
X 3), brine (8 cm 3 X 2), dried and evaporated to give 4-36 as a colourless oil 
( 0.041 g, 56.3%). vmalcm1 3303 (OH), 3286 (NH), 1689 (C=O), 1681 
(C=O), 1450, 1359, 1260, 1090, 1026; 8H  (200 MHz, CDCI3) 1.10, 1.11 (3H, 
d, J 6.2, CHCH3), 1.71 (2H, m, 6-H), 2.84 (1H, brs, OH), 3.67-3.46 (4H, m, 4-
H, 5-H, 7-H), 3.97, 4.08 (1H, q, J 15.4, 15.6, Ph-CH2, AB), 4.63, 4.74 (IH, q, 
J 15.4, 15.6, Ph-CH 2 , AB), 5.12, 5.26 (IH, brs, NH), 7.23 (5H, m, Ar-H); 6 
(50 MHz, CDCI3) 16.0, 21.5 (5-CH 3), 29.8, 33.9 (C-6), 44.7, 45.0 (C-7), 49.2, 
50.8 (C-5 or C-4), 55.8, 59.8 (C-4 or C-5), 58.1, 59.0 (Ph-CH2), 127.1, 127.2, 
127.5, 127.7, 128.4 (5 X Ar-CH), 137.0, 137.3 (Ar-C), 161.3, 162.5 (C0); 
m/z 235 (M + 1), 219 (M - CH 3), 217 (M - OH), 203 (M - CH 2OH)+, 189 
(M - CH2CH2OH), 143 (M - Bz). 
(S)30BenzyIoxyimino-4-t-butoxycarbOflYlamifloPefltafloiC acid, ethyl 
ester 4-39 
A solution of 4-21 (2.143 g, 8.27 mmol), O-benzylhydroxylamine 
hydrochloride (1.272 g, 8.61 mmol) and Et3N (1.2 cm3, 8.62 mmol) in 
benzene (50 cm
3) was heated at reflux for 10 h, then cooled to r.t. and 
diluted with EtOAc (50 cm3). The mixture was washed with aq. HCI (1M, 
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10cm3), aq. Na2CO3 (5%, 10 cm 3) and brine (10 cm 3 X 2), then dried and 
evaporated to give a residue which was purified by silica gel column 
chromatography eluting with CHCI3 and CHCI 3-EtOAc (8:1) successively. 4- 
39 was obtained from the CHCI 3-EtOAc eluate as a colourless oil (2.863 g, 
95%). [a]D2°  -19.050 (C, 1.12, CHCI3); vmaxlcm 1 3366 (NH), 1737 (C=O), 
1713 (C=O), 1510, 1499, 1453, 1367, 1246, 1157, 1026; 8H  (200 MHz, 
CDCI3) 1.15 (3H, t, J 7.1, CH2CH3), 1.32 (3H, d, J 6.8, 5-H), 1.41 (9H, 
3XCH39  Boc), 3.26 (1H, q, J 15.9, 2-H, AB), 3.32 (1H, q, J 15.9, 2-H, AB), 
4.05 (2H, q, J 7.1, CH2CH3), 4.36 (IH, t, J 6.7, 4-H), 5.08 (2H, s, OCH2Ph), 
5.09 (IH, brs, NH), 7.29 (5H,m, Ar-H); 5 c (50 MHz, CDCI 3) 13.8 (CH 3), 18.4 
(C-5), 28.1 (3XCH3, Boc), 33.1 (C-2), 49.6 (C-4), 60.8 (OCH2CH3), 75.9 
(OCH2Ph), 79.3 (C, Boc), 127.5, 127.7, 128.0 (5XAr-CH), 137.3 (C, Ph), 
153.5 (C=O), 154.9 (C=N), 168.5 (C=O); mlz 365.20897 [(M + 
C19 H29 N205  MH requires: 365.20765], 365 [(M + 1), 29.6%], 309 [(M - 55)t 
49.6 ]' 265 (50.3). 
(S)30Benzyloxyimino-4-t-butoxycarbOflylamiflOPefltaf101 4-40 
To a solution of 4-39 (2.811 g, 7.71 mmol) in dry THF (60 cm 3) solid LiBH4 
(0.43 g, 15.42 mmol) was added at r.t. and the mixture was stirred for 24 h, 
then water was added and the stirring for I h. The mixture was filtered and 
the solid was washed with acetone (20 cm 3 X 2). The combined filtrate and 
washings were evaporated to give a residue which was purified on a silica 
gel column eluting with CHCI3 and CHCI3-EtOAc (4:1) successively. After 
evaporation of the CHCI 3-EtOAc elute, 4-40 was obtained as a pale yellow oil 
(2.30 g, 92.4%). [a]D
20  -37.11 0 (C, 0.32, CHCI3); vmax/Cm 1 3428 (OH), 3337 
(NH), 1688 (C=O), 1577, 1497, 1453, 1391, 1366, 1249, 1167, 1044; 6H  (200 
MHz, CDCI3) 1.23 (3H, d, J 6.8, 5-H), 1.37 (9H, 3XCH 3, Boc), 2.6-2.2 (2H, m, 
2-H), 3.73 (3H, m, 1-H, OH), 4.15 (IH, t, J 6.8, 4-H), 5.01 (2H, s, OCH2Ph), 
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5.56 (IH, d, J 6.9, NH); 6 ( 50 MHz, CDCI 3) 18.5 (C-5), 27.9 (3XCH 3, Boc), 
30.3 (C-2), 49.5 (C-4), 58.6 (C-i), 75.4 (OCH2Ph), 79.0 (C, Boc), 127.3, 
127.5, 127.8 (5XAr-CH), 137.3 (C, Ph), 155.2 (C=O), 159.0 (C=N); m/z 
323.19670 [(M + i), C17 H27 N204 MH requires: 323.19708], 323 [(M + 1), 
42.8%], 305 [(M - OH)+, 8.2], 267 [(M - 55)t 52.1], 249 [(M - t-BuO)+, 10.0], 
221 [(M - Boc)+, 11.9], 203 (12.6). 
(3RS,4S)-3-0-Benzyloxyimino-4-t-butoxCarbOflYlamiflOPefltaf101 4-41 
A solution of 4-40 (0.598 g, 1.85 mmol), NaBH 3CN (0.4 g, 6.36 mmol) and 
conc. HCI (Ca 0.2 cm3) in MeOH (15 cm3) was stirred at r. t. for 3 h, then 
water (10 cm 3) was added. The mixture was evaporated to remove MeOH, 
diluted with aq. HCI (2 M, 30 cm 3), then extracted with Et20 (20 cm 3 X 2). 
The aq. phase was basified with Na 2CO3 to pH 10-12 and extracted with 
CH2Cl2 (20 cm3 X 4) which was washed with brine (20 cm 3 X 2), dried and 
evaporated to give 4-41 as an oil (0.267 g, 44.2%). [a]D20  -1.20 (C, 2.5, 
CH30H); vmaxlCm 1 3427 (OH), 3348(NH), 1692(C=O), 1498, 1453, 1365, 
1247, 1168;6H  (200 MHz, CDCI 3) 1.14 (3H, d, J 6.8, CHCH), 1.42 (9H, s, 
Boc, 3XCH0 1  1.65 (2H, m, 2-H), 2.98 (IH, brs, OH), 3.67 (IH, brs, 3-H), 3.70 
(2H, m, 1-H), 3.84 (IH, m, 4-H), 4.68 (2H, d, J 2.9, ArCH 2), 4.94 (IH, brs, 
NH), 5.88 (IH, brs, NH), 7.32 (5H, m, Ar-H). E (50 MHz, CDCI 3), 18.18 (5-
CH 3), 28.23 (Boc 3XCH 3), 31.19 (2-CH 2 ), 48.65 (4-CH), 61.27 (1-CH 2), 63.37 
(3-CH), 76.17 (Ar-CH 2), 79.04 (Boc, C), 127.85, 128.28 (5XAr-CH), 137.08 
(Ar-C), 155.56 (C=O). m/z 325 (M + i)+ , 269 (M - 55), 251 (M - t-BuO), 225 
(M - Boc), 180 (M -BocNHCHCH 3), 163, 91. 
(3S,4S)-3-Hydroxy-4-t-butoxycarbonylaminOpeflt-1 -ene 4-43 
To a solution of 4-18 (1.728 g, 9.97 mmol) in dry THF (20 cm 3) 




C under argon with stirring. After stirring at -78
0
C for I h and at 0 °C for 
0.5 h, sat. aq . NH4CI (5 cm3) was added. The mixture was extracted with 
CH2Cl2 (15 cm3 X 3) which was washed with aq. HCI (2 M, 5 cm 3 X 2), aq. 
Na2CO3 (5%, 5 cm 3 X 2), brine (8 cm 3 X 3), dried and evaporated to give 4- 
43 as a colourless oil (2.007 g, 100%). vmaIcm1 3446 (OH), 3352 (NH), 
1690 (C0), 1509 (C0), 1392, 1367, 1249, 1170; m/z 201.13807 (M t , 
C 10H 19 NO3  M requires: 201.13649), 184 (M - OH)+, 183 (M - H2O), 146 (M 
...55)+, 129 (M - t-BuQH)+, 102 (M - Boc). 
(S)-4-t-Butoxycarbonylaminopeflt-1 -en-3-one 4-44 
To a solution of 4-43 (1.663 g, 8.26 mmol) in acetone (50 cm 3) Jones 
reagent (5 cm 3 ca 40 mmol) was added at 0 °C with stirring. After 20 mm, 
MeOH (10 cm3) was added and the solution stirred for 30 mm. After 
evaporation, the mixture was extracted with CH 2Cl2 (30 cm 3 X 3) which was 
then washed with aq. Na 2CO3 (5%, 20 cm 3), brine (20 cm 3 X 2), dried and 
evaporated to give 4-44 as a colourless oil (1.646 g, 56.6%). A crystalline 
sample was obtained by crystallising 4-44 from Et 20-pentane (1:3). m.p. 61- 
62.5°C; [a]D20  -30.890 (C, 1.04, MeOH). vmaxlCm 1 3332 (NH), 2974, 1707 
(C=O), 1698 (C=O), 1612 (C=C), 1520, 1364, 1283, 1178. 6H (200 MHz, 
CDCI 3) 1.33 (3H, d, J 7.2, CHCH), 1.43 (9H, Boc, 3XCH 3), 4.62 (IH, dq, J 
7.2, CHCH), 5.34 (1H, brs, NH), 5.87 (IH, q, J 11.4, JBX  17.4, 2-H, ABX), 
6.37 (IH, q, J BX 17.4, J BA  11.5, 1-H, ABX), 6.43 (1H, q, J 11.4, J AB  11.5, 1- AX 
H, ABX); mlz 200.12850 [(M + 1), C 16H 18 NO3  MH requires: 200.12867], 144 
(M - 55), 128 (M - t-BuO)+, 100 (M - Boc) 
(4RS,5S)4Hydroxy4vinyl-5-t-butOXYCarbOflYlamiflOheX -1 -ene 4-45 
To a solution of 444 (0.094 g, 0.47 mmol) in dry THF (3 cm 3) a solution of 




C under argon with stirring. After stirring at -78 °C for 30 mm, sat. aq . 
NH4CI (1 cm 3) was added and the solution was warmed to r.t.. The mixture 
was extracted with CH 2Cl2 (5 cm3 X3) which was washed with aq. HCI (IM, 
3 cm ), aq. Na2CO3 (5%, 3 cm), brine (5 cm X 2), dried and evaporated to 
give a residue which was purified by silica gel column chromatography using 
pentane, Et20-pentane (1:3) as eluates. 4-45 was obtained from the Et 20- 
pentane eluate as a colourless oil (0.108 g, 95%). [a]D20  -26.40 (C, 0.87, 
MeOH); vmaxlCm 1 3434 (OH), 3366 (NH), 1693 (C=O), 1641 (C=O), 1504, 
1453, 1366, 1248, 1168; 8. (200 MHz, CDCI3) 1.05, 1.13 (3H, d, J 6.8, 
CHCH3), 1.41, 1.38 (9H, s, Boc, 3 X CH3), 2.30 (2H, m, 3-H), 2.45 (1H, brs, 
OH), 3.67 (IH, m, CHCH3), 4.70 (IH, brs, NH), 5.13 (4H, m, 1-H, 8-H), 5.28 
(2H, m, 2-H, 7-H); 6 (50 MHz, CDCI3) 15.3, 16.1 (CH3), 28.2 (Boc, 3 X CH3), 
42.2, 42.5 (C-3), 52.1, 52.4 (C-5), 76.5 (C-4), 79.3 (Boc, C), 114.6, 114.9 (C- 
8 or C-I), 119.2, 119.3 (C-I or C-8), 132:9 (C-2 or C-7); m/z 242.17539 [(M + 
1), C 13 H24NO3 MH, requires: 22.17562], 223 (M - H2O), 186 (M - 55), 
168 (M - t-BuQ)+, 140 (M - Boc). 
(4S,5S)-4-Hydroxy-5-t-butoxycarbonylaminohex-1 -ene 4-46 
To a solution of 4-18 (1.734 g, 10 mmol) in dry THE (15 cm 3) allylmagnesium 
bromide (10.5 cm 3 , 1.0 M in Et20, 10.5 mmol) was added at -78 °C under 
argon with stirring. After stirring at -78 °C for I h and at 0°C for 2 h, sat. aq . 
NH4CI (5 cm3) was added. The mixture was extracted with CH 2Cl2 (20 cm 3 
X4) which was washed with aq. HCI (1 M, 10 cm 3 X 3), aq. Na2CO3 (5%, 10 
cm3 X 3), brine (10 cm 3 X 3), dried and evaporated to give 4-46 as a 
colourless oil (1.235 g, 57.3%). A crystalline sample was obtained by 
crystallising 4-46 from Et20-pentane (1:5). m.p. 87-88.50C. [a]D2° -5.140 (c, 
0.51, MeOH). vmaxlcm 1 3434 (OH), 3350 (NH), 1681 (CO), 1644 (C=C), 
1531, 1445, 1326, 1176. H  (200 MHz, CDCI3) 1.05 (3H, d, J 6.8, CHCH3), 
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1.38 (9H, Boc, 3XCH 3), 2.14 (2H, m, 3-H, ABX), 2.80 (IH, m, 4-H, ABX), 
3.64 (2H, brs, OH, NH), 4.96 (1H, m, 5-H), 5.04 (2H. m, 1-H, ABX), 5.77 (IH, 
m, 2-H, ABX). 8 c (50 MHz, CDCI 3) 14.17 (C-6, CH), 28.20 (Boc, 3XCH 3) 1  
38.15 (C-3, CH 2), 49.93 (C-5, CH), 73.08 (C-4, CH), 79.21 (Boc-C), 117.63 
(C-I, CH 2 )
1 
 134.40 (C-2, CH), 155.59 (Boc, C=O). m/z 216.15996 [(M + 1), 
C 11 H 22NO3  MH requires: 216.15997], 198 ( M - OH), 197 (M - H 2O), 160 
(M - 55), 144 (M - t-BuQ)+, 116 (M - Boc). 
(4S,5S)-4-Acetoxy-5-t-butoxycarbOflYlamiflOheX-1 -ene 4-47 
A mixture of 4-46 (1.13 g, 5.24 mmol), Ac20 (5 cm3) and Et3N (5 cm 3) was 
stirred at r. t. for 20 h, then poured into ice-water (100 cm 3) and stirred at r. t. 
for I h. An oily material separated and this was dried by evaporation under 
reduced pressure. The residue was purified by silica gel column 
chromatography using hexane (100 cm 3) and CH 2Cl2 as eluates. 4-47 was 
obtained from the CH2Cl2 eluate as a colourless oil (0.423 g, 31.3%). [aID2° - 
27.140 (C, 1.12 MeOH). vmax/Cfl1 1 3355 (NH), 2977, 2934, 1741 (C0), 1713 
(C=O), 1643 (C=C), 1518, 1453, 1367, 1238, 1168, 1025. 8H  (200 MHz, 
CDCI3) 1.05 (3H, d, J 6.8, CHCH3), 1.40 (9H, s, Boc, 3XCH 3), 2.01 (3H, 5, 
Ac), 2.27 (d-t, J 1.1, 6.8, 3-H), 3.8 (IH, brs, 5-H), 4.6 (IH, brd, NH), 4.85 (IH, 
m, C=CH2, ABX), 5.68 (IH, m, CH=C, ABX); 6, (50 MHz, CDCI 3) 18.43 (6, 
CH 3), 20.74 (CH 3CO), 28.17 (3XCH 3), 35.95 (3-CH), 47.74 (5-CH), 75.45 (4-
CH), 79.12 (Boc-C), 118.02 (1-CH 2), 132.93 (2-CH), 155.17 (C0), 170.29 
(C=O). m/z 258.17251 [(M + 1), C 13H 24N04  MH, requires: 258.17053], 214 
(M - Ac), 202 ( M - 55), 184 (M - t-BuQ)+, 156(M - Boc) 
(RS)-N-Boc-alaninal benzylimine 4-49 
A solution of 4-18 (3.20 g, 18.47 mmol) and BzNH2 (2.5 cm 3) in benzene (40 
cm3) was heated at reflux under argon for 1.5 h, and a Dean Stark water 
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separator was used to separate the water produced in the reaction. The 
mixture was evaporated and the residue was dissolved in Et20 (30 cm 3), 
then passed through a silica gel column. The column was washed with 
another 20 cm3 Et20 and the combined eluate was evaporated to give 4-49 
as a colourless oil (3.546 g, 73%). A crystalline sample was obtained by 
crystallising 4-49 from Et20-pentane (2:1). m.p. 52-54°C; [aID2° 00  (C, 0.97, 
CH2Cl2); vrnax/cm 1 3400 (NH), 2976, 1712 (C=O), 1670 (C=N), 1494, 1452, 
1390, 1366, 1246, 1168, 1064; 6H  (200 MHz, CDCI3) 1.32 (3H, d, J 7.0, 
CHCH3), 1.43 (9H, s, Boc, 3 X CH3), 4.28 ( IH, brs, CHCH3), 4.61 (2H, s, 
Ph-CH2), 5.67 (1H, brs, NH), 7.36-7.29 (5H, m, Ar-H), 7.73 (1H, brs, N=CH); 
m/z 263 (M + 1)+, 207 (M - 55)+, 173 [(M + 2) - Bz], 163 [(M + 1) - Boc]+. 
I -Bromo-6-benzyloxyhexane 4-53 
A solution of 1,6-dibromohexane (5.12 g, 20.3 mmol) and NaOBz (2.64 g, 
20.3 mmol) in dry THF (100 cm 3) was stirred at r.t. under argon for 3 days, 
then evaporated to remove the solvent. The residue was washed with aq. 
HCI (2 M, 10 cm 3 X 3), aq. Na2CO3 (10% 1  10 cm3 X 3) and brine (10 cm 3 X 
3), then distilled under reduced pressure to give 4-53 as a colourless oil 
(2.26 g, 39.7%). b.p. > 210 0/10 cmHg; vmaxlcm 1 3028, 2933, 2855, 1494, 
1453, 1361, 1306, 1203, 1102. 5. (200 MHz, CDCI 3) 1.48 (4H, m, 3-H, 4-H), 
1.67 (2H, brt, J 6.5, 2-H), 1.89 (2H, brt, J 7.0, 5-H), 3.42 (2H, t, J 6.8, 6-H), 
3.51 (2H, t, J 6.4, 1-H), 4.54 (2H, s, ArCH 2), 7.37 (5H, m, Ar-H); & (50 MHz, 
CDCI3) 25.09 (CH 2), 27.65 (CH 2), 29.26 (CH2), 32.41 (CH 2), 33.52 (CH 2), 
69.83 (CH 2), 72.53 (CH 2), 127.15, 127.25, 128.00 (5XPh-CH), 138.29 (Ph- 
C). m/z 273.06804 [(M + 1), C 13H 20081 Br MH requires: 273.06784], 
271 .06768 [(M + 1), C 13H20O79Br MH requires: 271.06975], 192 (M - Br)t 
181 (M + 1 - Bz). 
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I -(4-Methoxyphenyl)-7-benzoxyheptan-1 -one 4-54 
To a solution of p-anisaldehyde (0.268 g, 1.968 mmol) in dry THF (5 cm 3) a 
solution of BrMg(CH 2)6OBz in Et20 [8 cm3 , ca 2.6 mmol, made from 4-53 
(1.83 g, 6.74 mmol) and Mg (0.197 g, 8.1 mmol) in 20 cm 3 of Et201 was 
added at r.t. with stirring. After heating at reflux for 20 mm, the mixture was 
cooled to r. t., then Jones reagent (2 cm 3) was added and stirring continued 
for I h. MeOH (5 cm 3) was added to the reaction which was stirred for a 
further 30 mm, then evaporated to remove the solvents. The residue was 
extracted with CH2Cl2 (10 cm3 X 3) which was washed with aq. HCI (2 M, 5 
cm3X2), aq. Na2CO3 (10% 1  5 cm3X2), brine (10 cm 3X3), dried and 
evaporated to give 4-54 as a colourless oil (0.463 g, 72%). vmaxlcm 1 2933, 
2855, 1676 (C=O), 1600, 1506, 1454, 1362, 1257, 1170, 1104, 1028; 6H  (200 
MHz, CDCI 3) 1.40 (4H, m, 4-H, 5-H), 1.63 (2H, brt, J 6.8, 3-H), 1.73 (2H, brt, 
J 7.2, 6-H), 2.90 ( 2H, t, J 7.7, 2-H), 3.46 (2H, t, J 6.5, 7-H), 3.84 (3H, s, 
OCH3), 4.49 (2H, s, Ar-CH 2), 6.90-7.95 (4H, q, Ar-H, A 2 132), 7.32 (5H, m, Ar- 
H); 5c (50 MHz, CDCI3) 24.32 (CH2), 25.89(CH2), 29.03 (CH 2), 29.44 (CH 2), 
37098 (CH2), 55.32 (OCH), 70.14 (CH 2), 72.64 (CH 2)
1 
 113.45 (2)(Ar-CH), 
127.26, 127.41, 128.14 (5XArCH), 129.92 (Ar-C), 130.10 (2XAr-CH), 138.46 
(Ar-C), 163.09 (Ar-C), 198.88 (C=O); mlz 327 (M + 1), 235 (M - Bz)t 219 
(M - BzO or M - PhOCH 3). 
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Appendix 2. 1 H COSY 2-0 spectrum of compound 4-24 
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Appendix 3. Structures of compounds synthesised in this thesis 
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